Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3020630	s-prot	g/l (g/l)	27931	71494	0.02%
3020630	s-prot	— (—)	4097	5741	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

1182

3682

3.83

323.31

3.2

1.6

64.46

66.75

g/l

14.54

1126

3250

Malignant neoplasm

5180

17150

1.88

322.83

4.4

1.6

65.96

67.00

g/l

16.19

4833

15501

Atrial fibrillation and flutter with reimbursement

1707

3887

3.06

319.73

2.6

2.7

65.65

67.49

g/l

15.66

1579

3536

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

832

1384

5.04

315.45

2.3

3.1

66.02

65.79

g/l

0.28

777

1259

Other specified/unspecified arthritis

1817

7156

2.78

314.11

2.4

2.7

67.06

66.29

g/l

4.13

1676

6520

Benign neoplasm: Colon

3060

11312

2.23

313.28

2.5

1.6

65.98

67.02

g/l

10.53

2753

10133

Extracorporeal dialysis

695

1554

6.08

311.09

3.6

2.7

61.72

66.53

g/l

38.91

660

1432

Enlarged lymph nodes

1148

3544

3.65

310.38

2.5

2.4

66.57

67.01

g/l

0.98

1085

3207

Neurological diseases

4835

13259

1.91

308.93

2.3

2.7

66.84

66.42

g/l

2.91

4426

12148

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1883

3405

2.89

308.82

2.7

2.3

66.77

67.53

g/l

3.29

1746

3102

Inflammatory bowel disease treatment related agents

8616

19965

2.64

307.65

2.3

2.6

66.16

66.81

g/l

9.83

7937

18081

ILD medications

8934

18033

2.95

307.65

3.2

2.0

66.07

66.94

g/l

17.06

8238

16300

Codeine

5799

15507

2.16

307.65

2.3

2.2

66.59

66.78

g/l

0.94

5291

14151

Infections, IBD-co-morbidities

1226

1783

5.62

307.65

4.0

2.9

64.26

66.04

g/l

8.15

1123

1647

Dental caries

1886

6649

3.12

307.65

4.0

2.3

64.51

66.74

g/l

22.92

1765

6087

ILD medications: prednisolone, methylprednisolone, prednisone

8637

17926

2.96

307.65

2.5

2.0

66.03

66.93

g/l

17.61

7947

16197

Other diseases of blood and blood-forming organs, wide

1777

6396

3.19

307.65

3.2

2.5

65.64

66.45

g/l

3.58

1657

5809

Other and unspecified iron deficiency

2490

9731

2.86

307.65

2.2

2.5

65.72

66.30

g/l

2.87

2234

8696

Other and unspecified anaemias

4527

12789

4.15

307.65

2.9

2.4

65.52

66.25

g/l

6.46

4092

11404

Low back pain

4315

17079

2.05

307.65

2.7

2.5

66.63

66.39

g/l

1.29

3871

15601

Viral Sepsis

1491

5216

3.25

307.65

3.6

2.3

63.92

66.61

g/l

27.16

1377

4664

Tramadol

5390

14965

2.48

307.65

2.7

2.2

66.23

66.72

g/l

4.10

4855

13631

Autoimmune diseases excluding thyroid diseases

7084

18340

2.27

307.65

2.2

2.6

66.62

66.55

g/l

0.30

6553

16634

Explicit Sepsis

3361

12650

2.84

307.65

3.4

2.4

64.38

66.80

g/l

44.41

3072

11378

Acute renal failure

2227

5850

4.78

307.65

3.2

2.4

63.23

66.36

g/l

45.85

2078

5171

Any gastric operation

4925

9806

2.65

307.65

2.6

1.9

66.19

67.62

g/l

25.42

4541

8887

Asthma (only as main-diagnosis), excluding more controls

3766

10294

2.29

307.65

2.2

2.3

66.37

67.67

g/l

20.00

3444

9325

Glomerular disorders in diseases classified elsewhere

1368

3134

5.78

307.65

3.5

2.5

64.37

66.54

g/l

15.55

1284

2863

Other diseases of intestines

5978

19964

1.81

307.65

2.6

2.5

66.40

66.74

g/l

2.52

5434

18291

Polymyalgia rheumatica

1276

4142

3.77

307.65

2.1

2.6

66.07

65.91

g/l

0.31

1141

3661

Cardiovascular diseases (excluding rheumatic etc)

3314

7231

2.78

307.65

2.6

2.4

66.42

67.80

g/l

16.70

3095

6664

All pneumoniae

7025

21522

2.41

307.65

3.2

2.3

64.96

67.15

g/l

85.26

6487

19557

Pneumonia, organism unspecified

6511

20308

2.50

307.65

3.1

2.3

64.99

67.14

g/l

76.37

5987

18432

Other heart diseases, wide

5462

16583

2.15

307.65

2.6

65.92

67.27

g/l

27.93

5020

15170

Cardiovascular diseases

2896

6058

2.72

307.65

2.5

2.3

66.72

67.84

g/l

9.85

2711

5603

Hypothyroidism, levothyroxine purchases

1120

1602

4.22

307.65

2.7

1.4

66.57

68.54

g/l

11.03

1045

1494

Implicit bacterial Sepsis

3439

11680

3.08

307.65

3.0

2.4

63.86

66.75

g/l

67.36

3112

10464

Hypothyroidism (congenital or acquired)

1138

1606

4.27

307.65

2.7

1.4

66.47

68.53

g/l

12.14

1062

1497

Other pleural conditions

1217

2942

5.47

307.65

2.7

2.5

63.27

66.23

g/l

26.07

1154

2617

Autoimmune diseases related-to ILD

5277

24035

2.04

307.65

2.2

2.6

66.93

66.49

g/l

3.63

4859

21806

ILD medications: immunosuppressive drugs

5282

15131

3.77

307.65

4.8

2.1

65.79

67.01

g/l

21.34

4959

13731

Heart failure, not strict

6704

16169

3.24

307.65

2.7

2.6

64.69

67.20

g/l

100.09

6199

14638

Other systemic involvement of connective tissue

2407

8175

3.40

307.65

2.1

2.6

67.39

66.23

g/l

10.23

2179

7334

Pneumonias (Asthma/COPD co-morbidities)

7012

21468

2.43

307.65

3.2

2.3

64.97

67.16

g/l

85.55

6471

19507

COPD/asthma related infections

6190

17302

1.87

307.65

3.1

2.2

65.71

67.13

g/l

33.55

5705

15710

Cardiac arrhythmias

3290

10055

2.27

307.65

2.5

2.7

66.34

67.30

g/l

9.67

3021

9244

Primary_lymphoid and hematopoietic malignant neoplasms

3083

6852

5.98

307.65

9.1

1.6

65.95

66.84

g/l

5.63

2965

6100

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6475

17294

2.52

307.65

3.2

2.2

64.98

67.13

g/l

73.07

5985

15703

Second line medication for Crohn's disease

4142

16580

2.74

307.65

5.3

2.1

66.34

66.66

g/l

1.72

3873

15104

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1292

1185

43.29

307.65

8.8

1.5

69.58

66.63

g/l

21.48

1226

1051

Aplastic and other anaemias

4857

13721

4.04

307.65

3.1

2.4

65.43

66.29

g/l

9.68

4407

12257

Disorders of lipoprotein metabolism and other lipidaemias

5246

17471

2.00

307.65

2.6

2.5

66.07

66.79

g/l

8.70

4787

15832

Multiple myeloma

563

687

22.02

307.65

23.3

2.1

67.39

65.98

g/l

2.14

549

609

Chronic kidney disease

4095

8907

6.18

307.65

2.8

2.4

65.24

66.27

g/l

11.05

3805

7854

Hypertensive diseases (excluding secondary)

3060

6283

3.02

307.65

2.6

2.5

66.46

67.76

g/l

14.40

2864

5775

Glomerular diseases

2017

5124

4.97

307.65

3.4

2.5

63.66

66.53

g/l

35.93

1910

4669

Other and unspecified polyneuropathies, also in other diseases

2426

5826

5.60

307.65

2.3

2.5

67.28

66.05

g/l

12.35

2244

5239

Autoimmune diseases

6752

18404

1.96

307.65

2.3

2.6

66.60

66.54

g/l

0.19

6222

16693

Erysipelas

3589

15871

2.21

307.65

2.5

2.3

65.47

66.99

g/l

23.99

3261

14326

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4432

20499

2.16

307.65

2.6

66.06

66.43

g/l

2.22

4076

18487

Other bacterial diseases

7699

20231

2.89

307.65

3.2

2.3

64.95

67.12

g/l

84.14

7072

18323

Osteopathies and chondropathies

4067

16354

2.59

307.65

3.2

2.5

66.06

66.49

g/l

2.86

3596

14809

Codeine or tramadol medication

6926

21793

1.84

307.65

2.4

2.5

66.56

66.55

g/l

0.04

6315

19824

General symptoms and signs

7518

16044

2.50

307.65

2.7

2.4

66.16

67.10

g/l

17.23

6940

14539

Heart failure,strict

4552

12151

3.08

307.65

2.3

2.6

64.48

66.99

g/l

69.69

4198

10883

All-cause Heart Failure

4736

14634

2.61

307.65

2.3

2.6

64.50

66.61

g/l

53.02

4344

13083

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

2123

2165

29.97

307.65

13.2

1.4

68.39

66.41

g/l

14.90

2036

1900

Dialysis, with operation codes

1594

3190

6.80

307.65

4.2

2.4

62.58

66.73

g/l

62.91

1523

2891

Heart failure and bmi 25plus

2699

7733

2.70

307.65

2.3

2.8

65.13

66.88

g/l

22.31

2462

6905

Systemic connective tissue disorders

3174

10665

3.44

307.65

2.1

2.6

66.67

66.27

g/l

1.97

2883

9569

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

5073

16484

1.90

307.65

4.1

1.6

65.91

67.11

g/l

20.76

4738

14905

ILD differential diagnosis

4599

11614

2.07

307.65

2.7

2.3

66.23

67.39

g/l

17.45

4250

10519

Diabetic nephropathy, excluding more controls

1289

3280

3.95

307.65

2.7

2.3

65.00

67.09

g/l

15.70

1203

2938

Other anaemias

4556

12901

4.12

307.65

2.9

2.4

65.52

66.25

g/l

6.61

4120

11505

Other arthritis (FG)

2064

8024

2.81

307.65

2.4

2.8

66.91

66.38

g/l

2.44

1908

7324

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6869

21576

2.40

307.65

3.1

2.4

64.98

67.11

g/l

78.93

6335

19605

Osteoporosis

2285

7623

3.36

307.65

2.6

2.5

65.89

66.01

g/l

0.27

1955

6794

Anaemias

2123

1517

10.74

307.65

3.1

1.4

65.97

68.45

g/l

23.52

1973

1414

First line medication for Crohn's disease

8445

17368

2.86

307.65

3.3

1.9

66.00

67.07

g/l

24.20

7814

15664

Reimbursement for rheumatic diseases

3836

18264

2.25

307.65

1.9

2.7

66.80

66.44

g/l

2.01

3567

16454

Finngen Rheumatological endpoints

5955

16574

2.16

307.65

2.2

2.6

66.94

66.51

g/l

3.75

5435

15138

Unspecified kidney failure

1106

2601

5.54

307.65

3.1

2.3

64.51

66.19

g/l

7.98

1024

2298

Other diseases of pleura

4154

13679

3.10

307.65

2.4

2.6

64.51

66.46

g/l

40.90

3874

12251

Malignant neoplasm, wide definition for exclusion

5074

16485

1.90

307.65

4.1

1.6

65.90

67.11

g/l

20.89

4739

14906

6475

17294

2.52

307.65

3.2

2.2

64.98

67.13

g/l

73.07

5985

15703

Asthma, unspecified (mode)

3264

10816

2.55

307.65

2.3

66.12

67.35

g/l

15.75

2969

9774

Primary_lymphoid and hematopoietic malignant neoplasms

3083

7324

5.57

307.65

9.1

1.8

65.95

66.29

g/l

1.16

2965

6511

Multiple myeloma, excluding all cancers (controls excluding all cancers)

1074

1166

24.23

307.65

20.4

1.6

67.34

66.66

g/l

1.18

1052

1036

COPD differential diagnosis

4601

11617

2.07

307.65

2.7

2.2

66.23

67.39

g/l

17.51

4252

10522

Autoimmune diseases excluding thyroid diseases, strict definition

6854

17824

2.27

307.65

2.3

2.6

66.62

66.57

g/l

0.21

6339

16156

Pleural effusion

2093

4636

6.25

307.65

2.4

2.5

64.22

66.30

g/l

22.31

2011

4112

Diseases of arteries, arterioles and capillaries (FINNGEN)

1743

3741

3.61

307.65

2.5

2.7

65.12

67.53

g/l

25.22

1604

3401

Abnormal findings on examination of blood, without diagnosis

3435

14817

2.38

307.65

3.0

2.5

66.81

66.32

g/l

2.74

3151

13478

Hypertensive diseases

4707

12498

2.25

307.65

2.4

2.6

66.39

66.86

g/l

3.51

4382

11388

Non-rheumatic valve diseases

3185

10716

2.35

307.65

2.5

2.7

65.66

67.03

g/l

17.41

2910

9672

Used for control exclusion in common control thyroid runs

6327

17101

1.96

307.65

2.3

2.6

66.53

66.58

g/l

0.19

5824

15507

Bacterial infection, other or unspecified

4778

14750

3.35

307.65

3.6

2.3

64.31

66.92

g/l

76.20

4379

13248

Iron deficiency anaemia

3132

12867

2.67

307.65

2.2

2.5

65.53

66.35

g/l

6.21

2795

11522

Implicit Sepsis

5738

18335

2.67

307.65

2.7

2.4

64.69

66.99

g/l

74.04

5177

16617

Asthma

4461

11524

2.18

307.65

2.2

2.3

66.43

67.39

g/l

12.49

4096

10438

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9324

20094

3.77

307.65

2.8

2.4

65.79

66.83

g/l

24.61

8555

18200

Condition for Implicit Sepsis (Organ dysfunction codes)

6185

19514

2.49

307.65

2.6

2.4

65.02

67.06

g/l

64.91

5613

17718

Certain infectious and parasitic diseases

6112

15325

2.09

307.65

2.8

2.2

65.83

67.32

g/l

35.76

5632

13897

L04AD Calcineurin inhibitors

1053

2422

5.45

307.65

3.8

2.8

63.30

66.96

g/l

32.83

1009

2231

Multiple myeloma and malignant plasma cell neoplasms

1061

1320

20.80

307.65

20.5

1.9

67.34

66.24

g/l

2.57

1040

1191

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5904

20988

2.01

307.65

3.1

2.4

65.65

66.83

g/l

23.83

5426

19104

Hypothyroidism and >3 levothyroxin purchases

1120

1602

4.22

307.65

2.7

1.4

66.57

68.54

g/l

11.03

1045

1494

Malaise and fatigue

3597

11565

2.84

307.65

2.3

2.4

65.29

66.86

g/l

23.34

3219

10370

Asthma (only as main-diagnosis)

3890

11524

2.13

307.65

2.2

2.3

66.31

67.39

g/l

14.33

3549

10438

Other disorders of fluid, electrolyte and acid-base balance

2331

8856

2.85

307.65

2.8

2.4

64.59

66.41

g/l

19.47

2111

7890

Atrial fibrillation and flutter

1979

4594

3.03

307.65

2.7

2.6

65.74

67.62

g/l

18.71

1837

4193

Nephropathy related operations

1503

3362

6.03

307.65

4.3

2.5

62.35

66.51

g/l

62.51

1441

3064

Neurological diseases, wide definition

1531

2247

3.58

307.65

2.4

2.8

67.04

66.23

g/l

2.67

1418

2083

Polyarthropathies

5478

13469

2.97

307.65

2.7

66.35

g/l

0.02

5080

12275

Influenza and pneumonia

7250

21281

2.39

307.65

3.3

2.3

65.06

67.18

g/l

81.80

6694

19348

Bacterial Sepsis

3891

12866

3.05

307.65

3.1

2.4

64.17

66.81

g/l

61.96

3532

11558

Valvular heart disease excluding rheumatic fever

3207

10763

2.35

307.65

2.5

2.7

65.62

67.03

g/l

18.44

2932

9717

Polyneuropathies and other disorders of the peripheral nervous system

2642

6688

5.17

307.65

2.5

2.6

67.15

66.08

g/l

10.46

2448

5998

Non-ischemic cardiomyopathy

2372

7977

2.75

307.65

2.4

2.7

64.23

66.56

g/l

31.53

2165

7069

Oral corticosteroids

8417

19715

2.81

307.65

2.3

2.6

66.05

66.80

g/l

12.60

7727

17850

GASTRO-related operations

4925

9806

2.65

307.65

2.6

1.9

66.19

67.62

g/l

25.42

4541

8887

Parasetamol

4548

11042

2.19

307.65

2.6

2.3

66.56

66.90

g/l

1.87

4173

10161

L04AA Selective immunosuppressants

1678

5710

3.35

307.65

2.7

2.5

64.74

66.81

g/l

20.26

1593

5234

L04AX Other immunosuppressants

4079

16245

2.76

307.65

5.3

2.1

66.31

66.66

g/l

1.95

3815

14797

Oxycodone

2828

10365

2.96

307.65

4.8

2.3

64.98

66.40

g/l

15.29

2569

9364

Other pulmonary diagnosis

4661

11637

2.10

307.65

2.7

2.3

66.22

67.38

g/l

17.83

4295

10541

Headache

3573

13840

2.27

307.65

2.2

2.4

66.79

67.11

g/l

1.76

3284

12517

Hypertension, essential

4772

12310

2.35

307.65

2.5

2.6

66.50

66.86

g/l

2.29

4426

11215

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1168

2288

7.58

307.65

3.6

2.5

68.84

66.08

g/l

19.80

1061

2058

Dyspnoea

6144

22544

2.24

307.65

2.6

2.5

65.78

66.67

g/l

14.72

5584

20452

Septicaemia

3279

12069

2.93

307.65

3.4

2.3

64.39

66.81

g/l

42.94

2995

10810

Multiple myeloma and malignant plasma cell neoplasms

1061

1161

23.90

307.65

20.5

1.6

67.34

66.65

g/l

1.17

1040

1033

Secondary hypertension

726

1392

6.25

307.65

3.7

2.6

64.41

67.49

g/l

17.31

693

1262

Gout

2398

7750

3.24

307.65

3.5

2.7

65.52

65.97

g/l

1.81

2216

6971

Implicit viral Sepsis

1487

5207

3.25

307.65

3.6

2.3

63.90

66.60

g/l

27.14

1373

4655

Oedema, not elsewhere classified

2184

8302

2.89

307.65

2.5

2.4

65.17

66.75

g/l

14.91

1999

7414

Cerebrovascular diseases (FINNGEN)

1955

4794

3.16

307.65

2.3

2.6

65.92

67.64

g/l

15.41

1800

4385

Abnormalities of breathing

5675

15964

2.23

307.65

2.5

66.16

66.77

g/l

6.61

5180

14602

Fever of other and unknown origin

4529

13474

3.47

307.65

3.9

2.4

65.31

66.96

g/l

30.71

4229

12158

Pain in throat and chest

4757

15634

1.94

307.65

2.4

2.5

66.57

66.78

g/l

1.05

4302

14289

Metabolic disorders

6509

18890

2.29

307.65

2.8

2.5

65.85

66.86

g/l

18.66

5970

17164

Diseases of oesophagus, stomach and duodenum

6477

21927

1.88

307.65

2.4

2.6

66.28

66.63

g/l

2.84

5873

20001

Dentinal caries

1681

5920

3.15

307.65

4.1

2.3

64.50

66.74

g/l

20.43

1569

5426

Complications of surgical and medical care, not elsewhere classified

6000

23766

1.90

307.65

2.6

2.5

65.85

66.67

g/l

11.98

5452

21591

Excluding asthma or asthma-COPD overlap

4644

11637

2.09

307.65

2.7

2.3

66.24

67.38

g/l

16.97

4288

10541

Asthma, unspecified (mode), excluding more controls

3171

9679

2.75

307.65

2.3

66.17

67.61

g/l

20.41

2892

8751

Gout, FINNGEN

2398

9552

2.86

307.65

3.5

2.5

65.52

66.22

g/l

4.07

2216

8533

Heart failure, strict

4861

14858

2.64

307.65

2.3

2.6

64.50

66.61

g/l

54.65

4464

13291

Asthma (mode)

4355

11614

2.16

307.65

2.2

2.3

66.47

67.39

g/l

11.52

4000

10519

Transplanted organ and tissue status

1157

2277

6.83

307.65

6.6

2.5

63.37

66.86

g/l

33.85

1111

2081

Heart failure and antihypertensive medication

2391

3852

4.80

307.65

2.4

3.0

64.51

66.75

g/l

25.98

2227

3493

Any reimbursement code in KELA

2744

5383

2.66

307.65

2.8

1.6

66.75

68.01

g/l

12.08

2575

4869

Type 2 diabetes, wide definition

5278

18107

2.02

307.65

2.3

2.7

66.28

66.40

g/l

0.49

4804

16407

Care involving dialysis

1018

1974

7.22

307.65

3.2

2.5

62.41

66.76

g/l

47.53

970

1809

Examination and observation for other reasons

3840

10421

2.38

307.65

2.6

2.3

66.27

66.57

g/l

1.46

3514

9575

Opioids

6055

15646

2.13

307.65

2.7

2.2

66.53

66.79

g/l

1.60

5518

14273

Medical observation and evaluation for suspected diseases and conditions

4127

10562

2.10

307.65

2.6

2.3

66.73

66.56

g/l

0.61

3708

9683

Acute tubulo-interstitial nephritis

3797

16368

2.19

307.65

2.5

65.27

66.77

g/l

22.80

3404

14722

Persons encountering health services for specific procedures and health care

6995

21268

2.16

307.65

3.0

2.3

65.39

67.05

g/l

51.37

6487

19251

Benign neoplasm of colon, rectum, anus and anal canal

3450

11814

2.24

307.65

2.4

1.6

65.99

67.08

g/l

12.74

3111

10603

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

563

687

22.02

307.65

23.3

2.1

67.39

65.98

g/l

2.14

549

609

Hypertension

4700

12492

2.25

307.65

2.5

2.6

66.39

66.86

g/l

3.53

4376

11382

Asthma, excluding more controls

4282

10294

2.33

307.65

2.2

2.3

66.49

67.67

g/l

18.06

3944

9325

Nutritional anaemias

3601

15532

2.47

307.65

2.3

2.5

65.57

66.33

g/l

6.35

3223

13953

Endocrine, nutritional and metabolic diseases

4320

11318

2.02

307.65

2.5

2.6

66.30

67.03

g/l

6.91

3988

10379

Other systemic involvement of connective tissue (FG)

2364

6704

4.09

307.65

2.0

2.7

67.40

66.09

g/l

11.81

2140

6013

Spondylopathies

5089

16267

2.01

307.65

2.6

2.5

66.72

66.30

g/l

3.30

4624

14806

Renal tubulo-interstitial diseases

7737

19937

3.34

307.65

2.8

2.5

65.26

66.91

g/l

51.37

7097

18043

Other soft tissue disorders, not elsewhere classified

5952

17800

2.19

307.65

2.5

2.6

66.51

66.57

g/l

0.23

5438

16184

Other septicaemia

2911

10949

2.93

307.65

3.2

2.3

64.08

66.75

g/l

47.17

2654

9780

COPD/asthma/ILD related infections

6190

17302

1.87

307.65

3.1

2.2

65.71

67.13

g/l

33.55

5705

15710

Pain in limb

5088

17389

2.25

307.65

2.4

2.6

66.35

66.54

g/l

0.91

4608

15807

Other heart diseases

2913

6266

3.30

307.65

2.6

2.5

65.64

67.73

g/l

32.25

2714

5765

Renal failure

5581

12726

5.13

307.65

2.9

2.5

64.82

66.45

g/l

34.55

5178

11317

Dorsalgia

5799

17462

1.87

307.65

2.6

2.4

66.87

66.39

g/l

4.65

5266

15936

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

5073

16483

1.90

307.65

4.1

1.6

65.90

67.11

g/l

20.84

4738

14904

Dialysis

502

845

8.47

307.13

4.0

2.6

62.60

66.98

g/l

24.58

485

783

Bleeding

5104

21309

1.84

305.27

2.5

2.6

65.57

66.56

g/l

14.48

4620

19316

Symptoms and signs involving the circulatory and respiratory systems

5549

15999

1.80

296.95

2.5

66.58

66.78

g/l

1.02

5102

14636

Other medical care

2727

12810

2.25

296.13

3.6

2.4

64.36

66.70

g/l

38.46

2546

11446

Depression medications

1203

1670

3.77

295.87

1.9

1.4

67.24

68.66

g/l

6.79

1122

1556

Other disorders of skin and subcutaneous tissue

4221

21450

1.91

295.81

2.6

65.65

66.52

g/l

10.12

3812

19412

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2239

5992

2.49

293.13

2.7

2.5

66.23

67.71

g/l

13.74

2083

5498

Abnormal findings on diagnostic imaging of lung

3253

16344

2.10

292.32

2.5

2.6

65.91

66.34

g/l

2.24

2986

14723

Antihypertensive medication - note that there are other indications

2731

6765

2.29

290.62

2.4

2.6

66.68

67.40

g/l

4.47

2538

6221

Other dorsopathies, not elsewhere classified

5647

17494

1.77

285.56

2.4

66.90

66.39

g/l

4.94

5114

15966

Symptoms and signs involving cognition, perception, emotional state and behaviour

5552

23211

1.75

284.39

2.1

2.6

66.33

66.57

g/l

1.49

4972

21217

Rheumatoid arthritis

2158

8674

2.45

283.45

2.0

2.8

66.22

66.23

g/l

0.02

2003

7846

Diseases of the skin and subcutaneous tissue

5833

17308

1.75

283.41

2.6

2.5

66.42

66.63

g/l

1.16

5326

15708

Glomerulonephritis

915

2635

4.19

283.26

3.2

2.7

62.49

66.56

g/l

29.88

878

2418

Lower back pain or/and sciatica

5810

24351

1.72

282.42

2.6

2.5

66.68

66.52

g/l

0.90

5237

22201

Kidney transplant status

560

1124

6.61

281.57

3.8

2.9

62.75

66.77

g/l

22.89

538

1039

Pure hypercholesterolaemia

4410

16602

1.88

280.01

2.6

2.5

65.92

66.71

g/l

9.03

4013

15028

Neoplasms

3796

10606

1.99

279.80

3.2

1.4

66.50

67.28

g/l

7.11

3546

9656

Hypertensive heart and/or renal disease

1876

6023

2.66

278.55

2.4

2.7

65.43

66.23

g/l

3.84

1707

5363

Diverticular disease of intestine

4439

16652

1.87

275.52

2.6

66.17

66.57

g/l

2.70

3991

15172

Gout, idiopatic and unspecified

1900

8225

2.62

275.47

2.3

2.6

65.53

66.18

g/l

3.00

1751

7376

Diseases of pulp and periapical tissues

2200

9999

2.37

274.56

3.9

2.3

65.21

66.76

g/l

15.26

2033

9158

Pain in joint

3281

11072

2.05

274.34

2.2

2.5

67.26

66.47

g/l

7.26

2988

10108

Insulin medication

3680

17064

1.95

273.22

2.4

2.6

65.83

66.34

g/l

3.34

3375

15494

Pain, not elsewhere classified

1582

6216

2.75

272.19

2.5

2.4

66.18

67.05

g/l

4.26

1457

5597

Coagulation defects, purpura and other haemorrhagic conditions

1385

5199

2.99

267.13

2.9

2.5

65.72

66.44

g/l

2.44

1295

4718

Diseases of arteries, arterioles and capillaries

4286

18226

1.86

266.61

2.2

2.6

65.30

66.48

g/l

17.54

3867

16460

Osteoporosis with pathological fracture (FG)

667

1625

5.24

264.18

2.1

2.8

65.81

65.58

g/l

0.27

550

1408

Complications of medical and surgical care

4268

23338

1.83

263.46

2.6

2.5

65.78

66.55

g/l

8.39

3882

21158

Other specific joint derangements/joint disorders

3780

13742

1.92

263.19

2.2

2.6

67.22

66.45

g/l

8.17

3451

12597

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2628

11365

2.19

262.96

3.5

1.6

64.36

66.88

g/l

43.23

2469

10149

Codes for special purposes

2563

12549

2.17

262.77

3.0

2.4

65.35

66.64

g/l

13.07

2385

11398

Provisional assignment of new diseases of uncertain etiology

2559

12534

2.17

262.10

2.9

2.4

65.35

66.64

g/l

13.18

2382

11384

Disorders of other endocrine glands

2588

12549

2.16

260.76

2.7

2.5

65.94

66.41

g/l

2.38

2329

11340

Chronic periapical parodontitis

1464

5724

2.84

259.14

4.7

2.4

64.75

66.69

g/l

14.77

1363

5235

Symptoms and signs involving the nervous and musculoskeletal systems

3441

18766

1.94

257.77

2.2

2.6

66.92

66.38

g/l

4.17

3169

16985

Diabetes mellitus

5658

20574

1.70

257.56

2.2

2.7

66.42

66.56

g/l

0.62

5152

18711

Gout, unspecified

1579

6503

2.78

256.26

2.3

2.5

65.61

66.13

g/l

1.80

1463

5830

Diabetes, varying definitions

5637

20541

1.70

255.88

2.2

2.7

66.41

66.56

g/l

0.67

5132

18685

Dermatitis

3526

19496

1.91

252.00

2.6

66.74

66.40

g/l

1.76

3259

17684

Covid-19 confirmed case

1848

8135

2.48

251.27

3.0

2.4

64.79

66.56

g/l

16.44

1715

7346

Complications of procedures, not elsewhere classified

4530

23130

1.77

249.93

2.5

65.97

66.66

g/l

7.00

4132

21028

Other and unspecified dermatitis

2987

15725

2.02

249.69

2.6

66.75

66.41

g/l

1.54

2770

14240

Gout, strict definition

1428

5699

2.90

248.81

2.3

2.6

65.32

66.17

g/l

3.79

1321

5106

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5379

20004

1.71

247.33

2.2

2.7

66.50

66.53

g/l

0.08

4895

18179

Persons encountering health services in other circumstances, wide

6757

22374

1.62

247.10

2.6

2.5

66.35

66.61

g/l

1.88

6263

20230

Diabetic nephropathy

1300

4933

3.07

245.74

2.7

2.2

64.98

66.56

g/l

10.44

1213

4459

Disorders of thyroid, IBD co-morbidities

899

1866

3.73

245.23

2.3

2.9

65.90

66.17

g/l

0.41

820

1720

Other CVD (FINNGEN)

842

1879

4.03

244.41

2.9

2.7

64.84

67.33

g/l

13.67

744

1683

Purpura and other haemorrhagic conditions

1051

3595

3.37

243.18

2.9

2.6

65.63

66.31

g/l

1.68

983

3280

Disorders of mineral metabolism

722

1978

4.42

240.45

3.8

2.5

65.44

66.69

g/l

3.36

648

1814

Non-follicular lymphoma, hilmo, excluding all cancers

832

2518

4.00

239.51

2.7

1.6

64.20

66.69

g/l

12.14

789

2236

Glucagon-like peptide-1 (GLP-1) analogues

3594

16626

1.90

239.36

2.4

2.8

66.51

66.13

g/l

2.01

3239

15025

Disorders resulting from impaired renal tubular function

443

854

7.50

237.38

4.9

2.7

64.35

66.62

g/l

6.67

427

788

Disorders of calcium metabolism

610

1508

5.10

236.41

4.0

2.5

65.11

66.61

g/l

3.87

546

1380

Ulcer of lower limb, not elsewhere classified

1148

4216

3.18

235.61

2.5

2.4

64.09

66.15

g/l

12.67

1046

3769

Small fibre neuropathy

390

681

9.17

235.59

2.4

2.9

67.37

66.09

g/l

2.38

359

616

Fall on same level

6215

22047

1.63

235.44

2.4

2.6

66.18

66.78

g/l

7.09

5585

20312

Syncope and collapse

2544

11398

2.09

233.01

2.3

2.4

65.61

66.82

g/l

11.68

2270

10224

Type 2 diabetes

5443

20038

1.67

231.69

2.2

2.7

66.49

66.53

g/l

0.15

4955

18199

Continuous positive airway pressure

1236

3980

2.92

229.45

2.3

3.0

66.02

67.04

g/l

3.79

1088

3657

Symptoms and signs involving the urinary system

4503

20952

1.74

228.85

2.4

2.6

66.03

66.49

g/l

3.51

4036

19020

Symptoms and signs concerning food and fluid intake

774

2271

3.92

228.25

2.1

2.4

66.15

66.71

g/l

1.04

700

2042

Hyperlipidaemia, other/unspecified

2531

12333

2.09

227.41

2.8

2.5

66.12

66.52

g/l

1.83

2308

11093

Diabetes, insulin treatment (Kela reimbursement)

5627

21661

1.65

227.07

2.2

2.7

66.51

66.47

g/l

0.15

5132

19666

Any event in cancer register

4937

17831

1.70

225.09

3.9

1.9

65.83

67.06

g/l

21.71

4580

16173

Other special examinations and investigations of persons without complaint or reported diagnosis

3752

10562

1.86

225.05

2.6

2.3

66.56

g/l

0.00

3444

9683

Insulin, combination of fast acting with intermediate-acting or long-acting

3685

19627

1.82

224.60

2.4

2.5

65.83

66.43

g/l

4.63

3378

17773

Insulin, intermediate and long-acting

3317

18319

1.88

223.95

2.4

2.6

66.00

66.45

g/l

2.60

3035

16609

Soft tissue disorders

5556

17972

1.66

223.78

2.4

2.6

66.66

66.58

g/l

0.34

5070

16332

Haemorrhage from respiratory passages

2206

10051

2.19

223.62

2.6

2.5

66.27

66.41

g/l

0.35

1994

9065

Constipation

5011

22237

1.68

223.54

2.8

2.5

65.89

66.54

g/l

7.28

4448

20274

Genitourinary diseases

3201

8482

1.96

223.44

2.6

2.4

66.18

67.34

g/l

12.53

2986

7811

Diseases of the musculoskeletal system and connective tissue

2669

6622

2.09

222.85

2.5

66.86

66.21

g/l

3.45

2469

6063

ILD medications: azathioprine

893

2884

3.40

222.20

2.0

65.85

66.99

g/l

3.51

836

2633

Symptoms and signs involving the skin and subcutaneous tissue

3813

22285

1.78

220.55

2.5

2.6

66.73

66.48

g/l

1.27

3508

20206

Other necrotizing vasculopathies (FG)

572

1419

5.03

219.95

1.8

3.0

64.71

66.18

g/l

3.85

524

1284

Nerve, nerve root and plexus disorders

5873

23676

1.61

219.40

2.4

2.6

66.64

66.47

g/l

0.94

5344

21505

Dorsopathies

5500

17537

1.65

217.65

2.4

66.88

66.39

g/l

4.54

4993

16008

Intracranial trauma

2815

11102

1.97

216.88

2.4

2.8

66.54

66.57

g/l

0.06

2533

10189

Hypothyroidism, drug reimbursement

647

1129

4.34

215.39

2.7

1.4

66.72

68.38

g/l

5.32

599

1042

Pain (limb, back, neck, head abdominally)

4112

11929

1.79

215.10

2.6

2.4

66.51

66.43

g/l

0.27

3762

10854

Asthma (diagnoses ohter than nonallergic)

4679

24761

1.68

214.74

2.2

2.6

66.17

66.58

g/l

3.20

4264

22483

Diabetes medication

5545

21427

1.63

213.43

2.2

2.6

66.52

g/l

0.01

5035

19492

STROKE

3285

12753

1.88

211.43

2.5

2.8

65.72

66.88

g/l

13.29

2998

11583

Spinal stenosis

3160

13867

1.89

209.86

2.5

2.6

66.27

66.17

g/l

0.32

2817

12550

Asthma, hospital admission 2, infections

3220

17970

1.85

209.68

2.4

2.5

65.76

66.46

g/l

5.67

2944

16229

Asthma-related infections

3220

17970

1.85

209.68

2.4

2.5

65.76

66.46

g/l

5.67

2944

16229

Seropositive rheumatoid arthritis

1576

6994

2.43

207.97

1.9

2.8

66.29

66.18

g/l

0.22

1472

6288

Other antidepressants

5799

19407

1.61

207.81

2.3

2.6

66.65

66.56

g/l

0.36

5238

17773

Dermatitis and eczema

5804

24697

1.59

207.19

2.5

66.87

66.46

g/l

3.64

5335

22419

Certain disorders involving the immune mechanism

1300

5357

2.69

206.80

2.9

2.5

65.59

66.59

g/l

4.32

1237

4895

Preparatory care for dialysis

480

1116

5.87

205.55

2.2

3.0

63.37

66.63

g/l

14.76

451

1027

Episodal and paroxysmal disorders

5974

19794

1.59

205.11

2.2

2.6

66.76

66.44

g/l

2.37

5438

18022

Disorders of lens

4012

15062

1.76

205.09

2.8

2.6

65.92

66.64

g/l

6.86

3649

13817

Diarrhoea and gastroenteritis of presumed infectious origin

3722

20016

1.76

204.64

2.9

2.3

65.57

66.71

g/l

14.61

3391

18149

Spondylosis

3097

14963

1.87

203.38

2.2

2.5

66.82

66.28

g/l

3.69

2815

13622

Ascites

660

1914

4.21

203.34

2.9

2.5

62.68

66.55

g/l

21.80

621

1736

Other nutritional deficiencies

3273

18411

1.81

201.82

2.1

2.6

66.63

66.71

g/l

0.25

2980

16893

Chronic lower respiratory diseases

6399

22881

1.56

201.56

2.2

2.6

66.31

66.68

g/l

3.19

5864

20821

Symptoms and signs involving the digestive system and abdomen

5595

17910

1.61

201.42

2.5

66.29

66.76

g/l

4.20

5131

16271

Other necrotizing vasculopathies

656

1917

4.21

200.54

1.8

2.8

64.54

66.26

g/l

5.78

599

1732

Other arrhythmias

3293

14398

1.82

199.84

2.3

2.6

66.12

67.20

g/l

13.29

2969

13110

Hypo-osmolality and hyponatraemia

1212

4907

2.75

199.73

2.9

2.4

64.72

66.36

g/l

8.53

1090

4331

Nephrotic syndrome

365

683

7.34

199.60

3.0

2.9

59.45

66.40

g/l

25.60

356

630

Benign neoplasm of colon, rectum, anus and anal canal

3740

20265

1.76

199.44

2.5

2.6

65.98

66.37

g/l

2.39

3374

18300

Disorders of parathyroid gland

1474

6457

2.50

199.21

2.8

2.5

65.56

66.10

g/l

1.95

1296

5732

Diseases of the respiratory system

3495

9889

1.83

198.95

2.7

2.3

66.26

67.34

g/l

12.41

3219

8937

Diseases of liver

2072

10446

2.13

198.83

2.2

2.6

66.75

66.48

g/l

0.70

1874

9522

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5951

22211

1.58

198.66

2.5

66.27

66.62

g/l

2.82

5515

20108

Intestinal infectious diseases

4940

24512

1.62

196.64

3.1

2.4

65.53

66.71

g/l

20.48

4502

22268

Lymphoid leukaemia

523

1332

4.93

194.87

3.3

1.6

64.43

66.56

g/l

5.93

495

1189

Non-follicular lymphoma

832

2861

3.48

194.41

2.7

2.6

64.20

66.16

g/l

7.90

789

2595

Disorders of choroid and retina

4651

21361

1.65

194.40

2.6

65.95

66.46

g/l

4.27

4186

19361

Azathioprine

893

3116

3.14

194.36

2.0

2.8

65.85

66.83

g/l

2.71

836

2855

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

413

891

6.30

192.92

2.8

1.6

66.60

66.32

g/l

0.27

389

784

Disturbances of skin sensation

1526

6907

2.37

192.25

2.0

2.5

67.70

66.74

g/l

6.37

1422

6328

Arthropathies

4584

14356

1.67

191.92

2.2

2.6

66.89

66.43

g/l

3.45

4201

13119

Insulin, fast-acting

2130

10971

2.07

190.44

2.4

2.5

65.33

66.53

g/l

9.91

1973

9949

Other dialysis

361

709

7.22

188.99

3.0

62.30

66.49

g/l

17.69

347

647

Benign neoplasms

3574

11758

1.77

188.90

2.6

1.6

66.46

67.38

g/l

9.67

3279

10726

Gastrointestinal diseases

2935

7975

1.90

188.75

2.7

2.2

66.54

67.21

g/l

4.22

2701

7335

Rheumatoid arthritis, including avohilmo

2331

12504

1.99

185.88

2.0

2.6

66.36

66.35

g/l

0.02

2160

11225

Paroxysmal tachycardia

1144

3837

2.68

184.83

2.4

2.6

65.84

67.58

g/l

11.07

1042

3494

6144

21652

1.54

184.44

3.2

2.3

66.14

66.68

g/l

5.77

5575

19654

Cardiomyopathy

1168

4846

2.66

182.48

2.8

2.6

64.50

66.94

g/l

20.49

1082

4357

Asthma-related pneumonia or sepsis

2174

11470

2.02

181.12

2.5

65.13

66.19

g/l

7.83

1986

10241

Asthma, hospital admissions 3, pneumonia

2174

11470

2.02

181.12

2.5

65.13

66.19

g/l

7.83

1986

10241

Asthma-related pneumonia

2170

11452

2.02

180.68

2.5

65.12

66.19

g/l

7.85

1982

10223

Chronic periodontitis

1054

4204

2.81

180.58

3.8

2.3

64.80

66.51

g/l

8.67

991

3849

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3409

20479

1.74

179.47

2.4

2.6

65.84

66.54

g/l

5.70

3106

18547

Other intervertebral disc disorders

4384

16833

1.65

178.76

2.4

2.5

66.93

66.34

g/l

5.56

3980

15341

Exposure to unspecified factor

5013

25427

1.58

178.62

2.4

2.5

66.17

66.61

g/l

3.71

4490

23222

Thrombocytopenia, unspecified

610

1827

4.03

178.55

2.8

2.7

65.42

66.42

g/l

1.86

567

1673

COPD (mode)

1826

7130

2.17

178.41

2.0

2.3

65.10

67.04

g/l

20.04

1646

6373

Hernia of abdominal wall, postoperative

976

3737

2.82

177.35

2.3

2.1

65.79

67.51

g/l

9.38

885

3380

Sleep disorders (combined)

5255

22669

1.57

176.70

2.2

2.6

66.97

66.46

g/l

5.32

4768

20718

Venous thromboembolism

3202

18540

1.77

176.28

3.1

2.5

65.15

66.48

g/l

17.63

2933

16654

Hypertensive Heart Disease

1504

5679

2.35

175.54

2.3

2.7

65.43

66.20

g/l

3.02

1353

5052

General examination and investigation of persons without complaint and reported diagnosis

3390

10537

1.77

174.85

2.7

2.4

66.19

66.56

g/l

1.82

3098

9666

Other disorders of urethra and urinary system

3738

17201

1.69

173.42

2.6

65.88

66.59

g/l

6.53

3388

15603

Dizziness and giddiness

4084

20937

1.65

171.90

2.2

2.7

66.41

66.48

g/l

0.23

3662

19072

Pulmonary heart disease, diseases of pulmonary circulation

2022

10656

2.04

171.43

2.8

2.5

64.85

66.24

g/l

12.01

1860

9492

Nausea and vomiting

1539

7210

2.24

169.86

2.9

2.5

65.08

66.31

g/l

6.75

1408

6411

Care involving use of rehabilitation procedures

3317

19060

1.72

169.35

2.5

2.4

65.98

66.95

g/l

10.61

3108

17212

Obesity and other hyperalimentation

3036

17869

1.75

166.61

2.0

2.6

66.71

66.70

g/l

0.02

2766

16385

Persons encountering health services for examination and investigation

3534

10562

1.73

166.55

2.5

2.3

66.63

66.56

g/l

0.18

3222

9683

Senile cataract

3680

14025

1.70

166.46

2.8

2.6

65.93

66.58

g/l

5.21

3333

12834

Insulin, fast-acting or short human

2135

11522

1.96

165.69

2.4

2.5

65.33

66.52

g/l

9.89

1978

10437

Obesity

3017

17778

1.75

165.30

2.0

2.6

66.72

66.70

g/l

0.07

2749

16300

Hypertensive Renal Disease

382

870

5.65

165.09

3.0

2.7

65.43

66.23

g/l

1.08

364

775

Concussion

2300

10849

1.90

165.05

2.2

2.8

66.70

66.53

g/l

0.47

2064

9953

Infections of the skin and subcutaneous tissue

2913

17147

1.76

163.77

2.7

2.5

65.78

66.73

g/l

8.54

2703

15668

Gastro-oesophageal reflux disease

3629

20033

1.67

163.66

2.3

2.6

66.63

66.58

g/l

0.13

3255

18277

DVT of lower extremities and pulmonary embolism

2517

14344

1.86

162.99

3.2

2.5

64.99

66.36

g/l

14.78

2292

12854

Type 2 diabetes, definitions combined

4984

19617

1.56

162.82

2.2

2.7

66.74

66.50

g/l

1.30

4526

17805

Use of hypnotics and sedatives

5651

22095

1.52

162.76

2.7

2.5

66.26

66.66

g/l

3.41

5121

20177

Sulfasalazine

1523

7349

2.20

162.15

1.9

2.7

66.99

66.82

g/l

0.36

1416

6667

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

332

693

6.63

161.79

2.8

1.6

66.68

66.53

g/l

0.12

311

606

Presence of cardiac and vascular implants and grafts

2832

12561

1.81

160.89

2.1

2.5

65.45

66.35

g/l

7.37

2560

11288

Other disorders of kidney and ureter

933

3739

2.84

159.94

3.7

2.6

65.22

66.32

g/l

4.08

885

3386

Type 2 diabetes, strict (exclude DM1)

4996

19770

1.56

159.54

2.2

2.7

66.74

66.49

g/l

1.37

4537

17942

Lymphoid leukaemia

523

1536

4.23

159.46

3.3

2.7

64.43

66.18

g/l

4.33

495

1413

Sicca syndrome [Sjögren]

654

2178

3.48

159.01

2.0

2.7

69.54

66.50

g/l

16.18

593

1974

Abdominal and pelvic pain

5343

17907

1.54

158.86

2.6

2.5

66.37

66.76

g/l

2.99

4874

16268

Anaemia in chronic diseases classified elsewhere

294

566

7.46

157.75

5.4

2.7

62.91

66.51

g/l

9.55

280

516

Other joint disorders

4234

14329

1.62

157.25

2.1

2.6

67.13

66.44

g/l

6.97

3873

13094

Other retinal disorders

3647

18445

1.66

157.13

2.6

65.81

66.35

g/l

3.86

3264

16618

Other disorders involving the immune mechanism, not elsewhere classified

319

653

6.40

156.76

3.7

2.8

65.13

66.85

g/l

2.75

306

599

Disorders of gallbladder, biliary tract and pancreas

5277

22976

1.53

156.41

2.6

66.08

66.59

g/l

4.64

4808

20889

Benign neoplasm: Colon

3128

18782

1.72

156.37

2.5

2.6

65.98

66.34

g/l

1.76

2816

16971

Hyperkalaemia

488

1379

4.32

156.34

3.3

2.4

63.33

66.35

g/l

13.66

453

1237

Presence of other functional implants

3387

14798

1.70

155.32

2.6

2.5

66.05

66.42

g/l

1.87

3004

13302

Other diseases of urinary system

5380

20433

1.52

155.15

2.5

2.6

66.13

66.67

g/l

5.28

4866

18657

Diseases of the digestive system

2648

15516

1.79

154.82

2.4

2.5

65.46

66.32

g/l

6.08

2412

13951

Benzodiazepine use

5183

24990

1.52

153.54

2.4

2.5

66.24

66.59

g/l

2.46

4612

22822

Deposits [accretions] on teeth

504

1392

4.02

153.51

5.1

2.3

64.63

66.60

g/l

5.37

483

1294

Coxarthrosis [arthrosis of hip](FG)

2965

12799

1.75

153.49

2.3

2.8

66.42

66.29

g/l

0.38

2659

11592

Other disorders of white blood cells

481

1363

4.30

153.32

2.2

2.8

66.02

66.37

g/l

0.38

444

1250

Conduction disorders

1713

7296

2.08

151.14

2.3

2.6

65.38

66.90

g/l

12.35

1529

6530

Other diseases of pericardium

398

996

4.94

151.09

2.3

2.7

63.25

67.02

g/l

14.84

378

905

Streptococcal septicaemia

626

2094

3.44

150.67

4.1

2.4

65.89

66.71

g/l

1.34

578

1898

Other (not insulin) diabetes medications

5071

20584

1.53

150.64

2.1

2.7

66.82

66.46

g/l

2.48

4587

18692

Suppurative and necrotic conditions of lower respiratory tract

493

1444

4.20

150.32

2.7

2.8

61.85

66.44

g/l

24.49

467

1323

Other disorders of teeth and supporting structures

1274

5943

2.31

150.16

3.7

2.3

65.64

66.57

g/l

3.60

1167

5407

Cerebrovascular diseases

4239

19912

1.59

150.00

2.3

2.7

65.55

66.48

g/l

11.28

3797

18045

2208

12278

1.86

149.65

2.6

2.5

66.01

66.51

g/l

2.35

2020

11109

Amyloidosis, other/unspecified

245

424

9.24

149.46

8.5

2.5

62.83

66.28

g/l

6.35

235

385

Agranulocytosis

773

2914

3.01

149.11

3.9

2.6

65.20

66.42

g/l

3.42

740

2672

Isolated proteinuria

301

616

6.44

148.21

3.5

2.8

64.52

66.61

g/l

3.67

293

557

Explicit bacterial Sepsis

712

2573

3.11

147.87

4.1

2.4

65.73

66.72

g/l

2.01

659

2328

Bacterial pneumoniae

2277

11413

1.86

147.86

3.5

2.3

64.53

66.96

g/l

34.93

2110

10261

Diseases of the eye and adnexa

3913

12363

1.63

147.40

2.6

2.4

66.77

66.84

g/l

0.18

3606

11408

Other cataract

2546

11483

1.81

147.38

2.7

2.6

65.91

66.48

g/l

3.19

2320

10452

Abnormalities of gait and mobility

871

3523

2.82

146.84

1.9

2.7

66.44

65.96

g/l

1.05

801

3180

Type 2 diabetes, definitions combined, including avohilmo

4918

19576

1.53

146.30

2.1

2.7

66.75

66.49

g/l

1.48

4468

17773

Benign neoplasms

4981

18686

1.53

145.90

2.6

2.4

66.35

66.73

g/l

2.82

4545

17099

Pyothorax

409

1086

4.79

144.93

2.7

61.77

66.50

g/l

21.45

387

986

Hyperparathyroidism

1225

5671

2.34

144.78

2.9

2.5

65.63

66.06

g/l

1.21

1082

5012

Other/unspecified dorsalgia

1956

10638

1.92

144.41

2.9

2.5

66.97

66.32

g/l

3.43

1756

9642

Pulmonary embolism

1799

9663

2.00

143.85

2.9

2.5

64.85

66.28

g/l

11.65

1657

8604

Other functional intestinal disorders

2400

13271

1.80

143.82

2.6

2.5

66.01

66.46

g/l

2.00

2158

12010

Obesity related asthma

1815

9753

1.97

143.26

2.1

2.6

66.72

66.59

g/l

0.31

1649

8915

Sleep apnoea

4800

22016

1.53

143.26

2.3

2.6

67.09

66.42

g/l

7.93

4356

20151

Gonarthrosis [arthrosis of knee](FG)

3873

14614

1.61

143.20

2.3

2.7

66.73

66.42

g/l

1.65

3529

13294

Amyloidosis

267

518

7.57

142.83

8.0

2.6

63.01

66.11

g/l

5.74

254

472

All influenza

1377

6730

2.18

142.63

4.8

2.2

65.32

67.02

g/l

11.88

1254

6052

Injuries to the head

5516

24916

1.48

142.35

2.4

2.6

66.16

66.63

g/l

4.33

4949

22751

Obesity due to excess calories

2232

12750

1.83

142.35

2.1

2.6

66.83

66.73

g/l

0.26

2031

11725

Pulmonary heart disease

1799

9710

1.99

141.72

2.9

2.5

64.85

66.27

g/l

11.47

1657

8648

Factors influencing health status and contact with health services

1705

4253

2.09

141.26

2.7

2.1

66.60

67.10

g/l

1.63

1561

3867

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5076

22622

1.51

141.19

2.6

2.5

66.10

66.61

g/l

4.52

4598

20596

Bronchitis

5418

24608

1.48

141.07

3.4

2.3

65.99

66.66

g/l

7.91

4937

22353

Cough

2106

11368

1.86

140.58

2.6

66.80

66.58

g/l

0.67

1912

10322

Asthma, including avohilmo

5968

24366

1.46

140.39

2.2

2.6

66.39

66.59

g/l

1.17

5457

22149

Hard cardiovascular diseases

4324

18461

1.56

139.50

2.4

2.7

65.73

66.65

g/l

11.11

3942

16767

Diseases of oral cavity, salivary glands and jaws

4916

17027

1.52

138.71

2.7

2.3

66.26

66.57

g/l

1.74

4446

15433

Sciatica+with lumbago

2524

14240

1.75

138.18

2.4

2.5

66.97

66.41

g/l

3.53

2309

13007

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

942

4035

2.58

138.00

3.3

1.6

64.57

66.84

g/l

13.21

900

3588

Disorders of eyelid, lacrimal system and orbit

4432

23429

1.53

137.92

2.7

2.5

66.44

66.45

g/l

0.03

4004

21267

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

287

599

6.21

137.70

3.4

2.8

64.78

67.08

g/l

4.32

274

548

Bacterial pneumonia, not elsewhere classified

2157

10885

1.84

136.83

3.4

2.2

64.43

66.94

g/l

36.45

2006

9769

Iron deficiency anaemia secondary to blood loss (chronic)

1040

4667

2.45

136.48

2.3

2.5

65.02

66.13

g/l

3.79

921

4168

Sleep apnoea, including avohilmo

4985

22256

1.50

135.02

2.2

2.6

67.08

66.42

g/l

8.08

4525

20365

Lung cancer and mesothelioma

1170

4700

2.30

132.05

1.9

2.3

64.72

66.84

g/l

15.47

1090

4188

Type 1 diabetes

1320

6513

2.14

131.78

2.4

2.6

65.02

66.62

g/l

10.99

1223

5955

AV-block

1100

4612

2.35

131.30

2.3

2.5

65.49

66.74

g/l

5.88

977

4070

Peripheral artery disease

2700

13334

1.72

130.89

2.3

2.7

64.91

66.26

g/l

14.76

2436

11962

Other acute lower respiratory infections

2760

16261

1.68

130.73

3.3

2.4

65.82

66.46

g/l

4.16

2518

14663

Chronic lymphocytic leukaemia, helper endpoint

301

691

5.87

130.67

2.3

1.6

63.94

66.94

g/l

6.26

286

616

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

301

691

5.87

130.67

2.3

1.6

63.94

66.94

g/l

6.26

286

616

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3058

19416

1.64

130.51

2.3

2.6

65.92

66.44

g/l

3.12

2780

17591

Pacemaker

2083

11723

1.85

130.34

2.3

2.6

65.31

65.98

g/l

3.40

1859

10397

Fracture of lumbar spine and pelvis

1342

6766

2.15

129.49

2.6

2.5

65.16

66.09

g/l

3.66

1120

6013

Injuries to the abdomen, lower back, lumbar spine and pelvis

2104

12103

1.81

128.83

2.5

65.57

66.34

g/l

4.17

1804

10924

Vocal cord dysfunction

663

2254

2.91

128.32

2.6

3.1

66.26

67.13

g/l

1.94

596

2100

Heart failure and coronary heart disease

2181

9479

1.84

128.03

2.3

2.6

64.74

66.05

g/l

10.92

1978

8388

Diabetic retinopathy, excluding more controls

1470

4155

2.15

127.83

2.4

2.2

65.69

67.09

g/l

8.59

1354

3728

Psychiatric diseases

5679

20051

1.45

127.17

2.2

2.7

66.32

66.65

g/l

2.24

5106

18433

Viral pneumonia

758

3043

2.73

126.74

4.3

2.2

64.61

66.87

g/l

10.85

696

2739

Postmenopausal osteoporosis with pathological fracture

506

1685

3.66

126.07

2.1

2.5

66.49

66.04

g/l

0.62

406

1479

Statin medication

3332

11872

1.62

125.83

2.4

2.7

66.22

66.89

g/l

5.14

3068

10836

Other and unspecified disorders of white blood cells

363

980

4.58

124.65

2.2

2.9

66.32

66.30

g/l

0.02

338

889

Adjustment and management of implanted device

1204

5939

2.21

124.54

2.4

2.3

65.54

66.37

g/l

3.35

1098

5210

Asthma, hospital admissions , main diagnosis only

4056

24630

1.52

123.98

2.2

2.6

66.28

66.58

g/l

1.77

3699

22373

Ischemic heart diseases

4237

17998

1.53

123.80

2.5

2.7

65.96

66.60

g/l

5.99

3909

16274

Other bacterial intestinal infections

1096

5216

2.28

123.49

3.7

2.4

64.03

66.39

g/l

16.31

986

4659

Coxarthrosis

2724

11388

1.69

123.13

2.2

2.8

66.42

66.21

g/l

0.73

2446

10330

Arthrosis

3642

13050

1.58

123.13

2.2

2.7

66.91

66.33

g/l

4.48

3315

11882

Abnormal findings on examination of urine, without diagnosis

379

1060

4.34

123.12

3.4

2.9

65.11

66.35

g/l

2.04

366

970

Shoulder lesions

3994

16359

1.54

123.00

2.3

2.7

66.52

66.50

g/l

0.05

3670

14861

Secondary and unspecified malignant neoplasm of lymph nodes

624

2345

3.06

122.32

2.6

2.7

64.03

66.32

g/l

8.20

597

2141

Unspecified haematuria

2403

12483

1.74

122.27

2.6

65.98

66.44

g/l

2.05

2165

11325

Myalgia

1154

5585

2.19

122.19

2.4

2.6

66.73

66.59

g/l

0.26

1050

5095

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

949

4311

2.44

122.10

1.8

2.6

65.99

66.31

g/l

0.52

870

3928

Type 1 diabetes, wide definition, subgroup 1

1056

4945

2.26

121.19

2.6

2.5

64.82

66.69

g/l

12.28

976

4556

Biguanides

4900

21103

1.47

120.92

2.1

2.7

66.87

66.37

g/l

4.33

4430

19176

Hernia

4750

22457

1.47

120.78

2.6

2.5

66.11

66.63

g/l

4.61

4273

20420

Ischaemic heart disease, wide definition

4189

17849

1.52

120.24

2.5

2.7

65.93

66.61

g/l

6.50

3856

16149

Other neurological diseases

3899

21225

1.53

120.06

2.4

2.6

66.06

66.39

g/l

1.93

3526

19163

Falls/tendency to fall

5477

19411

1.44

119.65

2.4

2.6

66.31

66.79

g/l

4.44

4943

17915

Chronic nephritic syndrome

350

947

4.52

119.44

3.2

2.8

64.02

66.54

g/l

6.43

337

866

Polyarthrosis

1171

5529

2.19

119.30

2.2

2.9

66.66

65.94

g/l

2.43

1036

4947

Any mental disorder

5782

20722

1.43

119.04

2.3

2.7

66.31

66.63

g/l

2.23

5181

19024

Weight loss

664

2602

2.89

118.90

2.1

2.6

66.34

66.33

g/l

0.02

596

2371

Hypothyroidism, strict autoimmune

3501

15220

1.57

118.52

2.4

2.7

66.59

66.49

g/l

0.29

3167

13732

Enterocolitis due to Clostridium difficile

738

3043

2.71

118.35

3.9

2.4

63.39

66.24

g/l

15.01

669

2724

Abnormal weight loss

625

2394

2.98

117.64

1.9

2.6

66.51

66.28

g/l

0.29

559

2184

Cardiomyopathies, Primary/intrinsic

775

3266

2.61

117.25

2.1

2.6

64.28

66.94

g/l

15.98

722

2932

Seropositive rheumatoid arthritis, wide

1575

8657

1.94

116.85

1.9

2.6

66.30

66.29

g/l

0.02

1471

7758

Other symptoms and signs involving the nervous and musculoskeletal systems

2115

12596

1.76

116.63

2.2

2.6

67.25

66.44

g/l

5.70

1963

11433

Fibrosis and cirrhosis of liver

550

1993

3.20

115.81

1.9

2.8

66.83

66.34

g/l

0.62

509

1815

Diaphragmatic hernia

2059

12261

1.78

115.44

2.5

2.6

66.00

66.39

g/l

1.38

1835

11069

ILD, hospital admission 2, with pulmonary infections

651

2563

2.86

115.27

2.3

2.2

65.68

66.67

g/l

2.22

601

2288

Coronary atherosclerosis

3780

16439

1.54

114.93

2.4

2.7

65.73

66.50

g/l

7.56

3500

14823

Bacterial intestinal infections, IBD co-morbidities

1099

5384

2.21

114.85

3.7

2.5

64.07

66.28

g/l

14.41

991

4826

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1532

8402

1.95

114.56

1.9

2.6

66.32

66.29

g/l

0.05

1430

7546

Cardiomyopathy (excluding other)

792

3409

2.55

114.23

2.1

2.5

64.34

66.99

g/l

16.36

736

3048

Seronegative rheumatoid arthritis

706

2880

2.68

114.14

2.1

3.0

65.85

66.17

g/l

0.43

650

2602

Bacterial pneumonia (organism specified)

2458

13911

1.68

113.75

3.6

2.4

64.48

66.53

g/l

27.08

2281

12468

Other headache syndromes

2000

11801

1.76

113.25

2.2

2.7

67.06

66.53

g/l

2.65

1834

10750

Other/unspecified seropositive rheumatoid arthritis

1551

8570

1.93

113.14

1.9

2.6

66.34

66.29

g/l

0.09

1447

7686

Volume depletion

614

2364

2.90

112.96

2.4

2.3

63.59

66.22

g/l

11.06

554

2094

Non-invasive ventilation

1014

4490

2.23

112.90

2.9

64.44

67.20

g/l

20.88

934

4131

Dysphagia

1384

7375

2.00

112.76

2.4

2.5

65.70

66.42

g/l

2.69

1240

6593

Direct fill therapy

768

3272

2.56

112.72

4.9

2.6

64.38

66.80

g/l

11.48

717

3010

715

2939

2.63

112.72

2.6

2.5

65.41

66.77

g/l

4.29

664

2672

Myeloid leukaemia

249

548

5.85

112.34

2.3

1.7

65.39

67.46

g/l

3.92

241

489

Mood disorders, excluding more controls

4656

19863

1.46

112.00

2.2

2.7

66.72

66.69

g/l

0.10

4177

18244

Asthma/COPD (KELA code 203)

4608

22837

1.46

111.79

2.2

2.6

66.09

66.68

g/l

5.83

4191

20780

Other diseases of the digestive system

1854

10826

1.81

111.67

2.3

2.5

65.15

66.14

g/l

5.54

1688

9661

Abnormalities of heart beat

1738

9825

1.83

111.30

2.3

2.5

66.23

66.53

g/l

0.89

1564

8857

GI-bleeding

1861

10893

1.81

111.05

2.3

2.5

65.17

66.14

g/l

5.39

1695

9710

Acute bronchitis

2165

12877

1.72

110.75

3.3

2.4

65.89

66.33

g/l

1.77

1963

11527

Other external causes of accidental injury

4260

14627

1.49

110.38

2.5

2.6

66.31

66.82

g/l

3.84

3847

13490

Persons encountering health services in other circumstances

1828

10599

1.80

110.19

2.6

2.4

66.38

66.59

g/l

0.57

1697

9567

Atherosclerosis, excluding cerebral and coronary sclerosis

2501

12560

1.68

110.10

2.2

2.6

64.93

66.20

g/l

12.09

2246

11236

SLE (Finngen)

273

649

5.02

109.59

2.0

3.1

66.07

67.30

g/l

1.58

254

590

Viral infections characterized by skin and mucous membrane lesions

2038

12243

1.74

108.37

3.5

2.5

65.59

66.58

g/l

6.70

1875

11121

Chronic lymphocytic leukaemia

301

802

4.99

107.97

2.3

2.9

63.94

65.92

g/l

3.06

286

722

Calcific aortic valvular stenosis, operated

1830

10551

1.81

107.83

2.3

2.5

65.75

65.90

g/l

0.34

1655

9334

Calcific aortic valvular stenosis

1830

10551

1.81

107.83

2.3

2.5

65.75

65.90

g/l

0.34

1655

9334

Accidents

4243

14627

1.49

107.71

2.5

2.6

66.29

66.82

g/l

4.09

3840

13490

Calcific aortic valvular stenosis, diagnosis (helper)

1826

10544

1.81

106.98

2.3

2.5

65.77

65.90

g/l

0.30

1651

9327

Operations 2 for CAVS

1826

10544

1.81

106.98

2.3

2.5

65.77

65.90

g/l

0.30

1651

9327

Giant cell arteritis

372

1139

4.07

106.97

1.7

3.0

65.18

66.03

g/l

1.20

334

1020

Hypokalaemia

711

3010

2.60

106.73

2.6

2.4

64.98

66.48

g/l

4.44

638

2681

Calcific aortic valvular stenosis, including rheumatic fever

1831

10583

1.81

106.54

2.3

2.5

65.78

65.90

g/l

0.26

1656

9363

Early onset COPD, excluding more controls

1038

5089

2.16

106.23

2.0

2.3

65.11

67.24

g/l

14.16

955

4624

Other reaction to severe stress, and adjustment disorders

1522

8453

1.87

105.77

2.7

2.4

66.43

67.00

g/l

2.12

1415

7818

Failure and rejection of transplanted organs and tissues

156

237

9.42

105.37

6.5

3.1

63.33

67.27

g/l

6.52

151

221

Undetermined asthma, excluding more controls

635

2539

2.68

105.36

2.4

2.1

66.12

67.41

g/l

3.83

581

2259

Chronic gastritis

1632

9358

1.85

105.03

2.2

2.6

66.05

66.16

g/l

0.22

1438

8359

Acquired haemolytic anaemia

247

575

5.67

104.99

3.6

2.9

65.79

66.54

g/l

0.60

233

524

Cirrhosis of liver, NAS

405

1315

3.71

104.72

2.0

2.8

66.20

66.29

g/l

0.07

379

1198

Other CVD

1200

6288

2.07

104.62

2.8

2.4

64.73

65.93

g/l

5.78

1049

5555

IgA nephropathy (IgA glomerulonephritis)

229

503

5.84

103.45

2.1

2.9

65.12

67.25

g/l

3.25

216

460

Depression or dysthymia

3643

13805

1.52

103.41

2.3

2.7

66.76

66.60

g/l

0.61

3252

12761

Mixed connective tissue disease

447

1530

3.34

103.37

2.1

2.8

68.18

66.72

g/l

3.19

419

1393

Convulsions, not elsewhere classified

1033

5020

2.13

103.27

1.9

2.3

65.54

67.10

g/l

7.14

944

4539

Diffuse large B-cell lymphoma, helper endpoint

360

1097

3.98

103.16

2.2

1.6

62.69

66.86

g/l

14.43

341

982

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

360

1097

3.98

103.16

2.2

1.6

62.69

66.86

g/l

14.43

341

982

Haemolytic anaemias

297

795

4.58

103.03

3.5

2.7

65.98

66.21

g/l

0.16

281

723

Immunodeficiency with predominantly antibody defects

237

535

5.56

103.01

4.1

2.8

62.83

67.15

g/l

10.01

228

492

Type 1 diabetes, wide definition

1088

5473

2.09

103.01

2.6

2.5

64.77

66.64

g/l

12.77

1004

5014

Other specified/unspecified systemic involvement of connective tissue

404

1310

3.53

102.40

2.1

3.0

67.96

66.71

g/l

2.30

379

1191

Cystitis

4187

17910

1.47

102.16

2.4

2.6

66.39

66.62

g/l

1.12

3793

16273

Vasculitis limited to skin, not elsewhere classified

253

611

5.34

102.11

2.4

2.8

67.13

66.41

g/l

0.68

235

550

Gingivitis and periodontal diseases

4618

16876

1.45

102.08

2.6

2.3

66.49

66.59

g/l

0.35

4186

15315

Immunodeficiencies

359

1091

3.85

101.79

3.8

2.8

63.66

66.69

g/l

8.40

346

996

Fibromyalgia

465

1623

3.13

101.42

2.2

2.7

67.65

66.84

g/l

1.66

428

1495

Gonarthrosis

3282

12549

1.55

101.41

2.2

2.7

66.74

66.31

g/l

2.49

2996

11410

Follow-up examination after treatment for conditions other than malignant neoplasms

2113

8365

1.71

100.97

2.4

66.49

66.51

g/l

0.04

1916

7667

Later onset COPD, excluding more controls

1215

4959

2.05

100.72

2.0

2.3

64.91

66.71

g/l

12.30

1075

4359

Benign neoplasm: Colon, unspecified

1314

7148

1.95

99.25

2.6

1.6

65.97

66.72

g/l

3.05

1168

6363

Visual disturbances and blindness

2543

16492

1.60

99.12

2.5

66.48

66.41

g/l

0.19

2291

14913

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

333

988

4.05

99.00

3.2

1.6

63.71

66.85

g/l

8.33

314

886

Lumbar disc prolapse

2992

15818

1.55

98.89

2.5

67.03

66.38

g/l

5.04

2741

14472

Other gastritis (incl. Duodenitis)

1301

7098

1.95

98.73

2.6

66.03

66.31

g/l

0.61

1169

6367

Anxiety disorders, excluding more controls

3831

17633

1.48

98.61

2.4

2.7

66.62

66.76

g/l

0.53

3480

16230

Pruritus

640

2674

2.62

98.52

2.2

2.6

66.75

66.35

g/l

0.69

589

2427

Parodontitis or operation codes

4492

23760

1.43

98.44

2.6

66.37

66.56

g/l

0.89

4069

21652

Secondary uncertain malignant neoplasm

827

3880

2.35

98.17

2.7

2.6

64.24

66.08

g/l

7.27

776

3485

Parodontitis

4485

23758

1.43

97.92

2.6

66.37

66.56

g/l

0.88

4062

21652

Sequelae of external causes of morbidity and mortality

1379

7684

1.91

97.80

2.8

2.6

65.53

66.36

g/l

3.44

1285

6942

Other (seronegative) rheumatoid arthritis, wide

1114

5816

2.06

97.38

2.1

2.6

65.70

66.33

g/l

1.67

1023

5230

Hypotension

1041

5339

2.13

97.00

2.7

2.4

64.63

65.95

g/l

5.98

901

4710

Chronic periodontitis, complicated

623

2615

2.67

96.61

4.0

2.8

64.14

66.51

g/l

10.49

589

2396

Chronic periodontitis, including avohilmo

4460

23759

1.43

96.37

2.6

66.38

66.56

g/l

0.77

4037

21656

Non-allergic asthma (mode), excluding more controls

902

4312

2.18

95.54

2.2

2.3

65.99

67.35

g/l

5.88

828

3850

Other and unspecified vasculitis limited to skin

233

557

5.43

95.42

2.3

2.9

67.08

66.27

g/l

0.76

217

502

Injuries to the thorax

2307

14777

1.63

95.19

2.6

2.5

65.75

66.43

g/l

4.18

2056

13391

External causes of morbidity and mortality

3338

11243

1.52

95.15

2.5

66.40

66.94

g/l

3.47

3044

10349

Other disorders of lacrimal gland

1720

10267

1.76

94.86

3.0

2.6

66.61

66.39

g/l

0.56

1554

9293

Methotrexate

769

3518

2.34

94.75

2.0

2.8

66.14

66.57

g/l

0.78

719

3175

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1248

6822

1.96

94.62

3.9

1.6

64.51

66.81

g/l

18.57

1162

6110

Other respiratory diseases principally affecting the interstitium

1100

5797

2.06

94.49

2.3

2.5

65.84

65.95

g/l

0.18

1020

5165

Fracture of rib(s), sternum and thoracic spine

1620

9572

1.79

93.49

2.7

2.5

65.78

66.38

g/l

2.42

1434

8639

Idiopathic gout

620

2658

2.64

92.38

2.3

2.6

64.88

66.16

g/l

3.79

569

2405

Dental operations

3594

12708

1.49

92.23

2.7

2.3

66.28

66.36

g/l

0.23

3232

11451

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

249

634

4.78

92.20

5.0

1.6

64.22

67.05

g/l

4.84

238

572

Retention of urine

1919

9996

1.71

91.86

2.3

2.6

65.73

66.35

g/l

2.71

1719

9047

Drug-induced osteoporosis with pathological fracture

188

399

6.91

91.44

1.9

2.9

63.62

66.72

g/l

4.91

162

361

Other arthrosis

2557

11940

1.58

91.20

2.3

2.8

66.75

66.29

g/l

2.48

2322

10887

ILD, hospital admissions 3, with pneumonia sepsis

558

2294

2.74

90.73

2.2

65.30

66.54

g/l

2.85

517

2047

Acute sinusitis

2261

13506

1.61

90.53

3.2

2.3

66.45

66.76

g/l

1.16

2055

12375

Gastroduodenal ulcer

1506

8787

1.81

90.12

2.3

2.6

65.34

66.15

g/l

3.29

1373

7847

Diseases of pulp and periapical tissues, including avohilmo

5410

20888

1.37

89.17

2.6

2.5

66.59

66.53

g/l

0.22

4925

18968

Cutaneous abscess, furuncle and carbuncle

1228

6773

1.91

88.83

2.5

2.4

65.76

66.73

g/l

4.25

1142

6209

Visual disturbances

2310

15036

1.60

88.63

2.5

66.57

66.44

g/l

0.38

2100

13624

Myeloid leukaemia

249

661

4.79

88.57

2.3

3.0

65.39

66.35

g/l

1.15

241

600

Undetermined asthma

635

2751

2.46

88.55

2.4

2.1

66.12

67.06

g/l

2.28

581

2459

Systemic lupus erythematosus

273

761

4.24

88.40

2.0

2.9

66.07

66.86

g/l

0.82

254

698

Migraine

1890

9881

1.67

88.29

2.2

2.6

67.17

66.73

g/l

1.88

1735

9076

Dental pulpitis 4

5408

20915

1.37

88.13

2.6

2.5

66.58

66.52

g/l

0.22

4926

18999

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

958

4819

2.09

88.12

4.7

1.5

64.93

66.74

g/l

10.89

891

4219

Other disorders of skin and subcutaneous tissue, not elsewhere classified

835

4083

2.21

87.99

2.6

2.5

65.50

66.37

g/l

2.29

736

3684

Temporal arteritis

323

1025

3.90

87.78

1.7

3.0

65.07

66.06

g/l

1.37

292

919

Dental pulpitis 1

5403

20924

1.37

87.39

2.6

2.5

66.58

66.52

g/l

0.23

4922

19006

Mycoses

1345

7678

1.85

87.39

3.0

2.5

65.30

66.52

g/l

6.50

1230

6975

Mood [affective] disorders

4809

23318

1.39

87.32

2.1

2.6

66.71

66.60

g/l

0.44

4319

21306

Disorders of lacrimal system

2065

13171

1.63

86.93

2.9

2.5

66.65

66.34

g/l

1.04

1869

11873

Viral hepatitis, IBD co-morbidity

220

515

4.57

86.87

2.1

2.7

67.72

66.88

g/l

0.67

202

485

Injuries to the hip and thigh

2440

14745

1.57

86.77

2.3

2.5

65.12

66.33

g/l

10.59

2084

13287

Mood disorders

4819

23365

1.38

86.73

2.1

2.6

66.71

66.59

g/l

0.51

4328

21349

Benign neoplasm of other and ill-defined parts of digestive system

926

4725

2.10

86.29

2.5

1.6

65.78

66.78

g/l

3.72

849

4196

Dental caries 1 and operation codes

4545

16966

1.41

85.80

2.5

66.17

66.42

g/l

1.23

4103

15377

Dental caries 1

4180

15365

1.42

84.67

2.5

66.22

66.38

g/l

0.60

3763

13913

Endocarditis

272

780

4.12

84.61

2.3

2.7

64.95

67.11

g/l

3.69

257

713

Fungal Sepsis

290

871

3.97

84.52

2.8

2.5

62.62

66.75

g/l

11.11

265

802

Depression

4359

21926

1.40

84.35

2.1

2.6

66.72

66.65

g/l

0.26

3917

20079

Chronic ulcer of skin, not elsewhere classified

474

1869

2.88

84.32

2.5

2.6

64.95

66.25

g/l

2.75

431

1695

Other diseases of liver

935

4823

2.07

84.24

2.2

2.6

67.30

66.53

g/l

2.10

843

4429

ILD, hospital admissions

925

4790

2.11

84.19

2.2

2.5

66.14

66.02

g/l

0.17

856

4288

Diseases of the myoneural junction and muscle

722

3405

2.32

84.18

2.1

2.6

64.78

66.30

g/l

5.30

641

3089

Dental caries, including avohilmo

4172

15353

1.42

84.04

2.5

66.23

66.38

g/l

0.58

3755

13901

COPD

2478

13613

1.57

84.03

2.1

2.7

65.12

66.34

g/l

11.51

2228

12270

Cardiomyopathy, other and unspecified

489

1947

2.78

84.02

2.4

2.6

64.76

66.98

g/l

7.38

447

1753

Parodontitis and operation codes

4160

23597

1.41

83.63

2.6

66.45

66.55

g/l

0.35

3767

21526

Cellulitis

1107

6054

1.93

82.94

2.8

2.5

65.35

66.59

g/l

5.24

1030

5514

Other symptoms and signs involving cognitive functions and awareness

2337

14505

1.57

82.86

2.1

2.6

65.96

66.29

g/l

1.19

2037

13116

Cholelithiasis, broad definition with cholecystitis

4310

21634

1.40

82.83

2.6

2.5

66.18

66.55

g/l

2.37

3896

19612

Other interstitial pulmonary diseases

933

4876

2.08

82.60

2.2

2.5

66.17

66.02

g/l

0.22

864

4358

Dental pulpitis 2

3780

13738

1.44

82.57

2.5

66.24

66.35

g/l

0.36

3403

12402

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2692

12392

1.53

82.54

2.8

1.6

65.98

66.89

g/l

7.48

2419

11073

Urticaria and erythema

1620

9844

1.71

82.39

2.7

2.5

66.88

66.57

g/l

0.91

1487

8990

Interstitial lung disease endpoints

933

4881

2.08

82.35

2.2

2.5

66.17

66.01

g/l

0.23

864

4364

Interstitial lung disease

933

4881

2.08

82.35

2.2

2.5

66.17

66.01

g/l

0.23

864

4364

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

442

1699

2.94

82.33

4.2

1.6

64.64

66.76

g/l

6.69

424

1505

Obesity, other/unspecified

1460

8635

1.76

82.26

1.8

2.5

66.46

66.79

g/l

0.92

1346

7927

Noninfective enteritis and colitis

2155

14023

1.59

81.68

2.5

66.22

66.60

g/l

1.33

1973

12748

Giant cell arteritis with polymyalgia rheumatica

323

1072

3.71

81.63

1.7

2.9

65.07

66.20

g/l

1.70

292

963

Diffuse large B-cell lymphoma

360

1267

3.40

81.38

2.2

2.9

62.69

66.36

g/l

11.55

341

1148

Cytomegalovirus infection, IBD co-morbidity

197

465

5.34

81.34

6.2

2.8

62.19

66.99

g/l

11.13

185

426

Substance abuse, excluding more controls

2588

15276

1.52

81.27

1.8

2.7

66.13

66.75

g/l

3.27

2306

14144

Disorders of the thyroid gland

4587

22203

1.38

81.07

2.4

2.6

66.41

66.53

g/l

0.47

4166

20181

Rotator cuff syndrome

3034

15630

1.48

81.06

2.4

2.7

66.58

66.50

g/l

0.23

2784

14199

Neurotic, stress-related and somatoform disorders

3906

20082

1.41

80.77

2.4

2.6

66.60

66.71

g/l

0.38

3554

18384

Anxiety disorders

3959

20343

1.41

80.63

2.4

2.6

66.62

66.70

g/l

0.25

3601

18607

Acute upper respiratory infections of multiple and unspecified sites

3319

17521

1.45

80.51

3.7

2.3

66.10

66.65

g/l

3.70

3035

15961

In situ neoplasms

1642

9617

1.70

80.15

2.5

1.6

65.44

66.81

g/l

10.29

1479

8519

SLE, ICD10

264

774

4.03

79.53

2.0

2.8

66.10

67.18

g/l

1.29

245

707

SLE, strict definition

264

774

4.03

79.53

2.0

2.8

66.10

67.18

g/l

1.29

245

707

Other/unspecified cytomegaloviral diseases

175

385

5.85

79.14

6.7

2.9

61.91

67.03

g/l

10.60

166

356

Cytomegaloviral disease

198

479

5.14

78.97

6.2

2.9

62.22

66.99

g/l

11.15

186

440

Zoster [herpes zoster]

999

5397

1.98

78.90

3.9

2.5

65.43

66.17

g/l

2.16

909

4814

Osteomyelitis

422

1625

2.93

78.42

2.8

2.5

65.03

66.36

g/l

2.60

381

1501

Other and unspecified types of non-Hodgkin lymphoma, hilmo

333

1142

3.46

78.41

3.2

2.8

63.71

66.17

g/l

5.45

314

1037

Non-allergic asthma (mode)

902

4633

2.02

78.39

2.2

65.99

67.07

g/l

3.92

828

4152

Other autoimmune haemolytic anaemias

148

291

7.45

78.25

3.2

3.1

66.89

66.20

g/l

0.35

141

260

Secondary right heart disease

331

1133

3.46

78.08

2.1

2.7

65.12

66.13

g/l

1.46

310

1018

Implicit fungal Sepsis

267

802

3.98

77.95

2.8

2.5

62.87

66.78

g/l

9.85

244

736

Anxiety (asthma-related co-morbidities)

2354

12320

1.54

77.82

2.1

2.6

66.75

66.95

g/l

0.59

2136

11408

Stroke, including SAH

3378

17854

1.45

77.80

2.3

2.7

65.39

66.43

g/l

11.08

3016

16129

Benign neoplasm: Sigmoid colon

946

5045

2.01

77.55

2.5

1.6

66.22

66.77

g/l

1.37

862

4467

Other respiratory disorders and diseases

1170

6671

1.87

77.38

2.2

2.5

64.82

65.97

g/l

4.76

1052

5954

Other diseases of the respiratory system

1170

6671

1.87

77.38

2.2

2.5

64.82

65.97

g/l

4.76

1052

5954

Osteonecrosis

385

1428

3.07

77.19

6.9

2.6

65.27

66.65

g/l

2.86

354

1318

Dental caries 3 and operation codes

4641

17682

1.38

77.11

2.5

66.22

66.46

g/l

1.16

4195

16040

Dental caries 3

4318

16209

1.39

77.03

2.4

2.5

66.28

66.43

g/l

0.56

3891

14695

Valvular operations

794

4016

2.12

75.87

1.9

2.5

65.51

66.85

g/l

4.80

735

3574

2749

17528

1.48

75.24

1.9

2.6

66.06

66.68

g/l

3.47

2465

16144

Injury, poisoning and certain other consequences of external causes

2657

8981

1.52

74.64

2.6

66.45

66.97

g/l

2.73

2415

8255

Dental pulpitis 2, only avohilmo

3822

14161

1.41

74.52

2.4

2.5

66.24

66.32

g/l

0.24

3433

12795

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1310

6475

1.79

74.43

2.0

1.7

64.88

66.71

g/l

13.87

1224

5746

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2458

11409

1.53

74.15

2.8

1.6

65.89

66.81

g/l

6.83

2207

10153

Other abnormalities of plasma proteins

162

358

6.19

74.08

4.2

2.7

63.28

66.22

g/l

2.89

152

317

Missing teeth due to accident, extraction or parodontitis

661

3163

2.26

73.89

4.0

2.3

65.60

66.46

g/l

1.87

605

2874

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

161

354

6.09

73.66

2.6

1.6

66.01

67.80

g/l

1.59

150

316

Amputation

634

3002

2.32

73.62

2.7

2.5

63.47

66.07

g/l

11.62

574

2683

Deforming dorsopathies

1285

7578

1.77

73.49

2.5

2.6

66.62

66.38

g/l

0.50

1165

6902

Rheumatism, unspecified

729

3612

2.15

73.41

2.0

2.8

66.89

66.48

g/l

0.83

675

3270

Cholelithiasis

4108

21375

1.38

73.04

2.7

2.5

66.24

66.56

g/l

1.77

3710

19365

Alcohol use disorder, Swedish definition

2625

16885

1.49

72.90

1.8

2.6

66.02

66.68

g/l

3.67

2353

15561

All anxiety disorders

2376

12903

1.52

72.89

2.1

2.5

66.76

66.93

g/l

0.50

2156

11909

2855

17979

1.46

72.71

1.9

2.6

66.08

66.70

g/l

3.60

2559

16568

Gastric ulcer

1019

5675

1.91

72.69

2.3

2.5

64.95

66.15

g/l

4.61

923

5036

Hypoparathyroidism

280

907

3.67

72.53

2.3

2.9

65.26

66.50

g/l

1.86

242

817

Other chronic obstructive pulmonary disease

2346

13258

1.53

72.19

2.0

2.7

65.02

66.32

g/l

12.23

2103

11946

Sequelae with surgical and medical care as external cause

1082

6154

1.87

72.16

2.7

2.6

65.59

66.31

g/l

2.23

1005

5535

Rare circulating lymphoid malignancy

249

754

3.97

72.00

5.0

3.0

64.22

65.90

g/l

2.05

238

685

Other diseases of hard tissues of teeth

2883

15080

1.46

71.89

3.0

2.4

66.44

66.74

g/l

1.18

2636

13787

Systemic lupus erythematosus, unspecified

229

654

4.15

71.85

1.8

2.7

66.08

67.28

g/l

1.38

213

601

Seropositive rheumatoid arthritis, strict definition

831

4362

2.04

71.58

1.8

2.6

66.61

66.49

g/l

0.17

771

3964

Cardiomyopathy in other diseases

123

14.41

71.13

9.6

2.5

63.41

66.95

g/l

2.90

108

Other pulmonary heart/vessel disease

345

1272

3.15

70.76

2.0

2.7

65.01

66.00

g/l

1.45

319

1150

ILD, hospital admissions 1, main diag only

813

4283

2.07

70.52

2.2

2.6

66.28

66.03

g/l

0.38

749

3851

Stroke, excluding SAH

3203

17144

1.43

70.36

2.3

2.6

65.33

66.39

g/l

10.90

2866

15456

Need for other prophylactic measures

356

1329

3.02

70.22

2.4

2.9

64.09

66.66

g/l

6.85

341

1218

Spondyloarthritis

890

4782

1.96

70.08

2.4

2.5

66.96

66.45

g/l

1.13

823

4336

Diagnoses used for exclusion with ILD

1357

8286

1.72

69.13

2.2

2.4

66.17

66.29

g/l

0.20

1244

7460

Myocardial infarction

2713

13661

1.48

69.11

2.4

2.7

65.32

66.41

g/l

10.70

2460

12270

Other diseases of blood and blood-forming organs

424

1738

2.72

69.10

3.4

2.8

66.80

66.37

g/l

0.51

380

1596

Hypothyroidism, other/unspecified

4198

20759

1.36

69.01

2.4

2.6

66.53

66.52

g/l

0.02

3803

18855

Other anxiety disorders

1669

9406

1.61

68.44

2.0

2.4

66.94

67.03

g/l

0.17

1524

8691

Sub-endpoint used in defining T1D endpoints

1401

8480

1.69

67.77

2.4

64.98

66.46

g/l

10.42

1291

7651

Hydronephrosis

594

2816

2.27

67.66

2.7

2.4

65.04

66.51

g/l

4.80

552

2549

Arthropathies in other diseases classified elsewhere

250

783

3.68

67.43

3.1

3.0

65.69

66.50

g/l

0.84

225

716

Acute peritonitis

413

1695

2.73

67.28

3.2

2.7

63.15

66.47

g/l

13.95

394

1546

Soft tissue disorders related to use, overuse and pressure

1275

7701

1.73

67.12

2.4

2.7

66.22

66.47

g/l

0.59

1144

6986

Other noninfective gastroenteritis and colitis

1170

6908

1.77

66.87

2.8

2.5

65.74

66.42

g/l

2.06

1071

6239

Fracture of femur

1434

8156

1.68

66.61

2.4

64.63

66.00

g/l

7.41

1164

7205

Other disorders of ear

4464

22619

1.34

66.50

2.7

2.5

66.30

66.49

g/l

0.86

3998

20628

Acute myeloid leukaemia and myelodysplastic syndromes

176

448

5.03

66.48

2.6

2.5

66.01

65.69

g/l

0.20

166

405

Other degenerative diseases of the nervous system

1360

6273

1.71

66.47

1.9

2.8

66.38

66.20

g/l

0.35

1159

5676

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2351

11127

1.51

66.42

2.7

1.6

65.85

66.79

g/l

6.84

2103

9891

Other general symptoms and signs

253

784

3.49

66.37

2.0

2.5

67.48

66.85

g/l

0.67

233

720

Amputation of toe

471

2071

2.56

66.36

2.7

2.6

63.52

66.23

g/l

9.73

430

1882

Other and unspecified immunodeficiencies with predominantly antibody defects

125

241

6.84

65.96

4.3

2.7

61.46

67.27

g/l

10.09

120

223

Exclusions for E4_PCOS_BROAD

797

4220

1.99

65.81

2.8

2.5

65.71

66.70

g/l

3.04

741

3882

Other diseases of anus and rectum

1459

9153

1.66

65.75

2.7

2.5

65.78

66.39

g/l

2.16

1267

8253

Benign neoplasm: Ascending colon

693

3531

2.12

65.59

2.6

1.6

66.21

66.75

g/l

1.08

634

3121

Diabetic retinopathy

1819

7516

1.61

65.30

2.4

2.2

65.74

66.61

g/l

4.72

1666

6806

Cardiodefibrillation

2004

13551

1.55

65.28

2.4

2.6

65.42

66.25

g/l

4.94

1829

12216

Acute upper respiratory infections

4936

23856

1.32

65.09

3.2

2.4

66.32

66.54

g/l

1.19

4484

21663

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2371

11253

1.50

65.07

2.8

1.6

65.87

66.80

g/l

6.83

2120

10008

Complications of internal orthopaedic prosthetic devices, implants and grafts

1223

7406

1.75

64.98

2.1

2.6

65.65

66.16

g/l

1.40

1077

6605

Hypothyreosis and Thyroxine purchase for inclusion criteria

4323

21657

1.34

64.93

2.5

66.54

66.49

g/l

0.17

3920

19669

Coxibs

1452

4707

1.69

64.92

2.1

2.4

66.54

65.87

g/l

2.26

1316

4289

Other and unspecified diseases of blood and blood-forming organs

208

601

4.21

64.86

4.4

3.0

66.79

66.72

g/l

0.04

194

553

Abnormal involuntary movements

689

3516

2.10

64.31

2.4

2.7

66.67

66.25

g/l

0.76

618

3200

Peripheral artery operations in Hilmo

758

4005

2.03

64.26

2.5

64.11

66.14

g/l

8.78

683

3568

Major coronary heart disease event

3704

18428

1.38

64.24

2.4

2.7

65.63

66.44

g/l

7.93

3374

16631

Allergic asthma (mode), excluding more controls

819

4289

1.93

64.17

2.0

2.1

66.81

67.73

g/l

3.19

756

3895

Other viral diseases

1156

6842

1.74

64.07

3.8

2.4

65.44

66.84

g/l

7.42

1088

6326

Non-Hodgkin lymphoma, all

307

1125

3.20

64.06

4.0

2.8

63.87

65.99

g/l

3.24

294

1020

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

385

1563

2.74

63.90

6.2

1.5

64.26

66.84

g/l

8.40

365

1370

Other chronic obstructive pulmonary disease, including avohilmo

2810

16800

1.44

63.78

2.0

2.7

65.14

66.39

g/l

13.56

2519

15219

Dental caries 1, only avohilmo

4172

16057

1.36

63.64

2.4

2.6

66.34

66.28

g/l

0.20

3750

14570

Abnormal findings on diagnostic imaging of other body structures

680

3477

2.10

63.42

3.0

2.6

65.89

66.47

g/l

1.08

631

3151

Disorder of lipoprotein metabolism, unspecified

757

4017

2.02

63.34

2.2

2.4

65.97

66.37

g/l

0.66

686

3586

Myocardial infarction, without ST-elevation

2184

13916

1.51

63.28

2.3

2.6

65.34

66.13

g/l

5.18

1951

12449

Ischaemic Stroke, excluding all haemorrhages

3004

16489

1.42

63.25

2.2

2.6

65.35

66.36

g/l

9.48

2690

14835

Intracranial injury

2636

18150

1.44

62.88

2.3

2.5

66.45

66.53

g/l

0.19

2345

16508

Demyelinating diseases of the central nervous system

409

1704

2.58

62.80

1.6

2.5

68.31

67.06

g/l

2.90

385

1574

Pain in thoracic spine

689

3529

2.06

62.66

2.7

2.5

67.00

66.46

g/l

1.18

629

3234

Polyuria

1172

7081

1.75

62.55

2.1

2.5

66.40

66.34

g/l

0.11

1038

6406

Artrosis, including avohilmo

4070

16814

1.35

62.53

2.1

2.7

66.94

66.39

g/l

4.72

3690

15394

Spondylopathies (FG)

600

2922

2.16

62.52

2.0

2.8

67.81

66.70

g/l

2.80

552

2701

Irritable bowel syndrome

1192

7193

1.72

62.45

2.4

2.5

66.63

66.71

g/l

0.14

1066

6555

Migraine without aura

680

3453

2.04

62.25

2.4

2.6

67.13

66.98

g/l

0.20

629

3206

Peripheral arterial reconstruction

994

5776

1.84

62.20

2.2

2.5

64.55

65.95

g/l

5.97

887

5116

Major coronary heart disease event excluding revascularizations

3426

17554

1.39

61.76

2.4

2.7

65.52

66.41

g/l

9.06

3104

15829

Spondylopathies in diseases classified elsewhere

131

284

6.31

61.33

17.2

2.1

64.65

66.58

g/l

2.01

123

257

Open wound of head

2432

16930

1.45

61.21

2.3

2.6

65.83

66.50

g/l

3.94

2160

15433

Injuries to the shoulder and upper arm

3878

24654

1.35

61.04

2.6

66.39

66.51

g/l

0.44

3479

22455

Disorders of continuity of bone

460

2048

2.41

60.96

3.4

2.5

66.45

66.70

g/l

0.30

420

1893

Other disorders of adrenal gland

273

952

3.23

60.94

2.5

3.0

64.91

66.65

g/l

2.99

257

874

Pericarditis

237

764

3.53

60.74

2.3

2.7

64.54

67.31

g/l

5.94

224

695

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

649

3324

2.10

60.45

3.0

1.6

65.57

66.65

g/l

2.74

596

2930

Myeloproliferative diseases

516

2440

2.33

60.45

2.7

2.6

66.49

66.32

g/l

0.19

472

2216

Adrenocortical insufficiency

239

780

3.53

60.38

2.5

3.0

64.60

66.84

g/l

4.15

224

714

Other disorders of veins

1816

12189

1.54

60.30

2.3

2.5

66.62

66.56

g/l

0.13

1592

11031

Alcoholic liver disease

572

2811

2.22

60.12

1.7

2.7

65.50

66.34

g/l

1.37

513

2574

Paralytic ileus and intestinal obstruction

1272

7911

1.68

59.81

2.7

2.5

65.38

66.33

g/l

3.80

1148

7104

Dental operations, only avohilmo

3673

14034

1.37

59.64

2.5

66.32

66.25

g/l

0.22

3300

12710

Temporomandibular joint disorders

632

3183

2.07

59.59

2.8

2.5

67.36

66.55

g/l

2.20

583

2889

Benign neoplasm: Transverse colon

550

2674

2.24

59.54

2.6

1.6

65.67

66.82

g/l

2.82

494

2361

Idiopathic thrombocytopenic purpura

218

682

3.74

59.36

2.8

66.42

66.33

g/l

0.05

205

617

Meniscus derangement

2553

12392

1.44

59.32

2.6

2.7

66.81

66.30

g/l

2.87

2318

11309

Mental and behavioural disorders due to psychoactive substance use

2677

18220

1.42

59.27

1.8

2.6

66.16

66.70

g/l

2.66

2386

16785

Personality disorders, excluding more controls

927

5282

1.81

59.19

1.9

2.6

66.66

67.18

g/l

1.37

843

4952

Functional dyspepsia

1217

7501

1.69

59.11

2.5

2.6

66.73

66.53

g/l

0.40

1111

6796

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

467

2127

2.37

59.00

3.8

2.5

66.11

66.58

g/l

0.65

434

1946

Urticaria

1224

7560

1.68

58.45

2.7

2.5

66.90

66.68

g/l

0.47

1121

6915

Unspecified fall

2247

15677

1.46

58.36

2.3

2.5

65.67

66.44

g/l

4.60

1957

14210

Biological medication for rheuma

656

3386

2.03

58.25

1.9

2.7

67.70

67.03

g/l

1.37

609

3138

Other symptoms and signs involving the digestive system and abdomen

779

4260

1.92

58.25

3.5

2.5

65.78

66.58

g/l

2.26

698

3835

Hodgkin lymphoma

181

508

4.09

57.58

2.6

1.6

65.94

67.30

g/l

1.14

173

465

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

573

2863

2.17

57.35

3.0

1.6

65.40

66.70

g/l

3.42

533

2531

Oesophageal varices

281

1039

3.11

57.19

1.7

2.7

64.82

66.61

g/l

2.71

261

945

Selective serotonin reuptake inhibitors

4751

19449

1.31

57.04

2.3

2.6

66.67

66.56

g/l

0.44

4274

17812

Carpal tunnel syndrome

2769

18242

1.40

57.02

2.4

2.6

66.76

66.53

g/l

0.92

2538

16549

Angina pectoris

3076

15348

1.39

56.90

2.6

2.7

66.04

66.48

g/l

2.47

2821

13799

Benign neoplasm: Colon, unspecified

1314

8376

1.65

56.85

2.6

65.97

66.13

g/l

0.32

1168

7518

Persons encountering health services for specific procedures, not carried out

377

1587

2.56

56.85

2.2

2.4

67.11

67.03

g/l

0.07

342

1462

Eosinophilic disease (BM)

124

267

5.66

56.76

2.2

2.3

65.25

66.94

g/l

1.28

112

237

Exposure to other specified factors

3140

21922

1.37

56.65

2.4

2.5

66.39

66.69

g/l

1.36

2821

20122

Hypothyroidism, strict autoimmune, 3 medication purchases required

3860

20069

1.34

56.62

2.4

2.5

66.63

66.48

g/l

0.59

3479

18183

Diabetic neuropathy

677

3600

2.05

56.62

2.3

65.91

66.45

g/l

1.06

616

3252

Other complications of surgical and medical care, not elsewhere classified

498

2369

2.26

56.29

2.9

2.5

65.76

66.65

g/l

1.74

457

2169

Other diseases of intestine

651

3416

2.04

56.24

2.6

2.5

64.62

66.31

g/l

5.76

611

3081

Dental caries 3, only avohilmo

4284

16841

1.33

56.24

2.4

2.6

66.35

66.33

g/l

0.06

3854

15294

Substance abuse

2588

17903

1.41

56.23

1.8

2.6

66.13

66.72

g/l

3.02

2306

16497

Drug-induced neutropenia

417

1866

2.47

55.87

3.6

2.8

64.38

66.63

g/l

5.89

399

1699

Diseases of spleen

148

375

4.90

55.77

2.1

2.8

64.60

66.54

g/l

1.70

140

341

Other and unspecified myopathies

497

2392

2.27

55.37

2.1

2.5

64.71

66.18

g/l

3.44

432

2170

Recurrent or chronic depression

1594

7548

1.56

55.32

2.1

2.7

67.11

66.99

g/l

0.26

1440

7055

Subjective visual disturbances

1129

6957

1.70

55.25

2.4

2.5

66.91

66.43

g/l

1.43

1019

6306

L01XE Protein kinase inhibitors

377

1637

2.61

55.01

3.9

2.9

64.21

66.48

g/l

5.92

361

1503

Fentanyl

536

2654

2.16

54.28

5.8

2.1

64.81

65.95

g/l

2.33

474

2361

Allergic asthma (mode)

819

4528

1.82

54.02

2.0

2.1

66.81

67.47

g/l

1.86

756

4124

All influenza (not pneumonia)

670

3574

1.97

53.97

4.3

2.2

65.82

67.15

g/l

3.99

613

3249

Disorders of synovium and tendon

2255

14436

1.44

53.94

2.3

2.7

66.46

66.61

g/l

0.45

2062

13142

Migraine with aura

845

4820

1.81

53.84

2.0

2.6

67.13

66.84

g/l

0.60

779

4430

Cervical disc disorders

1677

11346

1.53

53.59

2.3

2.6

66.81

66.39

g/l

1.52

1536

10379

Decubitus ulcer and pressure area

363

1567

2.58

53.10

2.1

2.6

63.98

66.08

g/l

4.33

318

1419

Charcot foot

145

375

4.75

53.05

2.9

3.0

65.92

67.30

g/l

1.20

132

343

Degeneration of macula and posterior pole

2455

14692

1.43

52.92

2.5

2.6

65.84

66.06

g/l

0.70

2170

13079

Benign neoplasm: Stomach

502

2460

2.20

52.88

2.6

1.6

65.53

66.76

g/l

3.04

449

2172

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

238

845

3.27

52.42

7.0

1.5

64.25

67.07

g/l

6.27

229

747

Elevated blood glucose level

434

2016

2.33

52.41

3.0

2.6

65.08

66.37

g/l

2.85

396

1852

Respiratory insufficiency

425

1952

2.34

52.28

1.8

2.0

64.46

66.59

g/l

6.43

381

1718

Benign neoplasm of other and ill-defined parts of digestive system

926

5526

1.78

52.22

2.5

2.6

65.78

66.22

g/l

1.00

849

4967

Other/unspecified rheumatoid arthritis

692

3800

1.95

52.20

2.0

2.5

65.46

66.25

g/l

1.60

631

3395

Cervicalgia

935

5563

1.75

52.16

2.2

2.6

67.05

66.31

g/l

2.40

835

5032

Nonalcoholic fatty liver disease

455

2154

2.27

52.15

2.1

2.8

68.48

66.75

g/l

4.63

409

1984

Pneumonia due to other infectious organisms, not elsewhere classified

206

671

3.50

52.08

5.1

2.3

62.66

66.69

g/l

7.39

199

599

Haemorrhage, not elsewhere classified

232

810

3.24

51.91

2.2

2.5

64.71

66.49

g/l

2.40

215

727

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

974

5834

1.72

51.89

2.0

2.5

66.30

67.07

g/l

2.43

889

5453

Diseases of peritoneum

556

2857

2.09

51.32

2.8

2.6

64.01

66.39

g/l

10.41

518

2599

Pyogenic arthritis

361

1565

2.50

51.31

2.7

2.9

66.37

66.03

g/l

0.34

335

1426

Sarcoidosis

678

3713

1.94

51.22

2.1

2.6

66.70

66.63

g/l

0.08

640

3409

Somatoform disorder

715

3962

1.89

51.16

2.2

2.6

66.70

66.85

g/l

0.24

642

3642

Phlebitis and thrombophlebitis (not including DVT)

1079

6707

1.68

51.16

3.3

2.5

65.29

66.40

g/l

4.48

990

6073

Conductive and sensorineural hearing loss

3885

20849

1.32

51.16

2.6

66.26

66.41

g/l

0.57

3436

18965

Dental pulpitis 4, only avohilmo

5250

21876

1.27

51.10

2.4

2.5

66.72

66.45

g/l

1.72

4800

19881

Viral pneumonia (unknown virus, not influenza)

343

1456

2.56

51.10

3.8

2.7

64.91

66.81

g/l

4.06

318

1340

Renal tubulo-interstitial disorders in diseases classified elsewhere

102

208

6.57

50.95

5.8

2.4

63.87

66.81

g/l

2.77

190

Insulin, fast-acting (human)

624

3312

1.97

50.93

2.7

2.3

64.26

66.86

g/l

14.73

581

3053

Chronic sinusitis

1873

13057

1.47

50.80

2.4

2.6

66.34

66.58

g/l

0.72

1712

11929

Problems related to lifestyle

452

2144

2.23

50.77

1.8

2.6

66.44

67.09

g/l

0.91

412

1970

Other diseases of arteries and capillaries

496

2460

2.18

50.61

2.4

2.6

65.62

66.39

g/l

1.36

440

2232

Abnormal findings on diagnostic imaging of central nervous system

251

925

3.01

50.41

2.2

3.1

67.61

66.95

g/l

0.67

233

851

Disorders of sclera, cornea, iris and ciliary body

2368

17263

1.41

49.81

2.5

67.02

66.52

g/l

2.52

2163

15739

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

516

2614

2.13

49.73

3.1

2.6

65.06

66.45

g/l

3.41

483

2393

Diseases of the ear and mastoid process

5337

21640

1.27

49.71

2.6

2.5

66.66

66.56

g/l

0.37

4844

19817

Papulosquamous disorders

1786

12432

1.48

49.49

2.2

2.6

67.03

66.52

g/l

2.00

1638

11335

L01XX Other antineoplastic agents

367

1651

2.50

49.33

4.8

2.8

65.12

66.43

g/l

2.28

338

1499

Symptoms and signs involving speech and voice

1531

10364

1.53

49.28

2.4

2.5

66.23

66.35

g/l

0.26

1389

9348

DVT of lower extremities

965

5902

1.72

49.13

3.7

2.5

65.33

66.26

g/l

3.14

862

5303

Asthma and allergy, excluding more controls

409

1850

2.26

49.10

2.1

66.88

67.89

g/l

2.10

376

1702

malignant neoplasm of female genital organs

779

4515

1.84

49.05

5.1

2.4

65.02

66.17

g/l

4.22

726

3967

Cerebral palsy and other paralytic syndromes

559

2912

2.04

49.05

2.0

2.6

65.94

66.41

g/l

0.66

504

2671

Abnormal results of function studies

427

2022

2.27

48.95

2.6

2.9

66.51

66.70

g/l

0.18

393

1865

Non-selective monoamine reuptake inhibitors

1828

12410

1.47

48.83

2.3

2.7

66.23

66.44

g/l

0.58

1639

11258

Persons with potential health hazards related to communicable diseases

1298

8391

1.57

48.60

2.5

2.3

65.79

66.98

g/l

6.47

1217

7798

Benign neoplasm of other and unspecified endocrine glands

580

3068

2.00

48.60

2.4

1.6

66.02

67.02

g/l

2.44

527

2744

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

196

656

3.53

48.23

6.7

1.4

63.62

67.10

g/l

7.38

190

581

COPD, hospital admissions

2353

14583

1.41

48.12

2.0

2.6

65.03

66.30

g/l

12.00

2105

13166

Other and unspecified drugs and medicaments

428

2047

2.26

48.03

3.7

2.6

66.14

66.61

g/l

0.61

399

1865

Lichen simplex chronicus and prurigo

359

1606

2.45

47.91

2.2

2.8

67.08

66.38

g/l

1.00

329

1454

Myocardial infarction, strict

2427

12996

1.41

47.74

2.3

2.7

65.39

66.40

g/l

8.50

2198

11667

Candidiasis

626

3413

1.94

47.72

3.3

2.4

64.72

66.53

g/l

6.35

564

3121

COPD, early/later onset

2367

14666

1.41

47.71

2.0

2.6

65.02

66.31

g/l

12.32

2118

13244

Paracetamol of NSAID medication

766

2121

1.86

47.65

2.7

2.3

66.73

66.27

g/l

0.77

694

1972

COPD related to multimorbidity

2063

12476

1.44

47.61

2.0

2.6

64.86

66.24

g/l

12.37

1832

11227

Benign neoplasm: Caecum

529

2750

2.08

47.53

2.8

1.6

65.88

66.62

g/l

1.31

488

2418

Other or unspecified ileus, impaction or obstruction

909

5519

1.73

47.37

2.7

2.5

65.35

66.24

g/l

2.40

819

4940

Other coagulation defects

356

1589

2.42

47.22

2.8

2.7

66.19

66.59

g/l

0.46

334

1464

Injuries to the knee and lower leg

5359

24805

1.25

47.20

2.3

2.6

66.17

66.63

g/l

4.00

4842

22622

Dental pulpitis 1, only avohilmo

5225

21967

1.26

47.12

2.4

2.6

66.73

66.44

g/l

1.87

4772

19965

Myeloproliferative diseases (CML excluded)

446

2195

2.22

47.08

2.9

2.7

66.75

66.32

g/l

0.55

405

1995

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1072

5638

1.66

46.89

1.9

1.6

64.82

66.68

g/l

11.54

993

4980

Diabetic retinopathy, strict definition

921

4947

1.74

46.85

2.6

2.2

65.26

66.67

g/l

6.16

839

4492

Other embolism and thrombosis

657

3665

1.90

46.76

3.2

2.5

64.88

66.27

g/l

3.93

606

3307

Prurigo nodularis

182

595

3.60

46.50

2.0

3.3

67.31

66.52

g/l

0.69

167

536

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1308

8666

1.56

46.37

2.4

65.84

66.56

g/l

2.73

1167

7913

Postprocedural disorders of nervous system

301

1251

2.56

46.33

2.0

2.4

67.92

67.69

g/l

0.24

282

1163

Disorders of skin appendages

1891

13421

1.44

46.27

2.4

2.5

66.62

66.73

g/l

0.27

1750

12284

Gonarthrosis,primary

4386

21938

1.28

46.22

2.3

2.7

66.58

66.38

g/l

1.02

3966

19922

Vitreous haemorrhage

531

2788

2.05

46.14

2.6

2.7

64.88

66.44

g/l

4.89

490

2542

Heart failure and hypertrophic cardiomyopathy

153

457

4.18

46.09

2.9

64.28

66.10

g/l

1.92

144

410

Chronic rhinitis, nasopharyngitis and pharyngitis

1346

8978

1.55

46.06

2.2

2.6

66.95

66.64

g/l

0.91

1217

8219

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

831

4977

1.76

45.98

3.6

1.6

64.34

66.78

g/l

14.85

782

4413

Misadventures to patients during surgical and medical care

680

3850

1.87

45.96

3.0

2.5

64.71

66.38

g/l

5.82

620

3500

Discitis, unspecified

138

384

4.42

45.77

2.9

2.6

65.63

65.95

g/l

0.18

133

355

Fracture of shoulder and upper arm

1621

11239

1.49

45.73

2.7

2.5

65.95

66.34

g/l

1.11

1417

10145

Serous carcinoma of ovary

238

910

3.02

45.72

7.0

2.7

64.25

66.73

g/l

5.04

229

814

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

197

668

3.23

45.69

2.3

2.4

64.55

68.10

g/l

8.96

182

642

Reactive arthropathies

418

2011

2.21

45.62

2.7

2.9

66.88

66.40

g/l

0.69

385

1851

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1437

9746

1.52

45.56

2.6

2.5

65.89

66.54

g/l

2.68

1315

8856

Sensorineural hearing loss

3705

20288

1.31

45.55

2.6

66.24

66.38

g/l

0.52

3275

18439

Follicular lymphoma

259

1029

2.84

45.53

3.0

1.6

63.60

67.05

g/l

9.41

246

932

Other diseases of upper respiratory tract

5289

22322

1.25

45.49

2.5

66.51

66.45

g/l

0.21

4817

20272

Vascular disorders of the intestines

390

1849

2.30

45.21

2.3

2.4

65.49

66.07

g/l

0.66

359

1660

Other skin changes

837

5050

1.75

45.16

3.4

2.6

65.39

66.21

g/l

2.20

764

4547

Psoriatic and enteropathic arthropathies

497

2550

2.05

45.14

1.9

2.9

67.67

66.63

g/l

2.53

461

2350

Unspecified privation

532

2807

2.02

45.14

2.3

2.5

65.35

66.49

g/l

2.90

486

2573

MS-disease / Multiple Sclerosis

317

1369

2.47

44.96

1.5

2.5

68.34

67.31

g/l

1.78

301

1266

Hodgkin lymphoma, hilmo

181

596

3.45

44.96

2.6

3.1

65.94

66.71

g/l

0.51

173

549

Benign neoplasm: Rectum, anus and anal canal

922

5702

1.70

44.93

2.4

1.6

65.94

66.76

g/l

2.71

845

5075

Acetic acid derivatives and related substances

1372

4688

1.56

44.91

2.3

2.4

66.42

65.85

g/l

1.76

1247

4271

Dentofacial anomalies [including malocclusion]

1010

6272

1.64

44.82

3.0

2.3

67.00

66.99

g/l

0.01

944

5766

Reactive arthropathies, FINNGEN

324

1418

2.44

44.66

2.7

3.1

67.11

66.42

g/l

0.97

297

1295

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

782

4373

1.78

44.44

1.8

1.6

65.04

66.66

g/l

6.80

725

3844

Other specified/unspecified necrotizing vasculopathies

119

304

4.85

44.43

2.0

3.1

64.74

66.56

g/l

1.45

113

277

Oxicams

1225

4500

1.60

44.16

2.3

2.5

66.80

65.80

g/l

4.11

1100

4091

Tumor necrosis factor alpha inhibitors

552

2952

1.95

44.13

2.0

2.7

67.76

67.00

g/l

1.48

511

2740

Bipolar affective disorders

692

3956

1.81

44.09

1.8

2.6

66.36

67.05

g/l

1.47

628

3678

Crystal arthropathies, rheuma endpoint

143

417

4.13

44.00

2.3

3.5

65.82

65.80

g/l

0.01

130

369

Cystic kidney disease

202

718

3.19

43.93

2.6

2.9

64.07

66.79

g/l

5.14

193

660

Benign neoplasm: Sigmoid colon

946

5940

1.68

43.86

2.5

2.6

66.22

66.20

g/l

0.03

862

5345

Disorders of muscles

469

2394

2.07

43.54

2.0

2.6

66.33

66.41

g/l

0.09

434

2189

Use of pramipexole

1080

6995

1.62

43.45

2.2

2.6

66.58

66.16

g/l

1.21

957

6290

Other metabolic disorders

546

2930

1.95

43.39

3.3

2.4

66.05

66.90

g/l

1.85

513

2678

Budesonide

535

2848

1.96

43.38

2.2

2.8

66.53

66.75

g/l

0.24

485

2595

Nonorganic sleeping disorders, excluding more controls

679

3882

1.81

43.35

1.9

2.6

66.54

66.86

g/l

0.55

618

3597

Invasive ventilation

400

1947

2.23

43.25

2.9

2.7

63.66

66.35

g/l

7.28

371

1781

Phobic anxiety disorders

424

2076

2.11

43.13

2.2

2.5

66.91

67.49

g/l

0.72

393

1947

Malignant neoplasm of mesothelium and soft tissue

281

1193

2.65

43.09

3.3

2.9

64.47

66.32

g/l

3.31

273

1090

Type of accident

1215

8061

1.56

42.90

2.4

65.90

66.55

g/l

2.11

1079

7350

Other disorders of bone

805

4845

1.72

42.88

3.9

2.4

66.48

66.86

g/l

0.76

738

4493

Other and unspecified aplastic anaemias

100

230

5.48

42.86

3.0

2.7

64.79

66.59

g/l

1.33

208

Other abnormal findings of blood chemistry

250

1002

2.77

42.84

3.9

2.7

66.72

66.52

g/l

0.15

242

916

Drug-induced adrenocortical insufficiency

136

391

4.21

42.82

2.6

64.48

67.02

g/l

3.00

127

359

Congenital malformations, deformations and chromosomal abnormalities

2217

15654

1.38

42.77

2.2

2.5

66.32

66.81

g/l

2.39

2050

14344

Asthma and allergy

408

1948

2.13

42.73

2.1

2.2

66.98

67.61

g/l

1.06

375

1790

Mental and behavioural disorders due to alcohol

2241

16143

1.38

42.69

1.8

2.6

66.10

66.68

g/l

2.64

2009

14908

Other peripheral vascular diseases

406

1990

2.19

42.66

1.8

2.7

67.04

66.69

g/l

0.48

375

1823

Other extrapyramidal and movement disorders in other diseases

1075

6980

1.61

42.65

2.0

2.6

66.86

66.29

g/l

1.91

967

6294

Acute pancreatitis

940

5921

1.66

42.37

2.2

2.5

65.84

66.41

g/l

1.28

862

5338

Benign neoplasm: Rectum

813

4948

1.73

42.34

2.5

1.6

65.90

66.76

g/l

2.59

744

4399

Gout due to impairment of renal function

105

258

5.44

42.22

3.1

2.7

63.12

66.10

g/l

2.86

235

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1065

6916

1.60

41.81

1.9

2.8

67.30

66.64

g/l

2.14

972

6378

Motor neuron disease

128

357

4.19

41.56

1.6

2.7

67.82

66.35

g/l

1.68

117

329

Chronic tubulo-interstitial nephritis

226

874

2.86

41.45

2.4

2.6

64.70

67.07

g/l

3.55

202

788

Injuries to the elbow and forearm

2922

20351

1.32

41.38

2.4

2.6

66.07

66.59

g/l

3.16

2609

18486

Intestinal stricture

1475

10275

1.49

41.24

2.8

2.5

65.31

66.17

g/l

3.60

1339

9208

Transient ischemic attack

2613

16474

1.35

41.20

2.3

2.6

65.72

66.35

g/l

4.02

2347

14792

Psoriasis

1251

8427

1.54

41.20

2.0

2.6

67.12

66.58

g/l

1.67

1155

7696

Protozoal diseases

189

676

3.24

41.19

5.6

2.8

63.17

66.63

g/l

5.52

181

618

Folate deficiency anaemia

187

6.21

41.01

2.5

2.9

64.30

66.54

g/l

1.33

167

Other infectious diseases

427

2169

2.12

40.95

3.3

2.6

64.52

66.34

g/l

4.72

393

1980

Extrapyramidal and movement disorders

1759

12657

1.44

40.91

2.0

2.6

66.40

66.20

g/l

0.53

1559

11387

Congenital malformations of the urinary system

286

1239

2.50

40.80

2.5

2.8

64.43

66.47

g/l

4.16

276

1141

Motor neuron disease (with DMD)

130

371

4.07

40.75

1.6

2.7

67.78

66.22

g/l

1.90

119

343

Unspecified acute lower respiratory infection

671

3913

1.79

40.60

3.5

2.3

65.27

66.54

g/l

3.89

625

3586

Other disorders of glucose regulation and pancreatic internal secretion

409

2044

2.13

40.60

2.3

2.6

64.52

66.47

g/l

4.51

373

1873

Eosinophilia

125

353

4.26

40.32

2.2

2.7

65.16

66.54

g/l

1.05

113

323

Other and unspecified coagulation defects

245

996

2.68

40.32

2.8

66.12

67.00

g/l

1.03

231

917

Collagenous colitis

446

2310

2.07

40.30

2.8

2.7

65.81

66.40

g/l

0.80

405

2114

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

659

3705

1.79

39.95

2.2

2.7

64.70

66.63

g/l

7.62

618

3424

2090

14613

1.39

39.79

2.8

2.5

65.57

66.05

g/l

2.06

1869

12978

Noninfectious colitis NAS

611

3493

1.84

39.74

2.8

2.5

65.56

66.58

g/l

2.41

565

3179

Carcinoma in situ of skin of other and unspecified parts of face

427

2200

2.11

39.74

2.4

1.6

65.31

66.10

g/l

1.20

390

1889

Chronic pancreatitis

607

3477

1.85

39.71

2.1

2.6

65.31

66.56

g/l

3.23

561

3167

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1953

14316

1.40

39.63

1.8

2.6

66.00

66.69

g/l

3.02

1749

13212

Radiculopathy

791

4854

1.70

39.62

2.4

2.5

66.60

66.05

g/l

1.21

716

4369

Polyarthritis, unspecified

210

801

2.90

39.62

2.4

2.9

65.62

66.12

g/l

0.38

194

731

Trochanteric bursitis

620

3570

1.82

39.42

2.4

2.7

66.47

66.41

g/l

0.07

547

3222

Internal derangement of knee

1521

10674

1.45

39.27

2.2

2.7

66.82

66.39

g/l

1.55

1382

9775

Oter anti-inflammatory and antirheumatic agents, non-steroids

1185

4329

1.57

39.22

2.3

2.5

66.14

65.74

g/l

0.92

1062

3931

Amiodarone users

559

3156

1.91

39.13

2.2

2.6

64.14

66.07

g/l

6.85

514

2865

Other crystal arthropathies

143

451

3.79

39.05

2.3

3.2

65.82

65.86

g/l

0.02

130

400

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

245

5.18

39.00

6.3

1.6

64.05

67.17

g/l

4.61

221

Actinic keratosis

1943

13611

1.40

38.98

2.8

2.5

65.48

66.02

g/l

2.32

1741

12072

Open wound of lower leg

666

3926

1.78

38.92

2.4

2.5

64.32

66.51

g/l

9.85

599

3557

Leukaemia of unspecified cell type

162

6.24

38.86

3.7

1.7

63.72

67.12

g/l

2.82

140

Unspecified nephritic syndrome

159

533

3.46

38.80

4.3

2.8

63.24

66.68

g/l

5.57

151

480

Migraine with aura and triptan purchases

489

2614

1.94

38.80

1.9

2.4

66.98

67.24

g/l

0.37

456

2403

Other symptoms and signs involving the circulatory and respiratory systems

312

1431

2.33

38.69

2.3

2.5

65.85

66.55

g/l

0.73

277

1305

Spondylolisthesis/Spondylolysis

798

4932

1.68

38.68

2.8

2.6

66.60

66.37

g/l

0.38

729

4492

Exclusions for E4_PCOS_CONSORTIUM

2822

13585

1.32

38.65

2.7

2.4

66.32

66.75

g/l

2.19

2525

12328

Benign neoplasm: Ascending colon

693

4167

1.77

38.57

2.6

66.21

66.20

g/l

0.01

634

3760

Hypertrophic cardiomyopathy

252

1072

2.64

38.47

3.1

3.0

64.74

66.34

g/l

2.67

238

982

Other benign neoplasms of skin

1510

10466

1.45

38.37

2.9

1.6

66.47

66.87

g/l

1.25

1328

9332

Myocarditis

200

750

2.84

38.07

2.6

2.5

64.80

67.86

g/l

5.62

188

678

Substance use, excluding alcohol

751

4578

1.70

38.04

1.8

2.6

66.18

66.90

g/l

1.54

660

4252

Speech therapy

1250

8573

1.51

37.93

2.4

2.5

66.33

66.32

g/l

0.01

1190

7712

Skin changes due to chronic exposure to nonionizing radiation

1980

13923

1.39

37.83

2.8

2.5

65.50

66.02

g/l

2.24

1773

12344

Alcohol use disorder, ICD-based

1802

13158

1.40

37.80

1.8

2.6

66.09

66.71

g/l

2.44

1619

12144

Epilepsy

1310

9016

1.49

37.78

2.2

2.6

66.13

66.32

g/l

0.35

1176

8163

Diseases of salivary glands

825

5169

1.66

37.67

2.3

66.45

66.60

g/l

0.22

742

4681

Nonischemic cardiomyopathy

313

1464

2.33

37.63

2.0

2.6

63.67

66.50

g/l

6.66

290

1328

Benign neoplasm: Transverse colon

550

3130

1.89

37.50

2.6

2.7

65.67

66.23

g/l

0.94

494

2841

Other demyelinating diseases of the central nervous system

178

638

3.04

37.43

1.7

2.7

68.66

67.86

g/l

0.80

167

597

Other and unspecified effects of external causes

1031

6791

1.56

37.41

2.5

66.61

66.74

g/l

0.22

958

6259

Generalized anxiety disorder

488

2637

1.91

37.38

1.9

2.7

67.05

67.32

g/l

0.37

447

2449

Disorders of adult personality and behaviour

978

6361

1.58

37.36

1.8

2.4

66.65

67.06

g/l

1.01

884

5921

Essential (haemorrhagic) thrombocythaemia

215

858

2.79

37.34

2.4

1.6

66.19

67.28

g/l

1.15

192

768

Other and unspecified urticaria

771

4762

1.68

37.21

2.5

66.84

66.69

g/l

0.22

705

4371

COPD, hospital admission 2, with asthma infections

1627

9998

1.44

37.05

2.1

2.6

64.59

66.19

g/l

12.79

1447

8967

Drug-induced osteoporosis

104

277

4.72

37.00

1.6

3.1

64.11

67.06

g/l

3.09

252

Postprocedural endocrine and metabolic disorders, not elsewhere classified

493

2697

1.91

36.97

3.3

2.4

66.29

66.91

g/l

1.13

462

2465

Delirium, not induced by alcohol and other psychoactive substances

587

3405

1.83

36.81

2.3

2.5

64.59

65.95

g/l

3.29

511

3040

Coxarthrosis, primary

2918

19876

1.31

36.63

2.3

2.6

66.39

66.26

g/l

0.42

2595

17908

In situ neoplasms

1642

11895

1.42

36.60

2.5

65.44

66.23

g/l

3.87

1479

10619

Other overlap syndromes

128

390

3.82

36.49

2.0

3.2

67.82

67.00

g/l

0.47

121

353

Pneumonia derived septicemia

202

791

2.84

36.42

5.6

2.7

67.57

66.20

g/l

1.00

177

716

Myositis

160

555

3.26

36.38

1.9

2.9

65.55

66.71

g/l

1.22

155

497

Panic disorder

475

2571

1.91

36.22

2.0

2.6

66.52

67.30

g/l

1.41

426

2388

Superficial injury of hip and thigh

676

4080

1.73

36.16

2.0

2.5

65.34

66.23

g/l

2.21

597

3662

Adverse effects, not elsewhere classified

762

4727

1.67

36.14

2.6

2.5

66.97

66.71

g/l

0.43

715

4356

Viral pneumonia (known virus, not influenza)

158

550

3.32

36.13

5.8

3.0

64.30

66.17

g/l

1.96

144

498

Hyperplasia of prostate

1839

7648

1.41

36.10

2.6

65.91

66.64

g/l

3.74

1671

7055

Superficial injury of head

964

6320

1.58

36.07

2.0

2.5

65.84

66.37

g/l

1.40

857

5690

Covid-19 suspected case

752

4644

1.67

36.06

2.9

2.5

66.51

67.10

g/l

1.34

700

4283

Behavioural syndromes associated with physiological disturbances and physical factors

1115

7510

1.52

36.04

2.1

2.4

66.10

66.81

g/l

2.51

1012

6923

Familial hypercholesterolemia

777

4877

1.67

35.88

2.8

2.4

65.71

66.32

g/l

1.33

716

4331

Acute pancreatitis (for exclusion)

940

6156

1.59

35.86

2.2

2.5

65.84

66.34

g/l

1.06

862

5582

Other and unspecified acquired haemolytic anaemias

208

5.38

35.84

3.0

2.1

65.63

66.31

g/l

0.22

191

Other enthesopathies

1207

8288

1.50

35.79

2.3

2.7

66.76

66.69

g/l

0.11

1097

7564

Injuries to the ankle and foot

2604

18352

1.31

35.68

2.5

66.60

66.75

g/l

0.51

2396

16876

Rash and other nonspecific skin eruption

464

2533

1.94

35.52

2.2

2.6

66.86

66.38

g/l

0.72

427

2309

Other viral diseases, not elsewhere classified

710

4336

1.69

35.40

3.7

2.5

65.39

66.71

g/l

4.30

664

4001

Poisoning by drugs, medicaments and biological substances

852

5444

1.61

35.38

2.0

2.5

66.23

66.96

g/l

1.89

767

5053

Parodontitis or/and operation codes

2793

12899

1.31

35.32

2.5

2.7

66.47

66.71

g/l

0.83

2534

11831

Sequelae of cerebrovascular disease

1750

11293

1.40

35.24

2.1

2.6

65.37

66.11

g/l

3.34

1529

10104

Disorders of conjunctiva

3309

22096

1.27

35.14

2.6

2.5

66.79

66.57

g/l

0.94

3031

20089

Bronchiectasis

441

2394

1.99

35.05

2.7

2.6

65.60

66.12

g/l

0.73

394

2148

Systemic sclerosis (FG)

142

470

3.41

34.98

1.9

3.3

65.44

66.68

g/l

0.97

131

426

Coronary revascularization (ANGIO or CABG)

2320

12355

1.35

34.95

2.3

2.7

65.79

66.36

g/l

3.04

2133

11089

Inflammatory bowel disease

1268

8833

1.47

34.87

2.3

2.5

66.73

66.72

g/l

0.02

1171

8120

Tubulo-interstitial nephritis, not specified as acute or chronic

336

1654

2.16

34.80

2.8

2.4

65.45

66.56

g/l

1.45

301

1488

Polycystic ovarian syndrome, consortium definition

2672

12460

1.31

34.71

2.4

2.5

66.59

66.62

g/l

0.07

2366

11268

Cervicobrachial syndrome

880

5706

1.59

34.50

2.5

2.6

67.30

66.51

g/l

2.73

821

5210

Vitamin deficiency, wide

255

1135

2.44

34.48

2.5

2.7

65.79

66.62

g/l

0.94

227

1034

Vitamin deficiency

255

1135

2.44

34.48

2.5

2.7

65.79

66.62

g/l

0.94

227

1034

Other abnormal immunological findings in serum

118

352

3.82

34.43

2.2

2.8

69.10

66.73

g/l

3.44

107

319

Drug-induced polyneuropathy

203

5.44

34.38

10.3

2.5

64.97

65.71

g/l

0.38

187

Superficial injury of lower leg

987

6570

1.55

34.31

2.1

2.5

65.84

66.69

g/l

3.09

875

5968

Drug-induced cataract

154

544

3.25

34.25

3.2

2.9

64.72

66.91

g/l

2.89

146

496

Infection of intervertebral disc (pyogenic)

107

307

4.30

34.15

3.0

2.7

64.21

66.10

g/l

1.38

282

Other diseases of lip and oral mucosa

713

4427

1.68

34.11

3.3

2.4

66.37

66.46

g/l

0.12

659

4008

Artificial joint operation, meniscal resection

4257

23237

1.24

34.09

2.4

2.6

66.55

66.43

g/l

0.48

3854

21115

COPD, hospital admissions 3, with asthma pneumonia sepsis

1386

8385

1.46

34.08

2.1

2.6

64.25

66.09

g/l

13.83

1236

7485

Malignant neoplasm of skin

3069

18369

1.29

33.93

2.7

2.6

65.74

66.27

g/l

3.36

2740

16488

Iridocyclitis

981

6549

1.55

33.92

2.8

2.5

67.22

66.52

g/l

2.06

900

5964

Stomatitis and related lesions

355

1796

2.08

33.83

3.2

2.3

65.80

66.63

g/l

1.13

329

1649

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

883

5682

1.57

33.54

2.5

2.4

66.18

67.01

g/l

2.46

817

5261

Basal cell carcinoma

2778

17436

1.30

33.54

2.7

2.6

65.75

66.20

g/l

2.25

2478

15591

Personality disorders

927

6105

1.56

33.54

1.9

2.4

66.66

67.06

g/l

0.94

843

5685

Diplopia

608

3652

1.75

33.44

2.2

2.5

66.19

66.31

g/l

0.15

561

3320

Hypoglycaemia, other or unspecified

320

1572

2.17

33.41

2.1

2.6

64.32

66.50

g/l

5.13

294

1441

Benign neoplasm: Adrenal gland

349

1775

2.11

33.40

2.3

1.6

65.64

67.07

g/l

2.84

315

1599

Other encephalitis

156

559

3.12

33.37

2.4

2.8

66.01

66.73

g/l

0.43

140

514

Thyroiditis, ILD-related definition

459

2536

1.89

33.37

2.4

2.6

67.69

66.55

g/l

2.98

425

2312

Basal cell carcinoma, including avohilmo

2834

17631

1.30

33.34

2.7

2.6

65.77

66.20

g/l

2.16

2527

15778

Migraine without aura and triptan purchases

484

2705

1.84

33.28

2.0

2.4

67.07

67.34

g/l

0.34

451

2506

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

332

1667

2.16

33.20

1.7

1.6

63.92

66.65

g/l

8.42

306

1477

Marginal zone B-cell lymphoma

210

5.25

32.96

2.2

2.7

67.45

67.14

g/l

0.12

187

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

245

1099

2.46

32.94

3.1

1.6

65.93

66.84

g/l

1.00

226

998

Secondary thrombocytopenia

261

4.48

32.91

5.3

2.9

64.16

67.09

g/l

2.95

242

Inflammatory diseases of female pelvic organs

2229

12832

1.33

32.88

2.2

2.5

66.74

66.63

g/l

0.29

1984

11614

Herpesviral [herpes simplex] infections

495

2816

1.84

32.85

3.1

2.5

65.01

66.66

g/l

4.30

457

2583

Other local infections of skin and subcutaneous tissue

454

2523

1.90

32.78

3.4

2.6

65.99

66.53

g/l

0.77

416

2318

Disorders of vitreous body and globe

2302

17377

1.32

32.72

2.6

2.7

66.24

66.34

g/l

0.27

2093

15716

Malignant neoplasm of ovary

263

1220

2.38

32.68

6.4

2.5

63.98

66.42

g/l

5.63

250

1093

Nonhereditary hypogammaglobulinemia

217

4.84

32.62

3.5

2.7

62.17

67.53

g/l

5.97

203

Psoriatic arthropathies

426

2320

1.93

32.54

2.0

2.8

67.69

66.32

g/l

3.37

392

2149

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2170

16297

1.33

32.41

2.5

2.6

66.69

66.61

g/l

0.20

1982

14939

Benign neoplasm: Stomach

502

2899

1.85

32.36

2.6

65.53

66.26

g/l

1.32

449

2636

Haemorrhoids and perianal venous thrombosis

1325

9446

1.44

32.28

2.4

2.5

66.31

66.40

g/l

0.15

1195

8503

5-aminosalicylic acid

746

4722

1.62

32.28

2.1

2.7

66.96

66.92

g/l

0.05

696

4332

Scoliosis

340

1721

2.07

32.22

2.1

2.5

66.18

66.34

g/l

0.14

305

1569

Voice disturbances

1142

7942

1.48

32.18

2.5

2.6

66.26

66.45

g/l

0.41

1039

7186

Lesion of lateral popliteal nerve

254

1163

2.37

32.12

2.6

67.00

66.32

g/l

0.75

235

1073

Pneumococcal septicemia

189

763

2.75

32.06

5.7

2.8

67.85

66.09

g/l

1.36

165

688

Follicular lymphoma, hilmo

259

1207

2.39

32.05

3.0

63.60

66.33

g/l

6.33

246

1100

Hepatic failure, not elsewhere classified

208

880

2.62

32.00

2.4

2.9

63.91

66.60

g/l

3.30

182

797

Ankylosing spondylitis

385

2042

1.98

31.95

1.9

2.5

67.73

66.74

g/l

1.53

355

1894

Encephalitis

162

608

2.96

31.73

2.3

2.8

66.12

66.72

g/l

0.36

145

557

Disorders of optic nerve and visual pathways

403

2179

1.95

31.66

2.2

2.7

66.52

66.70

g/l

0.17

377

2014

Cholecystectomy

3138

22314

1.27

31.58

2.6

2.5

66.28

66.43

g/l

0.54

2838

20158

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

225

989

2.50

31.57

5.7

1.6

64.80

67.21

g/l

4.66

214

894

Other and unspecified local infections of skin and subcutaneous tissue

426

2350

1.91

31.55

3.5

2.6

65.77

66.51

g/l

1.15

393

2168

Hernia of abdominal wall

2008

15341

1.34

31.40

2.5

2.6

66.07

66.49

g/l

1.67

1833

13944

Polyarteritis nodosa and related conditions

278

4.12

31.18

2.1

2.7

64.70

66.69

g/l

1.58

251

Poisoning by medicine

757

4851

1.60

31.13

2.0

2.5

66.30

66.99

g/l

1.58

680

4500

Psoriasis vulgaris

806

5262

1.59

31.08

2.0

2.6

67.23

66.52

g/l

1.76

736

4834

Bullous disorders

311

1565

2.16

31.00

2.3

2.7

66.36

66.12

g/l

0.24

288

1416

Gingival hyperplasia

172

673

2.81

30.91

2.4

2.3

64.51

66.49

g/l

2.07

155

617

Early onset COPD

1038

7158

1.50

30.84

2.0

2.6

65.11

66.52

g/l

6.85

955

6525

Myelodysplastic syndrome

216

4.94

30.76

2.7

2.3

65.84

65.44

g/l

0.16

192

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1878

11073

1.35

30.56

2.4

1.6

64.27

66.82

g/l

30.95

1695

9869

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2708

16982

1.29

30.51

2.7

2.6

65.72

66.21

g/l

2.58

2416

15182

Fissure and fistula of anal and rectal regions

1010

6922

1.50

30.50

2.5

66.53

66.68

g/l

0.27

905

6328

Dermatitis due to substances taken internally

260

1223

2.28

30.49

4.9

2.8

65.73

66.49

g/l

0.82

238

1113

Disorders of vitreous body

2226

16953

1.32

30.47

2.7

2.6

66.25

66.36

g/l

0.29

2026

15338

Carcinoma in situ of skin

391

2138

1.96

30.34

2.5

1.6

65.13

66.34

g/l

2.35

347

1872

Diseases of male genital organs

2314

9010

1.32

30.28

2.5

66.20

66.79

g/l

3.07

2136

8362

Disorders of ocular muscles, binocular movement, accommodation and refraction

1745

12995

1.36

30.26

2.5

66.70

66.67

g/l

0.07

1609

11890

COPD-related respiratory insufficiency

616

3829

1.70

30.09

2.1

2.6

64.18

66.10

g/l

7.27

543

3413

Conjunctivitis

2864

19957

1.27

29.94

2.6

2.5

66.90

66.60

g/l

1.39

2619

18154

Cramp and spasm

230

1041

2.39

29.92

2.5

2.8

66.74

66.59

g/l

0.12

213

958

L04AC Interleukin inhibitors

218

961

2.43

29.89

1.7

2.6

67.76

67.22

g/l

0.44

206

900

Viral and other specified intestinal infections

653

3974

1.64

29.86

2.8

2.2

65.83

67.07

g/l

3.36

612

3649

Leukaemia of unspecified cell type

202

4.94

29.80

3.7

2.9

63.72

66.11

g/l

1.71

183

Sleep disorders

794

5201

1.57

29.78

1.9

2.5

66.44

66.80

g/l

0.71

720

4795

Specific personality disorders

786

5128

1.57

29.78

1.8

2.5

66.47

67.09

g/l

1.60

711

4767

Acute and subacute iridocyclitis

818

5407

1.57

29.75

2.9

2.5

67.18

66.57

g/l

1.42

755

4940

Other disorders of nervous system

334

1746

2.05

29.67

2.7

65.65

66.67

g/l

1.44

308

1602

Gastrointestinal stromal tumor and sarcoma

299

4.18

29.64

6.3

2.8

64.05

66.74

g/l

3.69

266

Other specified/unspecified inflammatory spondylopathies

202

863

2.49

29.53

2.0

2.6

68.43

67.03

g/l

1.85

182

809

Other inflammatory liver diseases

313

1599

2.09

29.51

2.4

2.8

66.55

66.34

g/l

0.15

282

1460

Benign neoplasm: Caecum

529

3187

1.77

29.45

2.8

2.6

65.88

66.25

g/l

0.48

488

2905

Benign neoplasm of other and unspecified endocrine glands

580

3568

1.71

29.18

2.4

2.6

66.02

66.44

g/l

0.65

527

3267

Thyrotoxicosis, other and/or unspecified

788

5184

1.57

29.17

2.4

2.6

65.50

66.63

g/l

3.96

717

4710

Other shoulder lesions

375

2032

1.93

29.13

1.9

2.7

66.49

66.69

g/l

0.20

353

1863

Anterior Iridocyclitis

865

5812

1.54

29.11

2.9

2.5

67.23

66.52

g/l

1.84

795

5304

Microscopic polyangiitis

144

6.21

29.07

1.7

2.5

62.14

66.71

g/l

3.08

131

Other diseases of pancreas

378

2077

1.95

28.83

2.6

65.30

66.36

g/l

1.73

342

1888

Other diseases of oesophagus

470

2745

1.81

28.82

2.2

2.6

65.64

66.07

g/l

0.60

422

2484

Other disorders of gingiva or/and edentulous alveolar ridge

233

1075

2.32

28.75

2.7

2.3

65.04

66.64

g/l

1.97

212

983

Abscess of lung

103

320

3.75

28.62

2.3

2.9

61.68

66.62

g/l

5.90

294

Dermatophytosis

600

3743

1.68

28.57

2.6

65.87

66.40

g/l

0.88

551

3405

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

578

3575

1.70

28.53

2.4

1.6

64.91

66.38

g/l

4.70

523

3090

Carcinoma in situ of skin of scalp and neck

150

580

2.99

28.48

2.4

1.6

64.19

66.27

g/l

2.55

135

514

Speech and linguistic disorders, excluding more controls

231

988

2.28

28.43

2.2

2.7

65.94

66.88

g/l

0.97

208

920

Sequelae of other external causes

262

1274

2.21

28.38

3.0

2.8

65.37

66.62

g/l

1.68

250

1166

Adalimumab

334

1757

1.99

28.38

2.0

2.6

68.37

67.04

g/l

2.53

310

1638

Amputation of foot

166

675

2.81

28.38

3.4

2.9

62.98

66.02

g/l

4.59

147

612

Pleural plaque

515

3109

1.76

28.37

2.2

2.6

67.01

66.02

g/l

2.21

457

2761

Guillain-Barre syndrome

110

358

3.57

28.34

2.5

2.9

67.18

66.78

g/l

0.18

101

328

Pneumothorax

333

1763

2.01

28.25

2.4

2.5

64.35

66.71

g/l

5.81

307

1603

Thyrotoxicosis

1021

7123

1.48

28.23

2.3

2.5

65.48

66.53

g/l

4.42

927

6436

Traumatic subdural haemorrhage

597

3661

1.67

28.19

2.5

2.6

65.84

65.94

g/l

0.10

530

3268

Aortic aneurysm

1119

7828

1.45

28.00

2.4

2.6

65.47

66.30

g/l

3.04

1000

7085

Atopic dermatitis

1849

12030

1.33

27.98

2.0

2.5

67.28

66.81

g/l

2.07

1696

11052

Nonorganic sleeping disorders

679

4359

1.60

27.91

1.9

2.6

66.54

66.86

g/l

0.55

618

4034

Infective dermatitis

508

3051

1.74

27.91

2.2

2.7

66.67

66.35

g/l

0.41

467

2780

Melanocytic naevi

994

6905

1.47

27.77

2.8

1.6

66.43

67.17

g/l

2.69

927

6240

Etanercept

260

1268

2.17

27.63

2.1

2.8

67.29

66.97

g/l

0.28

240

1182

Neuralgia and neuritis, unspecified

232

1086

2.28

27.57

2.7

2.9

66.82

66.53

g/l

0.23

212

992

Alcohol abuse, main dg, excluding more controls

573

3552

1.67

27.42

1.7

2.7

65.98

66.83

g/l

1.65

515

3318

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

974

6753

1.47

27.36

2.0

2.4

66.30

66.98

g/l

2.03

889

6268

1475

9753

1.38

27.36

2.5

65.69

65.77

g/l

0.16

1287

8582

Lung transplant status

153

5.39

27.28

1.6

2.9

61.16

66.94

g/l

4.74

145

Lung transplantation

153

5.38

27.27

1.6

2.9

61.16

66.94

g/l

4.74

145

Duodenal ulcer

545

3360

1.70

27.25

2.1

2.6

66.04

66.06

g/l

0.01

502

3000

Dissociative [conversion] disorders

153

596

2.73

27.24

1.6

2.8

67.72

67.59

g/l

0.07

133

549

Coeliac disease

502

3023

1.73

27.16

3.0

2.6

66.84

66.62

g/l

0.26

455

2762

Insomnia

581

3623

1.66

27.12

1.8

2.6

66.32

66.87

g/l

1.02

530

3346

Diseases of external ear

1402

10393

1.38

27.06

2.6

2.5

66.76

66.40

g/l

0.95

1198

9446

Other inflammation of eyelid

564

3510

1.68

26.98

3.1

2.5

66.70

66.39

g/l

0.42

495

3191

Persistent mood disorders

782

5224

1.54

26.92

2.1

2.5

66.89

66.59

g/l

0.52

703

4772

Intestinal malabsorption

218

1011

2.32

26.71

2.2

2.9

65.07

67.11

g/l

2.94

204

929

Other problems related to primary support group, including family circumstances

361

1926

1.89

26.71

2.8

2.5

64.80

67.26

g/l

6.37

343

1794

Recurring oral aphthae, including avohilmo

576

3611

1.66

26.68

2.9

2.5

65.96

66.43

g/l

0.70

526

3295

Other disorders of eyelid

2051

15523

1.31

26.63

2.4

2.6

66.05

66.14

g/l

0.20

1831

13918

Other abnormal uterine and vaginal bleeding

978

4836

1.48

26.58

2.4

2.5

66.26

66.34

g/l

0.10

828

4319

Pneumonia due to Streptococcus pneumoniae

203

915

2.38

26.57

4.4

2.3

67.35

66.89

g/l

0.27

178

825

Fracture of lower leg, including ankle

2275

17952

1.28

26.53

2.2

2.6

66.22

66.62

g/l

1.66

2039

16329

Other diseases of jaws

294

1522

2.04

26.43

5.0

2.3

65.78

66.69

g/l

1.32

267

1397

Ventral hernia

1060

7551

1.45

26.33

2.4

2.5

65.77

66.43

g/l

2.02

962

6816

Vitamin D deficiency

102

329

3.48

26.29

1.7

2.5

65.96

67.41

g/l

0.90

301

Disorders of vestibular function (Vertigo)

2056

16035

1.30

26.19

2.4

2.6

66.73

66.30

g/l

1.99

1822

14418

Systemic atrophies primarily affecting the central nervous system

231

1112

2.28

26.18

2.4

2.9

67.37

66.36

g/l

1.53

214

1008

Dipeptidyl peptidase 4 (DPP-4) inhibitors

579

3669

1.66

26.11

2.2

2.6

66.55

65.95

g/l

1.11

525

3318

Systemic sclerosis

142

553

2.87

26.11

1.9

2.8

65.44

67.00

g/l

1.41

131

500

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

553

3436

1.66

26.04

2.1

2.6

66.58

67.14

g/l

0.94

500

3211

Xerosis cutis

108

368

3.46

26.02

2.1

2.9

65.30

66.25

g/l

0.76

100

337

Malignant neoplasm of urinary organs

502

3079

1.73

26.00

3.0

2.6

65.71

66.05

g/l

0.41

461

2783

Inflammatory diseases of the central nervous system

359

1996

1.89

25.97

2.7

2.6

66.09

66.50

g/l

0.39

330

1841

Neuromuscular dysfunction of bladder

420

2452

1.80

25.84

2.1

2.6

65.78

66.58

g/l

1.15

377

2232

Allergic purpura

151

605

2.72

25.81

1.9

2.7

66.92

66.86

g/l

0.03

143

549

Enthesopathies of lower limb, excluding foot

825

5621

1.51

25.67

2.4

2.6

66.50

66.56

g/l

0.08

744

5162

Disorders of magnesium metabolism

157

5.26

25.67

2.6

2.2

64.16

66.91

g/l

1.23

146

Acute posthaemorrhagic anaemia

186

825

2.46

25.57

3.1

2.8

65.30

66.41

g/l

0.96

160

740

Emotionally unstable personality disorder

369

2063

1.84

25.55

1.7

2.3

66.61

67.54

g/l

1.70

334

1934

Other symptoms and signs involving the urinary system

481

2922

1.73

25.55

2.3

2.7

64.93

66.25

g/l

3.30

461

2652

Chronic myeloproliferative disease

103

347

3.56

25.52

2.8

3.1

66.15

g/l

0.00

316

Lesion of ulnar nerve

595

3799

1.63

25.50

2.2

2.5

66.36

66.59

g/l

0.30

543

3493

Late syphilis

303

3.69

25.49

3.4

2.9

65.99

66.89

g/l

0.54

275

Metatarsalgia

383

2179

1.84

25.49

2.2

2.7

66.73

66.53

g/l

0.21

348

1985

Acute nephritic syndrome

129

485

2.98

25.44

3.1

2.8

63.17

66.77

g/l

4.42

121

441

Malignant neoplasm of kidney, except renal pelvis

462

2796

1.75

25.25

3.0

2.6

65.63

66.12

g/l

0.64

429

2538

Ovarian cyst

1372

5835

1.38

25.23

2.3

2.4

66.67

66.56

g/l

0.20

1246

5275

Carcinoma in situ of skin of other and unspecified parts of face

427

2540

1.80

25.21

2.4

2.5

65.31

65.89

g/l

0.77

390

2252

Vitamin B12 deficiency anaemia

520

3234

1.69

25.14

2.3

2.5

65.60

66.08

g/l

0.70

468

2896

Crohn disease

489

2983

1.70

25.03

1.9

2.6

66.32

66.81

g/l

0.65

455

2755

Respiratory disorders in diseases classified elsewhere

328

3.55

25.00

2.3

2.7

66.28

66.74

g/l

0.20

301

Hypermobility syndrome

180

787

2.40

24.86

1.9

2.5

67.42

67.35

g/l

0.05

167

736

Localized swelling, mass and lump of skin and subcutaneous tissue

1276

9448

1.38

24.83

2.5

66.31

66.46

g/l

0.29

1165

8554

Atopic dermatitis, strict definition with reimbursement

895

6027

1.47

24.68

2.2

2.3

67.17

67.01

g/l

0.27

829

5602

Fracture of foot, except ankle

878

6104

1.48

24.61

2.8

2.4

66.34

66.73

g/l

0.81

807

5633

Acute generalized exanthematous pustulosis

219

1053

2.24

24.58

5.3

2.9

66.00

66.61

g/l

0.49

200

956

Gonarthrosis, primary, with knee surgery

2671

17746

1.25

24.55

2.2

2.7

66.39

66.20

g/l

0.66

2384

15995

Conjunctivitis (acute, non atopic)

1023

7287

1.43

24.54

3.3

2.5

66.77

66.57

g/l

0.36

950

6677

Emergency coronary revascularization (for ACS)

2689

15701

1.26

24.53

2.2

2.6

65.81

66.17

g/l

1.57

2453

14084

Faecal incontinence

406

2383

1.79

24.52

2.0

2.5

66.14

66.40

g/l

0.30

363

2107

Monoarthritis, not elsewhere classified

195

893

2.33

24.51

1.7

3.1

67.07

66.36

g/l

0.63

187

816

Primary biliary cholangitis (PBC)

120

443

3.01

24.41

1.6

2.7

68.51

67.55

g/l

0.50

106

404

Other disorders of eye and adnexa

536

3373

1.65

24.31

2.6

66.05

66.58

g/l

0.89

486

3086

Varicose veins

2848

17598

1.24

24.27

2.5

2.6

66.41

66.48

g/l

0.18

2546

15910

Suicide or other Intentional self-harm

864

6002

1.47

24.23

2.0

2.5

66.14

66.86

g/l

1.97

787

5575

Restless leg syndrome

531

3349

1.66

24.23

2.0

2.6

66.95

66.44

g/l

0.95

488

3055

Non-small cell lung cancer

782

5366

1.52

24.22

1.8

2.5

65.04

65.95

g/l

2.54

725

4797

Lung diseases due to external agents

651

4300

1.58

24.17

2.4

2.5

65.53

66.00

g/l

0.67

577

3849

Heartburn

416

2461

1.76

24.09

2.2

2.6

66.83

66.65

g/l

0.19

370

2227

Agoraphobia

110

384

3.03

24.08

1.6

2.3

67.25

68.52

g/l

0.89

361

Speech disturbances, not elsewhere classified

414

2461

1.78

24.04

2.0

2.6

66.19

66.26

g/l

0.05

370

2230

Dermatographic urticaria

259

1327

2.05

23.98

2.4

2.6

67.45

66.93

g/l

0.62

241

1228

Hyperhidrosis

119

436

2.91

23.96

2.1

2.7

67.31

67.49

g/l

0.11

108

398

Sulfonylureas

1818

11323

1.31

23.95

2.1

2.7

65.97

65.81

g/l

0.35

1619

10108

Abnormal serum enzyme levels

1375

10241

1.36

23.91

2.4

2.6

65.91

66.33

g/l

1.17

1258

9353

Other enthesopathy of foot (+metatarsalgia)

396

2316

1.78

23.89

2.2

2.7

66.70

66.57

g/l

0.13

359

2116

Other diseases of stomach and duodenum

311

1705

1.94

23.88

2.3

2.7

65.47

66.39

g/l

1.21

286

1555

Combinations of oral blood glucose lowering drugs

1265

9443

1.38

23.68

2.0

2.7

67.01

66.24

g/l

2.87

1162

8636

Other disorders of bladder

563

3624

1.63

23.63

2.1

2.6

66.30

66.32

g/l

0.01

490

3276

Other obstructive and reflux uropathy

186

847

2.33

23.62

2.4

64.27

66.77

g/l

3.82

167

773

Cardiomyopathy, Hypertrophic obstructive

109

390

3.13

23.59

2.2

3.2

64.80

67.72

g/l

3.47

102

353

Cerebral cysts

234

1168

2.12

23.46

2.2

2.6

66.23

66.83

g/l

0.57

217

1080

Excessive, frequent and irregular menstruation

1435

5972

1.36

23.41

2.3

2.4

66.91

66.56

g/l

1.02

1283

5388

6-mercaptopurine

106

369

3.05

23.37

2.0

3.5

66.28

67.68

g/l

0.70

343

Retinal detachments and breaks

1589

12269

1.33

23.34

2.8

2.6

66.16

66.26

g/l

0.21

1431

11087

Cervicocranial syndrome

428

2574

1.73

23.30

2.3

2.6

67.33

66.36

g/l

2.18

395

2354

Ankylosing spondylitis, ICD10

366

2112

1.81

23.30

1.9

2.7

67.82

66.88

g/l

1.39

336

1961

Acidosis

122

469

2.95

23.26

2.5

2.6

65.19

66.84

g/l

1.04

116

434

Retinal vascular occlusion

582

3794

1.61

23.24

2.7

2.5

66.27

66.02

g/l

0.35

527

3369

Other bursopathies

562

3621

1.61

23.21

2.8

2.7

65.82

66.35

g/l

0.82

512

3281

Explicit fungal Sepsis

116

5.56

23.16

2.1

2.2

59.64

67.07

g/l

4.43

107

Cardiac arrest

263

1170

2.03

23.14

2.2

2.6

63.92

67.21

g/l

7.74

244

1046

Temporomandibular joint disorders, including avohilmo

1356

10198

1.35

23.13

2.5

67.23

66.87

g/l

1.18

1252

9362

Other chondrocalcinosis

325

3.54

23.09

1.9

2.6

65.38

65.98

g/l

0.32

291

Retinal vascular disorders

589

3857

1.60

23.00

2.7

2.5

66.24

66.00

g/l

0.32

532

3422

Benign neoplasm: Descending colon

310

1721

1.92

22.98

2.4

1.7

65.58

66.91

g/l

2.23

276

1544

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1569

7829

1.33

22.96

2.6

1.5

66.10

67.02

g/l

4.66

1414

6951

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1569

7829

1.33

22.95

2.6

1.5

66.10

67.02

g/l

4.65

1414

6951

Unspecified misadventure during surgical and medical care

262

1380

2.04

22.92

2.8

65.29

66.61

g/l

1.86

239

1267

Disorders of tooth development and eruption

160

668

2.43

22.89

4.1

2.1

65.08

67.59

g/l

3.02

154

626

Erosion of teeth, including avohilmo

692

4494

1.53

22.89

2.6

2.3

66.72

67.06

g/l

0.57

637

4180

Adhesive capsulitis of shoulder

704

4770

1.52

22.87

2.1

2.7

66.36

66.38

g/l

0.02

652

4337

Systemic sclerosis, icd10

141

585

2.68

22.84

1.9

2.7

65.50

67.20

g/l

1.62

130

529

Ulcerative colitis

938

6692

1.44

22.84

2.4

66.85

66.65

g/l

0.32

869

6153

Mixed and other personality disorders

282

1508

1.95

22.83

2.0

2.6

66.93

67.50

g/l

0.62

257

1411

Leisure time condition

711

4829

1.52

22.80

2.2

2.5

65.74

66.52

g/l

1.75

608

4395

Other and unspecified nerve root and plexus disorders, also in other diseases

734

5015

1.51

22.79

2.4

2.5

67.33

66.65

g/l

1.84

662

4623

Tobacco use

226

1132

2.13

22.59

1.8

2.7

66.63

66.93

g/l

0.22

209

1054

Acute gastritis

355

2056

1.82

22.53

2.4

2.7

66.49

66.25

g/l

0.22

319

1870

Fracture of forearm

2194

16515

1.26

22.50

2.4

2.6

66.06

66.49

g/l

1.93

1958

14922

Cholecystitis

638

4260

1.56

22.48

2.2

2.5

65.74

65.97

g/l

0.29

566

3782

Other lack of coordination

104

376

3.14

22.27

1.8

3.4

66.82

66.39

g/l

0.21

341

Hallux valgus (acquired)

1331

7247

1.36

22.15

2.4

2.8

66.40

66.17

g/l

0.52

1185

6541

Other/unspecified reactive arthropathies

285

1553

1.94

22.14

2.7

67.17

66.72

g/l

0.51

262

1434

Post-traumatic stress disorder

210

1020

2.12

22.11

1.6

2.3

67.91

67.89

g/l

0.02

192

963

Left bundle-branch block

315

1773

1.87

22.05

1.9

2.6

65.91

66.97

g/l

1.57

272

1584

Thoracic aortic aneurysm

639

4298

1.55

22.02

2.5

2.7

65.62

66.44

g/l

1.99

573

3910

Visual impairment including blindness (binocular or monocular)

317

1792

1.87

21.99

2.3

2.4

65.83

66.07

g/l

0.21

266

1595

Benign neoplasm: Small intestine

201

983

2.22

21.85

2.7

1.6

65.31

67.24

g/l

3.16

187

888

Generalized skin eruption due to drugs and medicaments

192

920

2.25

21.83

5.6

2.9

65.52

66.68

g/l

1.17

176

836

Diseases of inner ear

2355

18775

1.25

21.78

2.4

2.6

66.65

66.36

g/l

1.12

2087

16950

Benign neoplasm: Rectum, anus and anal canal

922

6650

1.44

21.69

2.4

2.6

65.94

66.15

g/l

0.36

845

5974

Other epidermal thickening

208

1031

2.17

21.59

2.5

2.8

65.09

66.53

g/l

2.17

194

942

Malnutrition

116

451

2.88

21.55

2.3

3.1

62.45

65.78

g/l

2.51

108

403

Other condition

525

3384

1.61

21.55

2.8

2.5

66.51

66.76

g/l

0.31

496

3119

Other hammer toe(s) (acquired)

740

4799

1.49

21.54

2.1

2.9

65.81

65.84

g/l

0.03

640

4281

Recurring oral aphthae

216

1088

2.13

21.42

3.7

2.8

65.22

66.45

g/l

1.34

202

997

Clear cell adenocarcinoma of kidney

245

1300

2.05

21.33

3.1

2.9

65.93

66.39

g/l

0.39

226

1192

Fitting and adjustment of other devices

1553

11236

1.31

21.32

2.8

2.4

66.04

66.50

g/l

1.47

1354

9956

Excessive attrition of teeth

1464

6049

1.34

21.27

2.5

2.3

66.86

66.88

g/l

0.04

1336

5568

Cardiac murmurs and other cardiac sounds

323

1817

1.82

21.26

3.0

2.5

67.05

66.45

g/l

0.77

301

1653

Fibroblastic disorders

1013

7425

1.40

21.22

2.3

2.6

66.45

66.30

g/l

0.25

921

6720

Other disorders of optic [2nd] nerve and visual pathways

272

1483

1.94

21.18

2.3

2.9

65.67

66.56

g/l

1.09

253

1366

Mixed hyperlipidaemia

210

1054

2.15

21.18

1.7

2.5

66.63

66.62

g/l

0.01

190

966

Artificial opening status

263

1427

1.98

21.09

2.6

2.7

64.84

66.55

g/l

2.53

238

1302

Arterial embolism and thrombosis

290

1618

1.90

21.07

2.2

2.6

63.68

66.29

g/l

6.57

255

1459

Open wound of ankle and foot

404

2462

1.71

21.04

2.6

65.53

66.67

g/l

2.19

372

2267

Nummular dermatitis

366

2181

1.77

21.04

2.5

2.7

66.90

66.32

g/l

0.80

331

1992

Hypopituitarism

264

1424

1.94

21.01

2.6

2.9

65.95

66.80

g/l

0.95

248

1337

Umbilical hernia

1082

8027

1.38

20.94

2.4

2.6

66.29

66.74

g/l

1.17

992

7410

Special screening examination for other diseases and disorders

318

1812

1.82

20.93

2.6

2.4

66.75

66.36

g/l

0.43

297

1651

Pain and other conditions associated with female genital organs and menstrual cycle

596

3789

1.54

20.92

2.0

2.2

67.15

66.98

g/l

0.25

534

3486

Spontaneous rupture of synovium and tendon

359

2131

1.77

20.86

2.2

2.7

66.38

66.31

g/l

0.05

322

1936

Benign neoplasm of mouth and pharynx

429

2662

1.68

20.83

3.6

1.6

66.33

67.00

g/l

0.99

383

2377

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

220

1125

2.08

20.82

3.1

1.5

64.33

66.56

g/l

3.23

199

982

1026

7169

1.40

20.81

2.5

2.4

65.70

65.64

g/l

0.08

884

6267

Syphilis

133

559

2.60

20.78

2.8

2.6

66.00

66.88

g/l

0.65

124

510

Extreme obesity with alveolar hypoventilation

201

1001

2.17

20.75

1.8

2.9

66.18

66.58

g/l

0.31

180

916

Benign neoplasm: Adrenal gland

349

2072

1.79

20.59

2.3

2.8

65.64

66.49

g/l

1.25

315

1901

Coronary artery bypass grafting

1386

8111

1.34

20.54

2.0

2.6

65.60

66.20

g/l

2.07

1265

7224

Other postsurgical states

278

1543

1.90

20.46

2.2

2.6

65.21

66.70

g/l

2.62

258

1416

Unknown and unspecified causes of morbidity

272

1491

1.90

20.45

2.5

2.4

66.58

66.86

g/l

0.23

259

1351

Alcohol-induced chronic pancreatitis

291

1641

1.88

20.39

1.9

2.8

65.71

66.70

g/l

1.23

265

1521

Injuries to the neck

810

5749

1.44

20.37

2.4

66.48

66.73

g/l

0.42

735

5287

Special screening examination for infectious and parasitic diseases

664

3357

1.50

20.18

2.2

2.3

67.32

67.27

g/l

0.06

600

3149

Juvenile arthritis (FINNGEN)

144

626

2.40

20.16

2.8

3.0

67.89

66.97

g/l

0.74

135

580

Emphysema

346

2059

1.78

20.15

2.4

2.7

65.27

66.02

g/l

0.90

320

1858

Transport accidents

1656

11561

1.29

19.96

2.2

2.5

66.71

66.90

g/l

0.47

1517

10721

Benign neoplasm: Rectum

813

5830

1.45

19.90

2.5

2.6

65.90

66.11

g/l

0.35

744

5240

Non-small cell lung cancer, adenocarcinoma

332

1968

1.80

19.90

1.7

2.7

63.92

66.21

g/l

6.24

306

1791

Non-small cell lung cancer, adenocarcinoma, helper endpoint

332

1968

1.80

19.90

1.7

2.7

63.92

66.21

g/l

6.24

306

1791

Keratitis

1342

10334

1.32

19.88

2.3

2.5

66.75

66.53

g/l

0.47

1221

9406

Acute suppurative otitis media

706

4561

1.47

19.85

3.2

2.3

66.84

67.17

g/l

0.53

661

4254

Cyst of kidney

336

1997

1.79

19.84

2.9

2.7

66.27

66.49

g/l

0.21

311

1825

Injuries to unspecified part of trunk, limb or body region

403

2496

1.68

19.81

2.1

2.6

65.17

66.50

g/l

2.66

361

2290

Parkinson's disease, excluding more controls

600

3955

1.53

19.80

1.9

2.8

65.97

66.10

g/l

0.15

515

3576

Intestinal adhesions without obstruction

373

2272

1.72

19.74

2.7

2.4

65.09

66.34

g/l

2.21

333

2051

Benign neoplasm: Rectosigmoid junction

195

979

2.15

19.73

2.7

1.6

66.50

67.08

g/l

0.53

172

874

Chronic hepatitis, not elsewhere classified

163

763

2.31

19.72

1.6

3.1

69.13

67.08

g/l

1.85

149

703

KRA_PSY_EATING, excluding more controls

185

891

2.12

19.69

1.5

2.4

66.27

67.83

g/l

2.14

167

837

Other nonthrombocytopenic purpura

183

4.08

19.64

2.3

2.8

66.82

66.10

g/l

0.28

162

Childhood asthma (age<16), excluding more controls

245

1023

1.93

19.49

1.9

67.01

68.76

g/l

2.83

228

965

Other and unspecified visual disturbances

392

2430

1.69

19.28

2.5

2.6

66.58

66.37

g/l

0.21

365

2231

Coronary angioplasty

1792

11005

1.28

19.24

2.3

2.7

66.04

66.27

g/l

0.62

1638

9839

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

511

3349

1.56

19.24

2.3

67.19

66.94

g/l

0.31

457

3064

Disorders of refraction and accommodation

877

6343

1.41

19.21

2.5

66.78

66.74

g/l

0.06

808

5853

Other disorders of the musculoskeletal system and connective tissue

618

4237

1.51

19.20

2.4

2.6

66.30

66.32

g/l

0.02

563

3853

Fall on and from stairs and steps

1010

7526

1.38

19.06

2.2

2.6

66.07

66.39

g/l

0.63

886

6830

Benign neoplasm: Duodenum

135

597

2.50

19.04

2.5

1.6

65.62

67.14

g/l

1.42

124

534

Disorders of oesophagus in diseases classified elsewhere

120

505

2.66

19.01

3.3

2.8

62.89

66.37

g/l

4.55

103

455

Carcinoma in situ of skin of upper limb, including shoulder

125

537

2.61

18.98

2.4

1.6

63.25

66.64

g/l

5.22

118

470

Carcinoma in situ of skin of scalp and neck

150

702

2.43

18.94

2.4

2.7

64.19

65.49

g/l

1.23

135

631

Personal history of other diseases and conditions

322

1886

1.75

18.82

3.4

2.4

65.07

67.39

g/l

5.19

296

1737

Need for immunization against other single viral diseases

103

403

2.82

18.78

2.7

2.5

63.56

66.92

g/l

3.94

372

Left ventricular outflow tract obstruction (LVOTO), broad definition

389

2420

1.67

18.75

2.1

2.8

66.07

66.71

g/l

0.83

361

2254

Viral infections of the central nervous system

287

1648

1.82

18.71

2.6

65.71

66.71

g/l

1.25

260

1513

Superficial injury of abdomen, lower back and pelvis

553

3717

1.53

18.68

2.2

2.5

66.20

66.54

g/l

0.51

496

3413

Other viral hepatitis

214

1119

1.99

18.68

2.3

2.5

67.56

67.48

g/l

0.05

198

1051

Emotional disorders starting during childhood or adolecense, excluding more controls

336

2.82

18.66

1.9

2.4

67.17

67.70

g/l

0.23

323

Propionic acid derivatives

1268

4831

1.34

18.66

2.6

2.5

66.57

65.88

g/l

2.27

1161

4412

Speech and linguistic disorders

238

1231

1.91

18.56

2.2

2.5

65.93

66.79

g/l

0.87

214

1140

Corns and callosities

301

1763

1.80

18.50

3.3

2.6

64.92

66.52

g/l

3.38

260

1612

Coxarthrosis, primary, with hip surgery

2160

16840

1.24

18.41

2.4

2.7

66.52

66.13

g/l

1.69

1923

15131

Hypersensitivity angiitis

104

5.28

18.38

1.7

3.0

60.48

66.80

g/l

6.16

Chronic laryngitis and laryngotracheitis

588

4025

1.51

18.36

2.2

2.5

66.67

66.34

g/l

0.48

517

3651

Vasomotor and allergic rhinitis

1272

9670

1.32

18.33

2.2

2.5

66.95

66.77

g/l

0.41

1152

8898

Parkinson's disease, strict definition, excluding more controls

557

3700

1.53

18.33

1.9

2.8

66.10

g/l

0.00

477

3339

Filling of root of tooth

144

661

2.35

18.31

5.3

3.1

64.87

67.08

g/l

2.66

134

612

Other mental disorders due to brain damage and dysfunction and to physical disease

517

3461

1.56

18.31

2.2

2.6

66.67

66.04

g/l

1.06

434

3111

Macular pucker

692

4908

1.47

18.27

2.4

2.6

65.92

66.07

g/l

0.21

611

4389

ILD-related respiratory insufficiency

181

916

2.17

18.26

2.2

2.7

64.99

65.90

g/l

0.72

171

819

Other disorders of patella

560

3785

1.51

18.20

2.2

2.8

67.19

66.69

g/l

0.95

509

3524

Other localized connective tissue disorders

106

428

2.74

18.20

3.2

2.9

65.82

67.22

g/l

0.83

384

Synovial cyst of popliteal space [Baker]

321

1921

1.75

18.18

2.3

2.7

66.04

66.26

g/l

0.18

287

1737

Melanocytic naevi of trunk

399

2511

1.64

18.18

2.7

1.6

66.49

67.17

g/l

1.26

372

2269

Other noninfective disorders of lymphatic vessels and lymph nodes

167

817

2.20

18.05

2.4

2.8

64.37

66.87

g/l

3.29

160

742

Pemphigoid

155

744

2.30

18.05

1.6

2.8

65.84

65.98

g/l

0.09

142

662

Colonic or urogenital fistula

1087

8258

1.35

17.99

2.5

66.58

66.52

g/l

0.09

976

7534

Barrett oesophagus

233

1282

1.94

17.97

2.5

2.8

65.15

66.23

g/l

1.15

210

1172

Other follicular disorders

259

1459

1.85

17.97

2.3

2.7

67.54

66.97

g/l

0.64

247

1346

Childhood asthma (age<16)

245

1052

1.87

17.96

1.9

67.01

68.57

g/l

2.33

228

994

Viral hepatitis

256

1437

1.85

17.92

2.2

2.5

67.61

67.27

g/l

0.25

233

1344

Paraplegia, diplegia of upper limbs

116

492

2.59

17.88

1.9

2.7

65.71

66.88

g/l

0.74

105

449

Sacroiliitis, not elsewhere classified

155

732

2.21

17.87

1.7

2.4

68.35

67.45

g/l

0.75

138

683

Arthropathic psoriasis

444

2883

1.60

17.85

1.9

2.8

67.30

66.64

g/l

1.09

410

2651

Unstable angina pectoris

1842

12373

1.26

17.85

2.3

2.7

66.02

66.22

g/l

0.53

1652

11069

Idiopathic pulmonary fibrosis

378

2383

1.68

17.78

2.0

2.5

66.46

65.97

g/l

0.56

341

2146

Asthma and opportunity respiratory infection

237

1318

1.93

17.78

2.6

2.8

65.31

66.23

g/l

1.03

212

1179

Alcohol induced polyneuropathy

221

3.59

17.77

1.6

2.9

65.35

66.69

g/l

0.61

201

Complications of cardiac and vascular prosthetic devices, implants and grafts

121

528

2.56

17.74

2.3

2.9

63.61

65.82

g/l

1.94

113

474

Menorrhagia

1322

5636

1.32

17.72

2.4

66.96

66.46

g/l

1.59

1151

5070

Psychotic depression

229

1247

1.91

17.69

2.0

3.1

67.11

66.66

g/l

0.35

196

1149

Primary gonarthrosis, bilateral

2301

16702

1.23

17.67

2.2

2.7

66.52

66.22

g/l

1.16

2057

15061

Opening and dilatation of root channel of tooth

239

1323

1.89

17.63

4.3

2.5

65.55

67.04

g/l

1.96

220

1229

Disorders of psychological development

291

1564

1.76

17.62

2.1

2.4

65.85

67.03

g/l

1.50

263

1458

Focal epilepsy

820

5989

1.40

17.58

2.3

2.5

65.87

66.34

g/l

0.87

741

5446

Psoriatic arthropathies, ICD10

414

2657

1.62

17.56

1.9

2.8

67.67

66.70

g/l

1.98

381

2442

Seborrhoeic dermatitis

395

2511

1.64

17.51

2.6

2.7

67.06

66.33

g/l

1.07

350

2300

Gangrene, not elsewhere classified

173

4.01

17.51

3.4

2.7

63.95

66.85

g/l

1.58

158

Carcinoma in situ of skin

391

2497

1.66

17.47

2.5

2.6

65.13

66.18

g/l

1.90

347

2239

Other specified/unspecified soft tissue disorders

217

1172

1.95

17.46

2.4

2.6

66.40

66.28

g/l

0.08

201

1054

Fracture of skull and facial bones

780

5660

1.41

17.35

2.6

2.5

66.14

66.61

g/l

0.92

698

5209

Ulcerative colitis, NAS

505

3385

1.53

17.33

2.3

2.6

66.73

66.76

g/l

0.03

473

3118

Other and unspecified haemorrhagic conditions

350

2.90

17.31

3.9

2.5

65.90

66.77

g/l

0.47

318

Infections with a predominantly sexual mode of transmission

882

6513

1.37

17.20

2.3

66.59

67.18

g/l

1.46

807

6057

Ocular pain

297

1763

1.75

17.20

2.7

66.77

66.82

g/l

0.04

267

1617

Familial hypercholesterolemia, with ischemic heart disease

467

3108

1.58

17.18

2.2

2.6

65.48

66.00

g/l

0.73

435

2736

Exfoliative dermatitis

242

3.37

17.06

1.8

3.2

66.89

65.84

g/l

0.63

216

Benign paroxysmal vertigo

1196

9283

1.32

17.05

2.5

2.6

66.98

66.23

g/l

3.13

1060

8344

Pain associated with micturition

466

3091

1.56

17.03

2.8

2.6

66.38

66.48

g/l

0.10

417

2802

Other sleep disorders

428

2785

1.59

17.00

2.2

2.7

66.23

66.42

g/l

0.22

383

2550

Alcohol abuse, main dg

573

3957

1.49

16.96

1.7

2.5

65.98

66.69

g/l

1.25

515

3681

Organic, including symptomatic, mental disorders

2329

14005

1.22

16.82

2.1

2.6

65.54

66.08

g/l

2.44

1972

12600

Other hearing loss

1255

9649

1.31

16.82

2.7

2.5

65.84

66.01

g/l

0.32

1100

8601

Papilloedema, unspecified

103

424

2.63

16.81

1.8

2.8

65.53

66.90

g/l

0.93

388

Other or ill-defined heart diseases

203

1083

1.96

16.80

2.8

2.5

64.63

67.20

g/l

3.84

182

987

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1870

14998

1.24

16.80

2.3

2.5

66.97

66.65

g/l

1.16

1692

13669

IBD patients in KELA-register

791

5780

1.40

16.78

2.3

2.5

66.99

66.85

g/l

0.21

743

5355

Other/unspecified synovitis and tenosynovitis

440

2890

1.57

16.70

2.4

2.6

66.40

66.44

g/l

0.04

408

2633

Carcinoma in situ of skin of ear and external auricular canal

319

3.01

16.62

2.4

1.7

65.35

66.41

g/l

0.41

273

Anti-inflammatory and antirheumatic products, non-steroids

1250

4833

1.32

16.61

2.7

2.5

66.56

65.88

g/l

2.10

1142

4414

Polycythaemia vera

164

824

2.14

16.60

2.8

1.6

66.26

66.90

g/l

0.52

155

733

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1316

6275

1.31

16.56

2.7

1.7

65.76

66.96

g/l

6.57

1193

5719

Anosmia

258

3.02

16.55

2.4

1.5

65.49

67.95

g/l

1.64

228

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1123

8633

1.32

16.48

2.4

67.15

66.98

g/l

0.38

1036

8020

Psoriasis (vulgaris), strict definition

139

656

2.27

16.46

1.7

2.8

68.51

66.99

g/l

1.33

124

607

Focal epilepsy, strict definition

764

5583

1.40

16.42

2.3

2.5

65.80

66.30

g/l

0.88

689

5070

Rosacea

433

2853

1.57

16.32

2.2

2.6

67.12

66.70

g/l

0.55

398

2616

Inguinal hernia

2535

14348

1.21

16.29

2.6

2.5

66.11

66.63

g/l

2.68

2304

13110

Mucosal proctocolitis

433

2847

1.56

16.27

2.2

2.6

67.43

66.92

g/l

0.69

413

2640

Malignant neoplasm of respiratory system and intrathoracic organs

1003

7040

1.35

16.27

1.9

2.5

64.76

65.94

g/l

5.16

933

6249

Injury of unspecified body region

310

1894

1.71

16.26

1.8

2.7

65.28

66.42

g/l

1.62

275

1734

Appendectomy

2384

19238

1.21

16.25

2.8

2.5

66.53

66.74

g/l

0.73

2197

17641

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

397

2576

1.61

16.25

3.6

1.5

65.90

66.62

g/l

1.25

358

2234

Disorders of myoneural junction and muscle in diseases classified elsewhere

166

3.91

16.23

1.9

3.0

64.02

67.27

g/l

1.95

152

Polyarteritis nodosa

127

4.33

16.21

2.1

2.9

64.08

66.00

g/l

0.83

113

Aortic valve malfunction, age under 60 years

358

2266

1.64

16.18

2.1

2.8

66.17

66.75

g/l

0.70

331

2113

Other psoriatic arthropathies

399

2590

1.60

16.14

2.0

2.8

67.68

66.68

g/l

1.97

367

2382

Social phobias

210

1141

1.89

16.12

1.6

2.5

67.01

67.94

g/l

1.00

198

1079

COPD, hospital admissions 1, only main diagnosis

1622

11174

1.26

16.10

2.0

2.6

65.10

66.16

g/l

6.00

1431

10045

Cholangitis (primary sclerosing, PSC)

263

1544

1.79

16.09

2.2

2.6

65.82

66.24

g/l

0.34

240

1404

Amputation of ankle bones

119

537

2.44

16.06

3.6

2.9

63.14

65.84

g/l

2.58

109

485

Diseases of tongue

264

1551

1.78

16.05

2.4

2.3

66.50

66.52

g/l

0.02

240

1404

Allergic conjunctivitis

1952

15820

1.23

16.04

2.3

2.5

66.98

66.65

g/l

1.30

1767

14444

Calculus of kidney and ureter

1280

10102

1.29

15.98

2.4

2.6

66.61

66.45

g/l

0.30

1164

9203

Cystic fibrosis with pulmonary manifestations

17.89

15.92

2.0

4.1

69.12

66.16

g/l

0.65

Other blood glucose lowering drugs, excl. Insulins

748

5490

1.40

15.91

2.0

2.6

66.42

65.91

g/l

0.99

684

4903

Amenorrhoea

193

1027

1.93

15.87

1.8

2.1

67.21

67.32

g/l

0.07

174

946

Idiopathic urticaria

363

2.71

15.83

2.6

2.7

68.34

67.34

g/l

0.75

333

Lupus erythematosus

125

579

2.35

15.75

2.2

3.0

67.60

67.18

g/l

0.25

114

525

Obsessive-compulsive disorder

165

835

2.03

15.70

1.7

2.5

66.58

68.09

g/l

1.69

146

784

Other forms of systemic lupus erythematosus

169

3.75

15.67

2.0

3.0

65.75

67.18

g/l

0.62

150

Viral warts

350

2216

1.63

15.67

2.5

2.6

65.36

66.87

g/l

2.83

324

2042

Focal epilepsy, mode (most common among epilepsy diagnosis)

715

5210

1.41

15.66

2.3

2.5

66.23

66.38

g/l

0.19

643

4734

Overexertion and strenuous or repetitive movements

368

2364

1.61

15.54

2.9

2.7

65.63

66.76

g/l

2.17

334

2188

Seborrhoeic keratosis

949

7241

1.35

15.52

2.9

2.5

65.59

66.21

g/l

1.68

861

6487

Bullous pemphigoid

125

588

2.36

15.45

1.5

3.0

65.75

65.65

g/l

0.05

115

522

Congenital malformations and deformations of the musculoskeletal system

262

1537

1.75

15.36

1.8

2.7

68.11

66.81

g/l

1.92

250

1422

Other and unspecified rosacea

335

2116

1.65

15.35

2.3

2.7

67.21

66.67

g/l

0.69

308

1936

Viral encephalitis, not elsewhere classified/unspecified

101

432

2.55

15.32

3.6

2.9

65.79

66.66

g/l

0.43

396

Mental and behavioural disorders due to sedatives or hypnotics

239

1381

1.80

15.26

1.6

2.6

65.76

67.16

g/l

1.70

216

1285

Atopic dermatitis, strict definition

811

5910

1.36

15.21

2.2

2.4

67.17

67.09

g/l

0.12

758

5497

Procreative management

961

6164

1.33

15.19

2.4

66.62

67.06

g/l

1.10

894

5728

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1122

7081

1.31

15.14

2.5

1.5

66.50

66.97

g/l

1.25

997

6265

Irregular menses

1412

9146

1.27

15.09

2.5

2.4

66.88

66.95

g/l

0.14

1278

8405

Squamous cell neoplasms and carcinomas of the skin

578

4117

1.46

14.94

2.4

2.5

64.91

65.81

g/l

2.08

523

3624

Pre-eclampsia or eclampsia

654

4724

1.41

14.92

2.5

66.43

67.18

g/l

1.55

603

4341

Total colectomy

175

931

1.99

14.89

2.7

2.9

65.70

66.71

g/l

0.83

168

859

Total colectomy operation

175

931

1.99

14.89

2.7

2.9

65.70

66.71

g/l

0.83

168

859

Paralytic strabismus

308

1926

1.68

14.88

2.4

2.7

66.64

66.35

g/l

0.29

278

1771

Alcohol dependence

1076

8380

1.31

14.88

1.8

2.7

66.00

66.60

g/l

1.46

960

7720

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

396

2352

1.55

14.87

1.9

2.1

67.02

67.64

g/l

0.90

364

2234

Hyperkinetic disorders, excluding more controls

183

947

1.91

14.85

1.4

2.3

67.46

68.02

g/l

0.55

169

907

Glaucoma

2513

18748

1.19

14.80

2.5

2.6

66.30

66.19

g/l

0.30

2244

16831

Postprocedural disorders of digestive system, not elsewhere classified

153

783

2.10

14.75

2.5

2.9

64.77

66.46

g/l

1.55

142

715

Fenamates

624

2997

1.43

14.69

2.3

2.5

66.55

65.95

g/l

1.15

564

2718

Inflammatory bowel disease, strict (require KELA)

791

5908

1.36

14.66

2.3

2.5

66.99

66.83

g/l

0.24

743

5472

Strabismus

931

7108

1.33

14.65

2.4

2.5

66.56

66.58

g/l

0.03

860

6510

Iridocyclitis in diseases classified elsewhere

398

2.59

14.63

2.3

3.0

66.46

66.66

g/l

0.09

362

Leiomyoma of uterus

1506

6809

1.26

14.63

2.6

1.5

66.72

67.12

g/l

1.25

1331

6115

Cluster headache, wide

143

711

2.11

14.62

1.8

2.8

67.82

67.21

g/l

0.42

137

662

Sequelae of injuries, of poisoning and of other consequences of external causes

864

6547

1.35

14.61

2.5

66.70

66.69

g/l

0.02

788

6035

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

141

704

2.16

14.60

3.6

1.6

64.91

67.18

g/l

2.24

128

631

Mental and behavioural disorders due to tobacco

327

2080

1.63

14.56

2.1

2.8

65.69

66.59

g/l

1.18

286

1925

Trigger finger

516

3600

1.47

14.55

2.0

2.6

66.39

66.53

g/l

0.15

478

3304

Hemiplegia

218

1249

1.83

14.54

1.7

2.6

65.66

66.68

g/l

0.94

187

1136

Impingement syndrome of shoulder

953

7332

1.33

14.47

2.5

2.8

66.93

66.64

g/l

0.60

859

6736

Acute pharyngitis

409

2701

1.53

14.43

3.1

2.4

67.31

67.24

g/l

0.07

379

2529

Fall on same level involving ice and snow

2215

18674

1.20

14.38

2.3

2.6

66.45

66.49

g/l

0.09

1970

16968

Bacterial, viral and other infectious agents

301

1878

1.66

14.37

3.0

2.6

66.07

67.06

g/l

1.34

279

1754

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1289

6132

1.29

14.37

2.7

1.7

65.74

66.93

g/l

6.38

1164

5581

Other juvenile arthritis

115

527

2.26

14.34

2.6

3.1

68.10

66.78

g/l

1.00

106

493

Algoneurodystrophy

126

604

2.21

14.28

2.1

2.8

67.20

67.49

g/l

0.20

115

562

Portal vein thrombosis

343

2.72

14.25

2.0

2.8

64.87

66.57

g/l

1.02

318

Smoking dependency

327

2091

1.63

14.25

2.1

2.8

65.69

66.60

g/l

1.21

286

1933

Attention to artificial openings

177

962

1.96

14.23

2.4

2.7

63.51

66.68

g/l

4.61

157

880

Acute bronchiolitis

152

693

2.03

14.17

5.7

2.8

65.18

66.00

g/l

0.53

141

645

Symptoms and signs involving emotional state

114

527

2.29

14.15

2.0

2.7

67.34

66.90

g/l

0.28

102

482

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

321

2050

1.63

14.15

3.3

2.6

64.34

66.59

g/l

4.85

288

1869

Benign neoplasm: Small intestine

201

1143

1.89

14.15

2.7

2.9

65.31

66.43

g/l

1.34

187

1036

Olecranon bursitis

257

1554

1.73

14.13

3.0

2.6

65.43

66.45

g/l

1.25

238

1421

Monoplegia

326

2.75

14.11

2.3

3.2

67.15

67.10

g/l

0.02

293

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

197

1098

1.85

14.09

1.5

2.3

66.84

67.52

g/l

0.48

174

1041

Other and unspecified disorders of skin and subcutaneous tissue

272

1671

1.70

14.08

2.5

2.7

66.34

66.50

g/l

0.10

216

1521

Benign neoplasm of urinary organs

192

1072

1.89

14.08

2.2

1.6

66.11

67.06

g/l

0.96

172

958

Benign neoplasm: Skin of eyelid, including canthus

566

4045

1.44

14.07

3.0

1.6

66.60

66.73

g/l

0.15

494

3586

Artificial joint re-operation

322

2071

1.64

14.03

1.9

2.7

66.13

66.22

g/l

0.07

290

1869

Other/unspecified enthesopathies of lower limb, excluding foot

249

1490

1.73

14.02

2.2

2.7

66.34

66.59

g/l

0.20

226

1370

Endometriosis

1225

5751

1.28

13.94

2.3

2.4

66.52

66.55

g/l

0.05

1108

5193

Brachial plexus disorders

297

1859

1.65

13.93

2.3

2.6

67.41

67.00

g/l

0.42

272

1741

Open wound of forearm

340

2202

1.60

13.91

2.4

2.5

65.81

66.53

g/l

0.91

309

2028

Other and unspecified tonsillitis

908

5881

1.32

13.90

2.3

67.08

67.32

g/l

0.40

854

5515

Panniculitis, unspecified

214

3.21

13.89

2.2

2.9

65.76

67.15

g/l

0.62

196

Benign neoplasm: Descending colon

310

1981

1.65

13.88

2.4

2.7

65.58

66.42

g/l

1.10

276

1811

Malignant melanoma, excluding all cancers (controls excluding all cancers)

659

4843

1.40

13.87

2.9

1.6

65.84

66.77

g/l

2.33

590

4282

Crohn's disease NAS

232

1368

1.76

13.84

1.9

2.6

65.45

66.99

g/l

1.85

214

1266

Third [oculomotor] nerve palsy

101

455

2.46

13.82

1.9

3.3

66.84

66.22

g/l

0.35

415

Ulcer of oesophagus

319

2049

1.63

13.82

2.6

2.7

65.68

66.15

g/l

0.49

287

1868

CR(E)ST syndrome

356

2.65

13.69

2.1

2.7

65.06

67.14

g/l

1.39

326

Infection due to other mycobacteria

368

2.61

13.69

1.5

2.4

64.58

66.76

g/l

1.45

323

Allergic contact dermatitis

452

3115

1.49

13.58

2.1

2.6

67.50

66.69

g/l

1.59

410

2865

Traumatic subarachnoid haemorrhage

145

747

2.05

13.58

2.5

2.4

66.15

66.42

g/l

0.15

129

675

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

631

2949

1.40

13.55

1.9

2.0

67.15

67.80

g/l

1.43

592

2764

Juvenile rheumatoid arthirtis

304

2.67

13.54

2.3

3.0

68.11

67.24

g/l

0.48

287

Benign neoplasm of meninges

374

2492

1.55

13.53

2.3

1.5

65.35

66.80

g/l

3.63

332

2199

Other obstetric conditions, not elsewhere classified

652

3070

1.39

13.46

2.0

67.19

67.78

g/l

1.27

612

2873

Congenital malformations of heart and great arteries

429

2838

1.50

13.45

2.3

2.7

64.94

66.60

g/l

3.82

394

2640

Other and unspecified vascular occlusions

422

2898

1.52

13.35

2.8

2.6

66.32

66.02

g/l

0.35

381

2584

Other specified and unspecified personality disorders

292

1841

1.63

13.32

1.8

2.5

65.81

67.17

g/l

2.34

266

1713

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

499

3523

1.46

13.24

2.4

1.6

65.61

66.55

g/l

1.82

441

3120

Cluster headache, strict

128

635

2.11

13.21

1.9

2.9

68.03

67.51

g/l

0.32

122

594

Fall involving bed

153

818

2.02

13.17

2.2

2.8

65.62

65.84

g/l

0.12

127

732

Urolithiasis

1362

11075

1.25

13.16

2.4

2.5

66.55

66.42

g/l

0.27

1237

10085

Right bundle-branch block

159

856

1.97

13.15

2.3

2.6

64.91

66.98

g/l

2.39

147

773

Other renal tubulo-interstitial diseases

101

460

2.34

13.13

2.6

2.3

65.91

67.20

g/l

0.77

420

Otitis externa

792

6024

1.34

13.12

2.6

2.5

67.01

66.54

g/l

0.97

686

5534

Pre-eclampsia

588

4267

1.40

13.11

2.7

2.4

66.41

67.20

g/l

1.52

545

3929

119

2318

0.49

13.11

1.5

2.6

64.40

65.99

g/l

1.04

104

2110

Carcinoma in situ of skin of trunk

145

763

2.06

13.10

3.0

1.6

63.73

66.47

g/l

3.79

131

671

Benign neoplasm: Skin of other and unspecified parts of face

401

2729

1.52

13.04

2.9

1.6

66.03

66.64

g/l

0.82

349

2410

therapeutic use

148

785

2.03

13.03

1.8

2.7

66.06

66.50

g/l

0.24

121

718

Bell's palsy

447

3109

1.48

12.97

2.6

66.30

66.45

g/l

0.17

408

2845

Colectomy operation

717

5402

1.37

12.97

2.5

2.6

65.49

66.16

g/l

1.37

655

4850

Vascular diseases of the intestine

181

1022

1.89

12.95

2.4

2.7

64.17

66.16

g/l

2.10

169

920

Benign neoplasm: Duodenum

135

698

2.11

12.93

2.5

3.0

65.62

66.38

g/l

0.53

124

633

Allergic rhinitis

905

6941

1.31

12.85

2.3

2.4

67.15

66.98

g/l

0.31

822

6441

Other diseases of biliary tract

361

2421

1.55

12.80

2.3

2.5

64.38

66.18

g/l

3.82

332

2173

Type 1 diabetes, definitions combined

264

1632

1.65

12.77

2.1

2.4

64.92

67.29

g/l

5.86

244

1542

Nail disorders

299

1922

1.61

12.72

2.3

2.7

65.55

66.67

g/l

1.79

278

1767

Other and unspecified injuries of head

238

1452

1.71

12.65

1.7

2.6

65.85

66.38

g/l

0.47

204

1329

Benign neoplasm of major salivary glands

360

2415

1.54

12.62

2.1

1.6

66.34

66.90

g/l

0.67

331

2148

Somnolence, stupor and coma

183

1041

1.85

12.60

1.7

2.9

64.72

66.44

g/l

2.14

169

949

Benign neoplasm of bone and articular cartilage

262

1633

1.65

12.60

2.6

1.6

67.21

67.28

g/l

0.06

240

1483

Superficial injury of thorax

553

4012

1.41

12.59

2.2

2.5

65.78

66.46

g/l

1.28

497

3670

Degenerative macular diseases

542

3935

1.43

12.57

2.3

2.5

66.08

66.02

g/l

0.06

488

3498

Other specified disorders of kidney and ureter

151

814

1.98

12.54

2.4

2.9

65.53

66.56

g/l

0.82

145

745

Superficial injury of wrist and hand

621

4584

1.38

12.51

2.3

2.5

67.04

66.84

g/l

0.29

567

4239

Other erythematous conditions

151

814

1.97

12.49

2.6

2.7

66.86

66.51

g/l

0.21

144

747

Astigmatism

210

1240

1.76

12.48

2.5

2.9

66.63

66.51

g/l

0.08

189

1142

Pediculosis, acariasis and other infestations

205

1205

1.77

12.46

2.8

2.6

66.65

66.78

g/l

0.08

189

1123

Striking against or struck by other objects

1074

8537

1.28

12.44

2.5

66.43

66.80

g/l

0.92

966

7885

Congenital malformations of the circulatory system

471

3221

1.45

12.44

2.1

2.7

65.11

66.63

g/l

3.76

438

2978

Bronchitis, not specified as acute or chronic

340

2259

1.55

12.44

2.4

2.6

66.62

66.51

g/l

0.09

304

2050

Type 1 diabetes, strict (exclude DM2)

262

1629

1.64

12.40

2.1

2.4

64.87

67.27

g/l

5.94

242

1538

Postmenopausal bleeding

1120

4879

1.29

12.40

2.6

2.5

66.29

66.30

g/l

0.01

980

4366

Inflammatory disease of uterus

410

2822

1.48

12.37

1.9

2.4

66.83

66.94

g/l

0.11

360

2596

Nontoxic multinodular goitre

811

6252

1.33

12.37

2.2

2.7

65.95

66.24

g/l

0.51

721

5602

Kyphosis

281

2.75

12.31

2.2

2.6

66.20

66.91

g/l

0.34

260

Respiratory conditions due to other external agents

110

538

2.24

12.30

3.8

2.7

64.81

66.44

g/l

1.35

481

Pre-eclampsia or poor fetal growth

804

6151

1.32

12.30

2.4

2.3

66.70

67.26

g/l

1.23

742

5673

Other nutritional anaemias

229

2.99

12.30

1.9

2.8

66.09

65.73

g/l

0.13

201

Schizophrenia or delusion, excluding more controls

960

7479

1.29

12.29

2.1

2.6

65.96

66.92

g/l

3.13

858

6913

Deficiency of other B group vitamins

107

516

2.24

12.27

3.3

2.9

65.99

66.34

g/l

0.21

469

Acute alcohol intoxication, ICD10

699

5276

1.35

12.25

1.8

2.6

66.21

66.75

g/l

0.97

629

4894

Dislocation, sprain and strain of joints and ligaments at neck level

457

3217

1.45

12.24

2.3

2.5

67.08

67.01

g/l

0.08

418

2980

Cerebral aneurysm, nonruptured

340

2273

1.55

12.20

1.9

2.8

66.28

66.50

g/l

0.20

312

2065

Entropion and trichiasis of eyelid

389

2680

1.51

12.17

2.7

2.5

65.98

66.07

g/l

0.07

346

2396

Other specified/unspecified bacterial intestinal infections

267

1695

1.64

12.16

3.5

2.7

65.46

66.50

g/l

1.28

238

1543

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

162

902

1.90

12.12

2.4

2.9

67.27

66.67

g/l

0.41

149

820

Mental and behavioural disorders due to opioids

109

525

2.16

12.10

1.8

2.2

67.31

67.96

g/l

0.31

494

Primary coxarthrosis, bilateral

1261

10279

1.25

12.10

2.3

2.6

66.52

65.99

g/l

1.76

1117

9184

Optic neuritis

149

804

1.94

12.09

1.8

2.7

68.47

67.40

g/l

1.02

139

744

Benign neoplasm: Rectosigmoid junction

195

1152

1.80

12.05

2.7

3.0

66.50

66.25

g/l

0.18

172

1045

Chronic viral hepatitis

162

897

1.87

12.00

2.1

2.3

68.27

67.55

g/l

0.47

149

847

Secondary systemic amyloidosis

5.34

12.00

5.6

2.2

59.13

65.85

g/l

2.64

Carcinoma in situ of skin of upper limb, including shoulder

125

649

2.12

11.99

2.4

3.0

63.25

65.68

g/l

3.05

118

581

Melanocytic naevi, other sites/unspecified

252

1578

1.65

11.95

3.2

1.5

65.83

67.41

g/l

2.71

236

1436

Other secondary coxarthrosis

153

842

1.93

11.93

1.7

2.8

66.60

66.62

g/l

0.01

136

766

Spirochaetal infections, other/unspecified

333

2230

1.55

11.92

2.4

2.8

66.82

66.41

g/l

0.49

290

2040

Visual field defects

352

2384

1.53

11.92

2.3

2.5

65.66

66.28

g/l

0.78

315

2170

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

132

690

2.01

11.84

2.0

2.8

66.95

66.92

g/l

0.01

127

638

Abscess of anal and rectal regions

294

1913

1.58

11.81

2.3

2.6

66.18

67.02

g/l

0.95

273

1786

Pneumonitis due to solids and liquids

342

2308

1.54

11.79

2.1

2.4

64.91

66.07

g/l

1.36

302

2083

Melanocytic naevi of lower limb, including hip

147

797

1.93

11.78

2.7

1.5

66.33

67.44

g/l

1.03

141

724

Superficial injury of forearm

311

2049

1.56

11.76

1.8

2.5

66.25

66.77

g/l

0.61

272

1893

Crohn's disease of small intestine

231

1422

1.68

11.76

1.8

2.6

65.14

67.01

g/l

2.68

213

1316

Benign neoplasm: Pancreas

117

593

2.13

11.76

3.0

1.5

66.41

67.21

g/l

0.57

111

528

Wet age-related macular degeneration

783

5952

1.33

11.74

2.5

2.4

65.52

65.67

g/l

0.23

691

5187

Testicular hypofunction

120

610

2.08

11.72

2.1

3.1

68.33

67.04

g/l

1.32

111

573

Ptosis of eyelid

462

3307

1.45

11.69

2.7

2.6

65.91

66.15

g/l

0.30

424

2992

Other benign neoplasms of skin

1510

12558

1.22

11.66

2.9

2.5

66.47

66.26

g/l

0.51

1328

11329

Benign neoplasm: Kidney

139

747

1.98

11.64

2.2

1.6

66.20

67.28

g/l

0.92

124

664

Moderate visual impairment, binocular

142

770

1.96

11.62

1.9

2.4

65.52

65.91

g/l

0.25

114

683

Fracture of neck

249

1575

1.66

11.62

2.9

2.6

65.90

66.47

g/l

0.57

226

1443

Other specified disorders of muscle

119

606

2.08

11.60

1.9

2.9

66.10

66.98

g/l

0.60

111

547

Allergic urticaria

270

1732

1.61

11.56

3.4

2.7

66.60

66.58

g/l

0.02

247

1598

Carcinoma in situ of skin of ear and external auricular canal

381

2.48

11.55

2.4

2.5

65.35

65.48

g/l

0.04

335

Benign neoplasm: Cerebral meninges

330

2218

1.54

11.54

2.4

1.5

65.16

66.81

g/l

4.19

296

1964

Type1 diabetes, definitions combined, early onset

153

836

1.87

11.52

2.0

2.4

64.13

67.81

g/l

8.67

145

800

Carrier of infectious disease

466

2.24

11.52

2.3

2.5

65.75

66.90

g/l

0.70

425

Thyroiditis

260

1659

1.62

11.50

2.4

2.7

67.28

66.76

g/l

0.57

236

1514

Status epilepticus

146

799

1.92

11.46

1.9

2.8

65.86

65.94

g/l

0.03

131

727

Other interventions on the root canals of the tooth

333

2.48

11.39

5.1

2.6

64.26

67.47

g/l

2.98

306

Testicular dysfunction

131

693

1.99

11.39

2.1

3.0

68.15

67.09

g/l

1.04

120

652

Other noninflammatory disorders of uterus, except cervix

885

4725

1.30

11.39

2.7

2.5

66.38

66.28

g/l

0.13

787

4216

Atypical facial pain

196

1171

1.75

11.36

2.4

2.6

67.28

66.67

g/l

0.64

177

1068

Carcinoma in situ of other and unspecified digestive organs

114

580

2.12

11.36

2.6

1.6

64.67

67.09

g/l

2.74

105

521

Other other unspecified disorders of the circulatory system

166

952

1.85

11.32

3.5

2.7

65.41

66.28

g/l

0.77

153

864

Autoimmune hyperthyroidism

197

1175

1.73

11.31

2.3

2.8

65.41

67.06

g/l

2.51

181

1068

Alcohol-induced acute pancreatitis

153

856

1.89

11.29

2.2

2.7

66.38

66.39

g/l

0.01

133

795

Other/unspecified crystal arthropathies

147

3.54

11.22

3.0

3.1

67.20

66.57

g/l

0.21

132

Iron deficiency

284

2.56

11.22

2.1

2.5

66.42

67.44

g/l

0.51

266

Multifocal fibrosclerosis

152

3.45

11.19

1.8

2.9

65.87

66.36

g/l

0.15

133

Hyperaldosteronism

129

688

2.01

11.18

2.5

3.0

66.07

66.67

g/l

0.40

115

634

Thyrotoxicosis with diffuse goitre

464

3334

1.42

11.18

2.2

2.5

65.78

66.86

g/l

2.42

428

3059

Cysts of oral region, not elsewhere classified

166

951

1.82

11.15

3.6

2.3

65.60

66.70

g/l

1.06

152

879

Other Crohn's disease

225

1397

1.66

11.07

1.8

2.5

65.75

67.20

g/l

1.90

210

1295

Other aneurysm

241

1533

1.65

11.03

2.6

65.90

66.40

g/l

0.47

223

1394

Disorders in reading

149

3.18

11.00

1.7

3.0

66.63

66.31

g/l

0.08

141

Other and unspecified psoriasis

264

1713

1.60

10.98

1.9

2.8

66.70

66.55

g/l

0.11

245

1565

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

156

887

1.86

10.94

1.9

1.6

59.67

66.84

g/l

13.92

148

799

Crohn disease (strict definition, all UC cases excluded)

170

985

1.79

10.92

2.0

2.7

65.95

67.00

g/l

1.05

153

917

Acne

218

1340

1.66

10.91

2.3

2.0

67.44

67.69

g/l

0.19

206

1260

Aneurysms, operations, SAH

651

4963

1.34

10.85

2.1

2.6

65.90

66.35

g/l

0.78

582

4463

Complications of other internal prosthetic devices, implants and grafts

169

986

1.81

10.84

2.2

2.6

66.50

66.32

g/l

0.11

154

894

Erythema multiforme

103

513

2.15

10.81

2.8

2.9

65.28

66.75

g/l

1.01

467

Nonsuppurative otitis media

635

4142

1.34

10.77

2.8

2.2

66.64

66.82

g/l

0.22

596

3819

Pregnancy hypertension

1171

8598

1.24

10.77

2.5

2.4

66.63

67.07

g/l

1.17

1092

7882

Plantar fascial fibromatosis

335

2287

1.51

10.76

2.4

2.7

67.28

66.63

g/l

0.94

308

2094

Other and unspecified nonorganic psychotic disorders

558

4151

1.37

10.72

1.9

2.5

66.12

67.15

g/l

2.18

505

3859

Other arterial embolism and thrombosis

137

755

1.93

10.72

2.5

2.9

64.08

66.22

g/l

2.54

120

677

Other disorders of pigmentation

182

1087

1.76

10.69

2.7

66.82

66.59

g/l

0.15

168

985

Other disorders starting during childhood or adolecense, excluding more controls

386

2.22

10.66

3.3

2.6

65.40

67.06

g/l

0.91

370

Scleritis and episcleritis

214

1330

1.67

10.60

2.0

2.6

68.02

66.88

g/l

1.41

200

1232

Fracture at wrist and hand level

1166

9530

1.24

10.58

2.6

2.5

66.40

66.77

g/l

0.97

1048

8737

Specific development disorders of speech and language

160

881

1.80

10.57

2.2

2.8

65.79

66.38

g/l

0.39

146

809

Hyperfunction of pituitary gland

156

890

1.82

10.55

3.0

2.7

66.38

67.15

g/l

0.60

142

833

Emotional disorders and disorders of social functioning with onset specific to childhood

100

483

2.09

10.52

1.9

2.4

67.32

67.35

g/l

0.01

459

Oesophagitis

229

1455

1.64

10.49

2.0

2.7

64.70

66.26

g/l

2.32

211

1327

Other and unspecified mononeuropathies, also in other diseases

131

716

1.94

10.46

2.5

2.7

66.40

66.60

g/l

0.12

112

648

Melanoma in situ

171

1013

1.79

10.46

2.9

1.6

65.73

66.89

g/l

1.12

151

904

Sequelae of injuries of lower limb

327

2237

1.50

10.43

2.1

2.7

66.72

66.75

g/l

0.03

303

2066

Suppurative and unspecified otitis media

1034

7391

1.25

10.42

3.0

2.3

66.95

66.86

g/l

0.13

966

6811

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

274

2.62

10.42

1.5

1.4

66.54

67.18

g/l

0.32

243

Drug-induced hypoglycaemia without coma

348

2.39

10.41

2.1

2.7

64.41

66.05

g/l

0.56

313

Specific development disorders of scholastic skills

467

2.11

10.41

2.2

2.5

66.41

67.43

g/l

0.60

446

Carbimazole or st.post thyroidectomy, condition for graves disease

706

5465

1.32

10.40

2.7

2.5

65.68

66.72

g/l

3.31

649

4978

Sacrococcygeal disorders, not elsewhere classified

114

594

2.01

10.38

2.0

2.7

67.50

67.09

g/l

0.23

102

549

Other and unspecified mood [affective] disorders

186

1117

1.71

10.34

2.0

2.5

65.83

67.52

g/l

2.26

170

1037

Other specified/unspecified spondylopathies

116

613

2.02

10.32

2.9

2.6

66.62

66.32

g/l

0.14

102

557

Golimumab

108

553

2.04

10.30

1.7

2.8

68.07

67.62

g/l

0.26

102

526

Carcinoma in situ of skin of lower limb, including hip

471

2.20

10.29

2.4

1.6

64.07

66.46

g/l

2.73

415

Chronic iridocyclitis

190

1157

1.71

10.28

2.2

2.8

68.78

66.51

g/l

3.52

167

1058

Certolizumab pegol

248

2.62

10.27

1.5

2.7

69.83

67.90

g/l

1.44

232

Atrial septal defect

133

726

1.90

10.26

2.1

3.1

64.96

66.36

g/l

0.97

120

671

Benign neoplasm: Parotid gland

283

1890

1.55

10.26

2.2

1.6

66.63

66.94

g/l

0.26

259

1680

Other and unspecified follicular disorders

147

835

1.85

10.25

2.7

67.66

66.73

g/l

0.97

139

771

Pollen allergy

457

3280

1.40

10.24

2.4

2.5

67.34

67.13

g/l

0.26

410

3077

Parodontitis, under 40 years, or operation codes

173

1019

1.73

10.21

2.2

1.8

67.25

67.75

g/l

0.37

165

967

Disorders of optic nerve, not elsewhere classified

103

527

2.12

10.20

2.6

3.2

64.58

66.64

g/l

1.91

479

Benign neoplasm of mouth and pharynx

429

3103

1.42

10.18

3.6

2.6

66.33

66.44

g/l

0.10

383

2841

Congenital malformations of cardiac septa

217

1319

1.64

10.17

2.3

2.9

64.94

66.54

g/l

1.83

196

1220

Background retinopathy and retinal vascular changes

101

513

2.12

10.15

2.4

2.8

66.69

66.28

g/l

0.21

467

Orchitis and epididymitis

355

2485

1.47

10.10

2.6

2.5

66.29

66.68

g/l

0.42

328

2277

Flat foot [pes planus] (acquired)

319

2186

1.50

10.09

1.9

3.0

66.83

66.16

g/l

0.89

283

1997

Benign neoplasm: Pituitary gland, craniopharyngeal duct

172

1024

1.75

10.09

2.6

1.5

66.39

67.40

g/l

1.07

165

933

Scabies

149

852

1.82

10.08

3.1

2.4

66.61

66.89

g/l

0.15

136

794

Congenital iodine-deficiency syndrome/hypothyroidism

135

755

1.89

10.05

2.5

2.6

64.12

66.44

g/l

2.68

117

685

Viral meningitis

120

643

1.94

10.01

2.0

2.5

66.37

67.27

g/l

0.60

113

594

Postzoster neuralgia

349

2.38

10.01

3.1

2.8

64.15

65.91

g/l

1.20

315

Morphin

387

2.29

9.99

1.9

2.3

65.42

66.31

g/l

0.43

356

Postprocedural musculoskeletal disorders, not elsewhere classified

287

1941

1.54

9.96

2.5

2.7

65.96

66.41

g/l

0.47

260

1768

Assault

357

2498

1.46

9.96

1.8

2.5

67.07

67.29

g/l

0.20

317

2356

Tongue abnormality

248

1627

1.59

9.92

2.5

2.8

66.39

66.36

g/l

0.02

224

1474

Other and unspecified erythematous conditions

132

736

1.90

9.92

2.7

2.8

66.90

66.54

g/l

0.22

126

671

Unspecified/other endometriosis

247

1607

1.57

9.88

2.1

66.78

66.95

g/l

0.14

225

1466

Chondrocostal junction syndrome [Tietze]

145

832

1.83

9.83

2.2

2.7

66.42

66.76

g/l

0.22

131

762

Palmar fascial fibromatosis [Dupuytren]

656

5081

1.32

9.80

2.2

2.6

66.12

66.10

g/l

0.02

596

4578

Later onset COPD

1343

8821

1.22

9.80

2.0

2.6

64.92

65.94

g/l

4.81

1174

7830

Parodontitis, under 40 years

171

1016

1.71

9.80

2.2

1.8

67.28

67.76

g/l

0.36

163

964

Melanocytic naevi

994

8070

1.25

9.77

2.8

2.5

66.43

66.64

g/l

0.42

927

7361

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

278

1867

1.53

9.77

3.5

1.5

66.52

67.08

g/l

0.59

257

1669

Eating disorder

185

1124

1.67

9.74

1.5

2.1

66.27

67.64

g/l

1.80

167

1056

Nonalcoholic steatohepatitis

158

3.14

9.74

1.7

2.9

68.39

67.58

g/l

0.28

148

Lichen simplex chronicus

142

813

1.84

9.74

2.8

3.0

67.01

66.74

g/l

0.18

132

742

Erythema nodosum

123

675

1.92

9.69

3.2

2.8

67.39

66.90

g/l

0.31

115

616

Suggestive for eosinophilic asthma

356

2516

1.46

9.69

2.1

2.6

65.92

66.47

g/l

0.68

328

2293

Other and unspecified injuries of lower leg

241

1572

1.58

9.68

2.1

2.7

65.55

66.97

g/l

1.92

216

1455

Universal erythroderma, KELA reimbursement

321

2.40

9.65

1.8

3.0

66.75

66.45

g/l

0.10

293

Biomechanical lesions, not elsewhere classified

194

1211

1.68

9.63

2.3

2.8

67.38

66.60

g/l

0.86

178

1108

Haemangioma and lymphangioma, any site

283

1914

1.52

9.58

3.0

1.6

66.75

67.20

g/l

0.45

253

1733

Glucosamine medication

2252

15682

1.16

9.56

2.5

2.6

66.09

66.12

g/l

0.06

1991

14028

Otalgia

264

1763

1.54

9.55

2.8

2.6

67.07

66.53

g/l

0.58

232

1616

Other specified and unspecified retinal disorders

151

887

1.80

9.54

3.1

2.8

66.66

66.35

g/l

0.19

133

810

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

517

3880

1.36

9.52

2.5

2.6

67.41

66.85

g/l

0.88

491

3588

Pure hyperglyceridaemia

503

2.08

9.51

2.0

2.5

66.27

66.54

g/l

0.13

467

Other secondary gonarthrosis

219

1412

1.62

9.51

2.1

3.0

65.83

66.49

g/l

0.55

207

1289

Chondropathies

512

3841

1.36

9.49

2.5

66.66

66.78

g/l

0.14

465

3547

Other and unspecified trigeminal disorders

303

2.41

9.49

2.8

66.93

67.02

g/l

0.03

278

Retinal detachment with retinal break

521

3931

1.36

9.49

2.6

65.68

66.22

g/l

0.81

466

3564

Other/unspecified enthesopathies, not elsewhere classified

328

2291

1.47

9.47

2.4

2.6

65.95

66.35

g/l

0.46

295

2077

Superficial injury of ankle and foot

339

2375

1.46

9.46

1.9

2.5

66.13

66.95

g/l

1.18

307

2197

Other female pelvic inflammatory diseases

553

4199

1.34

9.46

2.4

2.6

66.22

66.66

g/l

0.67

474

3804

Haemangioma, any site

268

1799

1.53

9.44

2.7

1.5

66.81

67.18

g/l

0.35

239

1631

Parodontitis, operation under 40 years and operation codes

162

959

1.72

9.43

2.3

1.8

66.94

67.89

g/l

0.85

155

913

Dislocation, sprain and strain of joint and ligaments of hip

155

920

1.78

9.42

2.4

2.7

64.42

66.40

g/l

2.19

139

834

Benign lipomatous neoplasm

994

8112

1.24

9.34

2.8

1.6

66.39

67.01

g/l

1.89

902

7282

Benign neoplasm of eye and adnexa

346

2448

1.45

9.33

2.7

1.6

66.06

66.78

g/l

1.11

309

2166

Pustular psoriasis

183

1135

1.68

9.31

2.2

2.8

67.14

66.67

g/l

0.36

171

1036

Ulcerative colitis (strict definition, require KELA)

534

4040

1.35

9.31

2.5

67.49

66.84

g/l

1.15

507

3741

Glaucoma secondary to other eye disorders

172

1052

1.71

9.28

2.5

2.8

67.01

66.22

g/l

0.61

158

955

Contact with and exposure to communicable diseases

783

6188

1.27

9.28

2.7

2.4

66.62

67.19

g/l

1.36

732

5780

Hallux rigidus

519

3921

1.35

9.26

2.2

2.9

66.82

66.01

g/l

1.64

454

3541

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

580

4445

1.33

9.22

2.5

2.6

67.34

66.80

g/l

0.96

552

4114

N06DA Anticholinesterases

1039

10194

0.81

9.21

1.8

2.5

65.68

65.73

g/l

0.07

837

8981

Use of anticholinesterases

1039

10194

0.81

9.21

1.8

2.5

65.68

65.73

g/l

0.07

837

8981

Arterial embolism and thrombosis of lower extremity artery

159

956

1.75

9.21

2.0

2.9

62.67

66.12

g/l

5.45

139

863

Cluster headache, wide,, including avohilmo

169

1027

1.70

9.19

1.7

2.7

68.00

67.24

g/l

0.67

161

955

Otitis externa, unspecified

355

2527

1.44

9.18

2.7

2.6

66.97

66.62

g/l

0.40

322

2335

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

116

638

1.93

9.16

2.7

1.6

66.30

66.67

g/l

0.17

104

564

Disorders of orbit

168

1025

1.71

9.10

2.5

2.8

66.73

66.82

g/l

0.06

156

933

Presbycusis

620

4797

1.32

9.09

2.6

2.4

65.35

65.70

g/l

0.51

528

4198

Nontoxic goitre/thyroid nodule

1169

9735

1.22

9.08

2.3

2.6

66.27

g/l

0.01

1047

8716

Follicular cysts of skin and subcutaneous tissue

657

5137

1.30

9.07

2.3

2.5

66.25

66.57

g/l

0.48

602

4698

Progressive vascular leukoencephalopathy

160

973

1.75

9.04

2.1

2.5

65.84

65.70

g/l

0.08

136

858

Adult respiratory distress syndrome

299

2.41

9.01

3.2

2.7

62.29

66.15

g/l

2.43

267

Blindness, monocular

188

2.83

9.00

3.3

2.6

64.08

66.66

g/l

1.40

168

Sixth [abducent] nerve palsy

145

857

1.79

9.00

3.1

3.0

66.30

g/l

0.00

129

780

Parodontitis, under 40 years and operation codes

160

957

1.70

8.99

2.3

1.8

66.97

67.90

g/l

0.83

153

911

Renal agenesis and other reduction defects of kidney

3.82

8.97

2.5

4.1

64.29

66.11

g/l

0.71

Emotional disorders starting during childhood or adolescence

475

2.01

8.94

1.9

2.5

67.17

67.29

g/l

0.05

453

Neovascular glaucoma

171

1055

1.70

8.94

2.5

2.7

67.06

66.30

g/l

0.58

157

950

Impacted cerumen

394

2879

1.41

8.92

2.4

2.5

66.48

66.09

g/l

0.42

299

2617

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

288

1988

1.50

8.91

2.4

2.6

65.79

66.09

g/l

0.29

263

1785

Salpingitis and oophoritis

601

4657

1.31

8.88

2.1

2.7

66.35

66.76

g/l

0.65

538

4254

Injuries to the wrist and hand

3846

25167

1.11

8.86

2.4

2.5

66.56

66.60

g/l

0.11

3528

22973

Other disorders of bone density and structure

486

2.03

8.85

2.0

2.8

68.26

67.22

g/l

0.80

449

Other bullous disorders

117

653

1.90

8.83

3.4

2.9

67.18

66.52

g/l

0.44

111

591

Carcinoma in situ of skin of trunk

145

866

1.79

8.81

3.0

2.7

63.73

65.68

g/l

2.17

131

782

Correction of physiology of bite - demanding therapy visit

214

1390

1.58

8.80

3.3

2.7

67.83

67.15

g/l

0.80

200

1292

Panniculitis affecting regions of neck and back

139

813

1.78

8.78

2.0

2.5

67.05

66.76

g/l

0.19

129

748

Anogenital herpesviral [herpes simplex] infection

161

975

1.69

8.77

2.6

2.3

65.84

67.78

g/l

2.66

148

909

Monoamine oxidase A inhibitors

442

3289

1.38

8.77

2.0

2.8

66.42

66.59

g/l

0.18

389

3007

Deviated nasal septum

1265

10629

1.21

8.76

2.7

2.6

66.84

66.58

g/l

0.66

1158

9809

Superficial injury of shoulder and upper arm

384

2795

1.41

8.74

2.1

2.6

66.54

66.45

g/l

0.08

341

2568

Unspecified mental disorder

1368

11568

1.19

8.74

2.0

2.5

66.16

66.87

g/l

2.75

1231

10606

Type 1 diabetes, strict definition

175

1078

1.65

8.73

1.8

2.2

64.91

67.82

g/l

6.38

163

1032

Use of teriflunomide

143

3.00

8.72

1.3

2.3

68.90

68.41

g/l

0.24

135

Manic episode

107

580

1.93

8.71

1.8

3.1

66.14

67.27

g/l

0.67

537

Erythema intertrigo

103

556

1.97

8.69

2.5

3.3

66.18

66.56

g/l

0.20

503

Pustulosis palmaris et plantaris

165

1016

1.70

8.68

2.4

3.0

67.34

66.84

g/l

0.37

155

931

Thrombotic microangiopathy

118

3.35

8.67

3.0

2.3

61.46

66.03

g/l

1.95

106

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1326

9774

1.20

8.67

2.4

2.5

66.67

66.99

g/l

0.82

1237

8928

Ganglion

657

5159

1.29

8.65

2.3

2.6

66.60

66.67

g/l

0.09

596

4729

Crohn's disease of large intestine

172

1067

1.67

8.65

2.0

2.7

66.29

67.23

g/l

0.77

160

992

Melanocytic naevi of trunk

399

2930

1.39

8.62

2.7

2.5

66.49

66.63

g/l

0.15

372

2702

Other symptoms and signs involving general sensations and perceptions

146

873

1.75

8.57

2.2

2.8

66.40

66.04

g/l

0.18

122

797

Carcinoma in situ of colon

306

2.36

8.57

3.4

1.6

64.30

67.71

g/l

3.03

272

Lateral epicondylitis

424

3142

1.38

8.56

2.2

2.6

67.60

66.73

g/l

1.94

388

2903

Special screening examination for neoplasms

174

1088

1.66

8.55

2.8

2.4

65.73

66.23

g/l

0.33

151

986

Crohn disease (strict definition, require KELA)

195

1249

1.61

8.54

1.9

2.5

65.83

67.13

g/l

1.48

175

1161

Malignant neoplasm of corpus uteri

338

2430

1.44

8.53

3.6

2.4

65.70

66.19

g/l

0.62

307

2135

Unspecified urinary incontinence

339

2433

1.44

8.53

1.9

2.6

66.26

66.28

g/l

0.02

269

2171

Central retinal artery occlusion

108

598

1.94

8.50

3.5

2.8

67.46

65.67

g/l

1.55

539

Congenital malformations of trachea and bronchus

206

2.69

8.50

2.8

3.6

66.81

66.27

g/l

0.21

183

Abnormal blood-pressure reading, without diagnosis

155

942

1.71

8.49

2.7

2.5

66.89

66.66

g/l

0.16

141

857

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

208

1354

1.58

8.48

1.9

2.6

65.93

67.12

g/l

1.35

188

1259

Acquired absence of limb

220

2.62

8.37

3.9

2.6

65.04

66.19

g/l

0.42

199

Congenital malformations of the respiratory system

354

2.21

8.33

2.9

3.2

67.26

66.26

g/l

0.56

326

Other retinal artery occlusion

112

631

1.90

8.33

2.4

2.9

65.88

66.00

g/l

0.06

573

Other and unspecified disorders of vitreous body

1644

14124

1.17

8.32

2.6

2.7

66.70

66.32

g/l

1.32

1490

12782

Event of undetermined intent

196

1266

1.59

8.31

2.7

66.81

g/l

0.00

180

1182

Ingrowing nail

180

1141

1.63

8.31

2.1

2.7

65.54

66.83

g/l

1.59

167

1049

Cluster headache, strict, including avohilmo

154

939

1.70

8.31

1.7

2.7

68.19

67.36

g/l

0.72

146

877

Other disorders of iris and ciliary body

112

629

1.88

8.30

2.4

3.1

67.02

66.54

g/l

0.25

101

569

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

232

2.52

8.28

2.1

2.7

65.50

67.22

g/l

1.08

218

Open wound of abdomen, lower back and pelvis

102

554

1.92

8.27

2.0

2.6

66.09

66.84

g/l

0.36

516

Benign neoplasm: Other and unspecified parts of mouth

126

732

1.80

8.25

3.2

1.6

67.05

67.29

g/l

0.11

112

663

Exposure to other and unspecified inanimate mechanical forces

223

1485

1.55

8.24

2.6

2.7

66.34

66.82

g/l

0.44

209

1370

Fasciculation

220

2.56

8.24

1.8

2.7

68.87

67.25

g/l

0.97

207

Atypical mycobacterium lung infection

292

2.37

8.22

1.6

2.4

64.59

65.75

g/l

0.47

262

Causalgia

302

2.28

8.20

1.4

2.3

66.88

67.80

g/l

0.53

283

D07AA Corticosteroids, weak (group I)

457

3442

1.35

8.19

2.0

2.6

67.14

66.71

g/l

0.61

414

3172

Assault by bodily force

202

1315

1.57

8.18

1.7

2.6

66.55

67.63

g/l

1.01

180

1238

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

227

1523

1.54

8.17

2.4

1.6

62.37

66.45

g/l

10.81

210

1347

Bursitis of shoulder

537

1.94

8.15

2.7

2.9

66.45

66.90

g/l

0.22

488

Follow-up examination after treatment for malignant neoplasms

392

2904

1.38

8.07

2.8

2.4

66.06

65.90

g/l

0.15

355

2616

Disorders of speech understanding and production

120

675

1.80

8.07

2.4

2.9

65.60

65.76

g/l

0.07

110

608

Hypotension due to drugs

348

2.22

8.03

3.0

2.4

65.38

65.92

g/l

0.23

311

Other disorders of electrolyte and fluid balance, not elsewhere classified

187

2.71

8.02

1.6

2.0

65.57

67.18

g/l

0.68

169

Other congenital malformations

243

1652

1.50

8.01

2.2

2.7

66.42

66.86

g/l

0.35

228

1536

Eating disorders

246

1672

1.49

8.01

1.8

2.3

66.29

67.30

g/l

1.44

224

1563

Granulomatous disorders of skin and subcutaneous tissue

540

1.93

8.01

3.5

2.8

67.35

67.38

g/l

0.01

492

Acute lymphadenitis

185

1190

1.60

7.99

2.4

2.6

65.72

67.03

g/l

1.27

176

1098

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

4.01

7.97

2.4

2.1

65.63

67.04

g/l

0.46

Other diseases of spinal cord

119

688

1.82

7.96

3.5

2.9

65.72

66.84

g/l

0.83

112

632

Ankylosing spondylitis, strict definition

139

835

1.72

7.95

1.7

2.7

68.87

67.39

g/l

1.26

130

787

Benign neoplasm of urinary organs

192

1255

1.60

7.94

2.2

2.9

66.11

66.37

g/l

0.18

172

1145

Use of disulfiram, acamprosate or naltrexone

288

2032

1.45

7.92

1.7

2.7

66.54

67.10

g/l

0.59

262

1899

Crohn disease (strict definition, require KELA, min 2 HDR)

189

1224

1.59

7.92

2.0

2.6

65.82

67.12

g/l

1.44

171

1139

Behavioural disorders, excluding more controls

190

2.55

7.92

1.7

3.0

67.13

68.01

g/l

0.32

183

Protein-energy malnutrition of moderate and mild degree

183

2.74

7.90

3.2

2.5

65.93

65.47

g/l

0.11

163

severe traumatic brain injury, does not include concussion

879

7227

1.24

7.89

2.4

65.97

66.14

g/l

0.26

786

6455

Prepatellar bursitis

164

1032

1.65

7.89

2.2

2.8

66.71

66.52

g/l

0.11

146

943

Abdominal aortic aneurysm (AAA)

443

3330

1.35

7.89

2.0

2.6

65.46

65.92

g/l

0.59

393

2953

Secondary parkinsonism, excluding more controls

521

1.94

7.88

2.3

2.6

64.20

65.97

g/l

1.29

477

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

213

1414

1.54

7.88

2.1

2.8

67.23

66.87

g/l

0.32

196

1318

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

513

3965

1.32

7.87

2.8

1.6

65.90

66.72

g/l

1.62

459

3513

Acute alcohol intoxication

931

7691

1.23

7.86

1.8

2.6

65.94

66.56

g/l

1.52

828

7055

Early complications of trauma

152

940

1.68

7.86

3.0

2.6

65.70

66.57

g/l

0.64

134

870

!Aliquae complicationes praecoces traumatis

152

940

1.68

7.86

3.0

2.6

65.70

66.57

g/l

0.64

134

870

Other misadventures during surgical and medical care

503

1.97

7.85

2.5

2.9

64.32

66.50

g/l

1.80

452

Mental disorders, not otherwise specified

234

1589

1.51

7.80

2.6

2.5

66.10

67.33

g/l

1.95

222

1486

Lichen ruber planus, wide definition including periferal and oral lichen planus

781

6352

1.25

7.80

2.4

2.6

67.20

66.41

g/l

2.44

712

5756

Septal defects

194

1241

1.57

7.79

2.2

2.9

65.52

66.51

g/l

0.86

178

1150

Other strabismus

667

5304

1.27

7.79

2.4

2.5

66.55

66.74

g/l

0.27

620

4885

Acute laryngitis and tracheitis

277

1907

1.45

7.78

2.0

2.4

66.60

67.25

g/l

0.74

255

1784

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

230

1565

1.52

7.78

2.1

1.6

65.73

66.50

g/l

0.66

206

1378

Pigmented purpuric dermatosis

228

2.52

7.75

2.4

3.7

67.08

66.62

g/l

0.15

210

Sequelae of injuries of neck and trunk

111

634

1.83

7.73

2.7

2.9

66.20

66.98

g/l

0.51

103

585

Other prurigo

240

2.44

7.72

1.3

3.1

66.67

66.56

g/l

0.03

209

Medial epicondylitis

129

767

1.74

7.72

2.7

2.9

67.19

66.59

g/l

0.41

118

705

Ulcerative colitis (strict definition, all Crohn cases excluded)

448

3404

1.34

7.69

2.7

2.6

67.82

66.82

g/l

2.13

423

3151

Impetigo

126

744

1.75

7.66

3.1

2.5

67.65

67.26

g/l

0.23

117

691

TMD related operations

507

3921

1.31

7.64

2.6

67.30

67.03

g/l

0.40

477

3628

Episcleritis

174

1118

1.61

7.64

2.0

2.7

68.32

66.87

g/l

1.75

164

1042

Hydrocele

469

3600

1.33

7.60

2.5

2.6

65.72

66.45

g/l

1.32

426

3275

Alzheimer’s disease (Early onset)

1280

0.49

7.59

1.3

2.4

65.52

65.64

g/l

0.04

1123

Lesion of radial nerve

138

842

1.71

7.56

2.5

2.6

65.31

66.80

g/l

1.37

119

770

Other specified and unspecified disorders of eye and adnexa

147

912

1.68

7.55

2.3

2.9

65.61

66.85

g/l

1.00

131

831

Other bacterial agents as the cause of diseases classified to other chapters

224

2.49

7.54

3.6

3.1

64.48

66.18

g/l

0.84

204

Acne vulgaris

159

998

1.62

7.50

2.2

2.0

67.66

67.94

g/l

0.18

151

941

Hyperprolactinaemia

102

571

1.85

7.49

2.9

2.7

66.48

67.55

g/l

0.82

535

Other benign neoplasms of connective and other soft tissue

312

2255

1.42

7.48

2.8

1.6

66.25

67.09

g/l

1.22

280

2026

Disturbance of activity and attention

179

1140

1.57

7.46

1.4

2.1

67.49

67.82

g/l

0.27

164

1085

Otitis media, unspecified

282

1837

1.44

7.43

3.3

2.4

66.97

66.87

g/l

0.07

270

1702

Impotence

213

1444

1.53

7.42

2.1

2.7

66.35

66.52

g/l

0.11

197

1314

Blepharochalasis

1174

9975

1.20

7.41

2.3

2.6

65.95

66.13

g/l

0.38

1041

8953

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

202

1348

1.54

7.41

2.0

2.6

65.60

66.89

g/l

1.74

180

1246

Other and unspecified disorders of orbit

102

3.35

7.40

2.6

2.2

68.51

66.89

g/l

0.56

Other and unspecified glaucoma

286

2052

1.44

7.36

2.1

2.7

65.99

66.09

g/l

0.07

250

1829

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

269

2.27

7.35

5.3

2.6

63.17

66.79

g/l

1.84

246

Thyrotoxicosis with toxic multinodular goitre

237

1644

1.50

7.35

2.2

2.6

64.06

66.37

g/l

4.72

208

1473

Other specified/unspecified disorders of bone/cartilage

105

600

1.83

7.33

2.5

2.7

66.72

66.87

g/l

0.07

562

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1008

8448

1.21

7.32

2.6

2.5

66.71

66.61

g/l

0.16

922

7751

Viral agents as the cause of diseases classified to other chapters

449

1.97

7.30

3.6

2.8

65.28

66.88

g/l

0.93

414

Diseases of middle ear and mastoid

1857

13332

1.15

7.28

2.8

2.4

66.66

66.68

g/l

0.04

1715

12172

Gluteal tendinitis

130

789

1.71

7.27

2.0

2.7

66.49

66.45

g/l

0.02

116

722

Varicella [chickenpox]

136

833

1.68

7.24

5.3

2.5

65.81

67.13

g/l

1.02

127

786

TMD related pain

110

638

1.79

7.22

2.4

2.8

67.60

67.30

g/l

0.18

101

597

Type 1 diabetes, strict definition, subgroup 1

155

974

1.61

7.22

1.7

2.3

64.82

67.88

g/l

6.06

144

930

Recurrent dislocation and subluxation of joint

181

1184

1.56

7.22

2.1

2.8

67.28

66.96

g/l

0.23

165

1114

Other noninflammatory disorders of vulva and perineum

277

1973

1.43

7.21

1.8

2.3

66.23

66.58

g/l

0.31

249

1784

Malignant neoplasm of bronchus and lung

799

6145

1.24

7.21

1.8

2.5

64.74

65.92

g/l

4.09

736

5443

Lichen planus

481

3737

1.32

7.19

2.5

2.6

67.19

66.23

g/l

1.99

435

3387

Other and unspecified pemphigoid

218

2.51

7.17

1.6

3.1

65.62

66.47

g/l

0.37

196

Abrasion of teeth

917

5592

1.22

7.17

3.0

2.4

67.04

66.81

g/l

0.42

829

5149

Injury of other and unspecified intrathoracic organs

231

1600

1.49

7.16

2.2

2.6

64.76

66.55

g/l

3.14

207

1467

Oral leukoplakia and related diseases, including avohilmo

330

2433

1.40

7.15

2.7

67.13

66.50

g/l

0.81

292

2216

113

669

1.80

7.14

2.2

3.0

64.59

66.13

g/l

1.19

593

Melanoma in situ of other and unspecified parts of face

277

2.30

7.11

2.9

1.6

64.99

66.99

g/l

0.92

242

Sleep disorders, other/unspecified

537

1.85

7.10

2.0

2.5

67.24

67.30

g/l

0.03

498

Disorder of external ear, unspecified

123

743

1.73

7.08

2.3

2.9

66.10

66.63

g/l

0.33

111

686

Other ulcerative colitis

186

1234

1.55

7.07

2.1

2.7

67.16

66.91

g/l

0.17

179

1140

Pemphigus

157

2.77

7.03

1.9

2.6

66.95

66.18

g/l

0.31

148

Nosocomial condition (hospital)

122

3.04

7.01

1.4

3.5

61.52

66.24

g/l

2.31

109

Benign neoplasm: Parathyroid gland

238

2.38

7.01

2.1

1.4

67.63

67.52

g/l

0.03

211

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1013

8257

1.20

6.97

2.4

1.7

64.89

66.66

g/l

9.70

903

7324

Other endocrine disorders

151

921

1.62

6.95

2.6

3.1

66.15

66.22

g/l

0.04

140

850

Malignant neoplasm of pancreas

113

1849

0.59

6.94

1.6

2.7

63.85

65.94

g/l

1.77

102

1670

Malignant neoplasm, without specification of site

136

849

1.68

6.93

3.0

2.5

64.68

65.96

g/l

0.84

119

748

Mouth breathing

1469

12744

1.16

6.92

2.5

2.6

66.73

66.72

g/l

0.02

1352

11757

Endocrine disorders, other/unspecified

429

1.97

6.91

1.9

3.0

67.87

67.08

g/l

0.49

392

Melanocytic naevi of lower limb, including hip

147

932

1.63

6.91

2.7

2.9

66.33

66.97

g/l

0.48

141

856

Other abnormal findings in urine

375

2.06

6.89

3.5

2.5

67.57

65.84

g/l

1.23

337

Other specified/unspecified dorsopathies

125

762

1.70

6.88

2.8

2.6

66.27

66.63

g/l

0.22

110

702

Spinal instabilities

102

589

1.81

6.86

1.9

2.6

67.41

67.03

g/l

0.22

551

Respiratory tuberculosis, confirmed

468

1.92

6.81

1.7

2.6

66.31

66.07

g/l

0.10

417

Urethral stricture

239

1686

1.47

6.80

2.4

2.7

66.65

66.39

g/l

0.20

214

1523

Cytomegaloviral pneumonitis

5.43

6.79

2.4

2.6

66.15

65.74

g/l

0.05

Other dermatomyositis

3.28

6.79

1.3

3.0

64.62

66.56

g/l

0.68

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

692

5645

1.25

6.77

2.5

1.6

64.89

66.51

g/l

5.61

613

4970

Hyperosmolality and hypernatraemia

322

2.14

6.77

2.6

2.4

63.74

66.30

g/l

1.26

288

Melanoma in situ

171

1134

1.58

6.77

2.9

65.73

66.18

g/l

0.31

151

1028

Hereditary sideroblastic anaemia

3.74

6.77

2.7

2.4

66.74

65.20

g/l

0.43

Ectropion of eyelid

175

1165

1.57

6.76

1.8

2.5

65.91

65.67

g/l

0.15

152

1023

Delayed milestone in childhood

168

2.47

6.75

3.3

4.3

63.76

63.04

g/l

0.19

161

Inflammatory diseases of prostate (prostatitis)

495

3893

1.30

6.74

2.4

2.6

66.33

66.67

g/l

0.47

449

3573

Other otitis externa (chronic)

227

1586

1.47

6.73

2.4

2.8

66.59

66.46

g/l

0.08

178

1462

Other disorders of central nervous system

228

2.35

6.73

1.9

2.1

68.40

67.36

g/l

0.66

210

Noninflammatory disorders of female genital tract

1393

6023

1.17

6.72

2.5

2.4

66.86

66.57

g/l

0.74

1264

5437

Benign neoplasm of middle ear and respiratory system

263

1886

1.43

6.71

2.2

1.6

66.07

66.95

g/l

1.25

243

1687

Asthma mixed form (mode), excluding more controls

154

990

1.59

6.69

2.1

67.00

67.41

g/l

0.32

141

871

Excessive vomiting in pregnancy

208

1425

1.49

6.68

2.7

2.6

66.43

67.49

g/l

1.40

193

1325

Other and unspecified localized connective tissue disorders

3.89

6.68

4.5

3.1

69.52

66.33

g/l

0.69

Radial styloid tenosynovitis [de Quervain]

164

1072

1.57

6.67

2.5

2.8

66.06

66.84

g/l

0.74

151

985

Chorioretinal inflammation

109

649

1.76

6.64

2.0

2.8

67.48

66.77

g/l

0.55

103

593

Oesophageal obstruction

148

953

1.62

6.63

2.6

2.9

63.56

66.27

g/l

3.21

129

870

Benign neoplasm: Spinal meninges

231

2.36

6.61

1.8

1.4

66.40

67.95

g/l

0.72

203

Secondary polycythaemia

509

1.86

6.59

2.3

3.0

64.82

66.53

g/l

1.09

465

Other disorders of binocular movement

399

1.96

6.58

2.5

2.4

67.16

66.99

g/l

0.07

366

Hypergammalglobulinemia, unspecified

7.98

6.56

4.6

1.7

74.16

67.94

g/l

1.00

Lichen planus, including avohilmo

667

5443

1.25

6.55

2.4

2.6

67.12

66.39

g/l

1.78

607

4937

Benign neoplasm: Pancreas

117

717

1.73

6.54

3.0

66.41

66.32

g/l

0.05

111

645

Other disorders of conjunctiva

541

4319

1.28

6.53

2.5

2.6

66.24

66.14

g/l

0.12

501

3892

Spinal osteochondrosis

192

2.44

6.52

1.4

2.7

67.22

66.83

g/l

0.13

180

Hereditary ataxia

292

2.17

6.51

1.7

3.0

66.58

66.29

g/l

0.13

266

Diseases of appendix

2740

22573

1.11

6.49

2.6

2.5

66.60

66.67

g/l

0.19

2509

20707

Maternal care for other conditions predominantly related to pregnancy

447

3424

1.30

6.49

2.4

2.2

67.84

67.53

g/l

0.44

417

3195

Malignant neoplasm of small intestine

559

1.83

6.47

4.3

3.2

64.47

66.51

g/l

1.47

510

Redundant prepuce, phimosis and paraphimosis

643

5198

1.25

6.47

3.1

2.5

66.95

g/l

0.01

594

4821

Ulcerative ileocolitis

132

829

1.64

6.45

2.3

2.6

68.19

67.21

g/l

0.75

126

772

Herpesviral keratitis and keratoconjunctivitis

161

1062

1.57

6.43

2.7

65.75

66.68

g/l

0.85

151

972

Paralytic ileus

150

975

1.60

6.42

2.8

2.5

65.39

66.56

g/l

0.84

134

890

Benign neoplasm: Kidney

139

890

1.64

6.42

2.2

3.0

66.20

66.54

g/l

0.21

124

809

Acute appendicitis, no complications

1870

16534

1.14

6.38

2.6

2.5

66.72

66.80

g/l

0.18

1718

15248

Sudden idiopathic hearing loss

384

2947

1.34

6.37

2.5

2.6

66.49

66.32

g/l

0.16

335

2687

Other/unspecified disorders of vestibular function

152

994

1.59

6.37

1.9

2.9

65.76

66.52

g/l

0.73

128

902

Use of donepezil

567

6737

0.79

6.36

1.9

2.4

65.55

65.59

g/l

0.04

454

5874

Rheumatoid lung disease

113

3.13

6.35

1.7

2.4

64.35

65.11

g/l

0.18

Other keratitis

344

2595

1.35

6.33

2.2

2.6

67.38

66.76

g/l

0.77

315

2384

Use of levodopa decarboxylase inhibitor

551

4431

1.27

6.32

1.9

2.5

66.28

65.87

g/l

0.61

469

3951

Carcinoma in situ of other and unspecified digestive organs

114

701

1.73

6.31

2.6

3.2

64.67

66.28

g/l

1.44

105

635

Dystonia

191

1309

1.50

6.30

2.0

2.8

66.90

66.48

g/l

0.28

177

1202

Bicipital tendinitis

170

1139

1.54

6.28

2.8

3.0

66.50

66.72

g/l

0.17

159

1048

Mental and behavioural disorders due to use of other stimulants, including caffeine

340

2.00

6.28

1.2

2.2

67.65

68.50

g/l

0.35

323

Orthopaedic devices associated with adverse incidents

484

1.89

6.28

1.8

3.1

67.09

66.19

g/l

0.45

432

246

2.19

6.24

3.1

2.5

65.80

68.03

g/l

1.53

226

Other papulosquamous disorders

243

2.26

6.23

2.9

2.6

66.48

67.01

g/l

0.20

223

Alzheimer’s disease, wide definition

736

7406

0.82

6.22

2.0

2.4

65.33

65.71

g/l

0.62

587

6491

Atrophic disorders of skin

476

3761

1.29

6.22

2.4

2.5

66.68

66.67

g/l

0.01

441

3393

Other congenital malformations of the digestive system

135

855

1.62

6.20

2.7

3.1

65.23

66.37

g/l

0.94

125

786

Other and unspecified mononeuropathies of upper limb

107

646

1.72

6.18

3.4

2.7

67.15

67.05

g/l

0.05

100

600

Post-traumatic wound infection, not elsewhere classified

534

1.80

6.16

3.0

66.95

67.00

g/l

0.02

489

Achilles tendinitis

341

2582

1.35

6.15

2.8

2.6

66.55

66.43

g/l

0.11

306

2390

Respiratory tuberculosis, bacteriologically and histologically confirmed

491

1.85

6.15

1.7

2.7

66.41

66.04

g/l

0.16

438

Diffuse brain injury

110

667

1.70

6.15

2.7

2.5

67.17

66.63

g/l

0.32

101

609

Benign neoplasm: Long bones of lower limb

532

1.79

6.14

2.2

1.5

67.32

67.99

g/l

0.51

488

Polyp of the female genital tract

1096

5436

1.19

6.13

2.5

2.4

66.64

66.43

g/l

0.39

983

4887

Pulmonary oedema

463

1.88

6.12

2.9

2.6

64.90

65.56

g/l

0.30

406

Other superficial mycoses

381

1.95

6.12

2.2

3.1

66.90

67.35

g/l

0.22

357

Corneal ulcer

586

4747

1.25

6.12

2.2

2.5

66.63

66.66

g/l

0.04

535

4359

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

350

2665

1.34

6.11

2.7

1.6

65.28

66.68

g/l

2.70

323

2361

Other specified/unspecified hearing loss

309

2315

1.37

6.09

2.8

2.4

65.79

66.29

g/l

0.58

290

2088

Kela-code for severe mental illness

1204

10404

1.17

6.07

1.9

2.5

66.16

66.82

g/l

2.16

1076

9529

Infectious mononucleosis

175

1181

1.50

6.05

2.9

2.1

67.97

67.96

g/l

0.00

170

1112

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

850

7142

1.20

6.05

2.0

2.5

66.88

66.84

g/l

0.06

775

6602

Recurrent dislocation of patella

109

661

1.68

6.02

3.4

2.6

66.59

67.14

g/l

0.36

104

625

Appendicitis, broad definition

2702

22415

1.11

6.01

2.6

2.5

66.61

66.68

g/l

0.20

2476

20571

Carcinoma in situ of skin of lower limb, including hip

566

1.80

6.01

2.4

3.0

64.07

65.83

g/l

1.71

501

Other surgical follow-up care

104

627

1.72

6.01

2.1

2.4

65.79

67.14

g/l

0.84

574

Other disorders of penis

333

2525

1.35

6.00

2.0

2.6

66.76

66.54

g/l

0.21

307

2324

Retinal haemorrhage

103

624

1.74

6.00

3.8

3.0

66.26

66.03

g/l

0.09

565

Memory loss

376

2907

1.33

6.00

2.1

2.6

65.72

66.21

g/l

0.63

325

2624

Acute appendicitis

2506

21378

1.11

6.00

2.6

2.5

66.62

66.71

g/l

0.25

2298

19643

Endometriosis of pelvic peritoneum

438

3391

1.29

5.96

2.3

2.4

67.47

66.80

g/l

1.25

395

3108

177

1201

1.49

5.95

1.4

2.0

67.37

68.00

g/l

0.53

167

1123

Alzheimer disease, including avohilmo

1183

9856

0.86

5.95

2.1

2.5

65.29

65.75

g/l

1.17

960

8677

Inflammatory disorders of male genital organs, not elsewhere classified

288

2.11

5.94

1.3

3.2

65.53

66.51

g/l

0.33

264

Autonomic disorders

496

1.82

5.94

2.7

2.9

65.42

67.01

g/l

1.16

454

Alcohol withdrawal state with delirium

254

1855

1.41

5.92

1.6

2.7

66.01

66.64

g/l

0.59

225

1722

Myopia

325

2455

1.34

5.90

2.1

2.5

67.47

67.06

g/l

0.46

305

2278

Degeneration of the brain due to alcohol

582

1.76

5.88

1.6

2.9

67.06

66.43

g/l

0.28

538

Benign neoplasm: Connective and other soft tissue, unspecified

228

2.25

5.88

2.2

1.7

66.21

68.23

g/l

0.88

208

Other eating disorders

102

612

1.70

5.87

1.2

2.1

65.89

67.86

g/l

1.91

579

Melanocytic naevi, other sites/unspecified

252

1838

1.40

5.86

3.2

2.7

65.83

66.74

g/l

1.14

236

1696

Other infective otitis externa

206

1453

1.46

5.86

2.8

2.7

67.24

66.45

g/l

0.82

182

1337

Behavioural disorders

219

2.21

5.86

1.7

2.6

67.13

67.56

g/l

0.14

207

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

232

1670

1.42

5.83

3.2

1.5

66.94

67.12

g/l

0.13

214

1497

Injury of intra-abdominal organs

475

1.82

5.82

2.2

2.7

64.55

67.24

g/l

1.95

435

Autoimmune thyroiditis

338

1.98

5.80

2.4

2.8

68.40

67.85

g/l

0.28

310

Trigeminal neuralgia

201

1414

1.46

5.80

2.8

2.6

66.80

66.48

g/l

0.26

187

1291

Other salmonella infections

134

869

1.60

5.80

3.1

2.7

67.22

67.04

g/l

0.10

122

788

Adenomyosis (Endometriosis of uterus)

460

3654

1.28

5.78

2.5

66.29

66.32

g/l

0.03

415

3284

Benign neoplasm of breast

364

2807

1.32

5.77

2.4

1.5

66.30

66.97

g/l

1.07

321

2486

Tuberculosis, IBD comorbidity

296

2224

1.37

5.76

2.2

2.4

66.10

65.98

g/l

0.09

254

1997

Intermittent heterotropia

149

986

1.54

5.75

2.0

2.7

66.38

66.72

g/l

0.22

138

916

Degeneration of nervous system due to alcohol

586

1.75

5.74

1.6

2.8

67.06

66.45

g/l

0.27

538

Localized scleroderma [morphea]

313

2.04

5.73

2.4

2.8

67.08

67.34

g/l

0.08

282

Burns and corrosions

420

3301

1.29

5.73

2.3

2.6

66.51

66.78

g/l

0.30

386

3065

Benign neoplasm of meninges

374

2906

1.32

5.72

2.3

2.7

65.35

66.25

g/l

1.68

332

2615

Dental caries 2 and operation codes

2521

18141

1.11

5.72

2.7

2.5

67.17

66.75

g/l

2.11

2295

16701

Other specified congenital malformation syndromes affecting multiple systems

216

2.22

5.69

2.0

3.5

64.68

66.09

g/l

0.51

204

Hypertrophic disorders of skin

162

1096

1.51

5.67

3.0

2.7

67.41

67.00

g/l

0.32

149

1016

Hyphaema and other vascular disorders of iris and ciliary body

452

1.84

5.65

1.8

3.3

66.76

66.52

g/l

0.09

408

Benign neoplasm of bone and articular cartilage

262

1936

1.38

5.62

2.6

67.21

66.73

g/l

0.53

240

1779

Hyperkinetic disorders

184

1256

1.46

5.62

1.4

2.2

67.46

67.70

g/l

0.20

169

1196

Complications peculiar to reattachment and amputation

143

2.61

5.62

4.8

2.8

66.01

66.21

g/l

0.06

129

Convalescence

175

1207

1.49

5.61

3.0

2.5

66.42

67.10

g/l

0.57

156

1099

Heterophoria

231

1672

1.41

5.60

2.5

2.7

66.67

66.68

g/l

0.01

216

1545

Tinnitus

845

7160

1.20

5.60

2.8

2.6

66.61

66.58

g/l

0.04

772

6540

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

351

1.96

5.60

4.0

1.6

63.46

67.22

g/l

3.34

313

Ulcer of vagina/vulva

476

1.79

5.51

2.3

2.6

68.08

66.82

g/l

0.96

436

Benign neoplasm: Choroid

198

1405

1.45

5.51

3.1

1.5

66.07

67.00

g/l

1.05

175

1257

Campylobacter enteritis

583

1.72

5.49

2.3

2.9

65.10

66.83

g/l

1.29

530

Focal brain injury

207

1477

1.43

5.47

2.2

2.6

66.00

66.28

g/l

0.20

187

1339

Conduct disorder

239

2.11

5.46

1.7

2.7

66.64

67.89

g/l

0.47

224

Ménière disease

362

2819

1.31

5.46

2.7

66.18

66.39

g/l

0.23

332

2568

Amblyopia ex anopsia

122

784

1.60

5.46

2.0

3.1

66.89

66.42

g/l

0.27

109

722

Complications of genitourinary prosthetic devices, implants and grafts

563

1.73

5.41

2.0

2.5

65.19

66.78

g/l

1.05

512

Carcinoma in situ of colon

366

1.95

5.38

3.4

2.7

64.30

66.44

g/l

1.49

326

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

194

1375

1.45

5.37

3.3

1.5

67.16

67.43

g/l

0.19

180

1237

Benign neoplasm of ovary

538

4386

1.24

5.37

2.7

1.5

65.82

66.94

g/l

2.92

493

3864

Other and unspecified abdominal hernia

156

1067

1.52

5.34

2.2

2.6

66.29

66.40

g/l

0.06

144

975

Benign neoplasm: Pituitary gland, craniopharyngeal duct

172

1196

1.48

5.33

2.6

2.8

66.39

66.85

g/l

0.36

165

1099

Benign neoplasm: Skin of ear and external auricular canal

138

920

1.55

5.31

1.9

1.6

66.10

66.90

g/l

0.56

119

822

Unspecified event, undetermined intent

489

1.76

5.30

2.6

3.0

66.98

67.24

g/l

0.12

451

Use of antiglaucoma preparations and miotics

329

2545

1.33

5.27

2.4

2.5

66.52

65.96

g/l

0.65

281

2233

Disorders of synovium and tendon in diseases classified elsewhere

447

1.80

5.22

2.8

2.6

65.93

66.77

g/l

0.43

410

Triptan medication for migraine, min. 3 purchases

1540

10768

1.14

5.22

2.4

67.44

67.02

g/l

1.64

1422

9961

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

102

623

1.64

5.21

3.1

2.5

65.73

67.02

g/l

0.76

599

Benign neoplasm: Spinal meninges

255

2.12

5.21

1.8

2.7

66.40

66.66

g/l

0.09

228

Benign neoplasm: salivary glands, exclude unknown (D119)

321

2479

1.33

5.19

2.2

2.7

66.67

66.39

g/l

0.26

294

2269

Car occupant injured in other and unspecified transport accidents

551

4517

1.23

5.18

2.4

2.5

67.09

66.80

g/l

0.40

516

4155

Other disorders of the genitourinary system

472

3822

1.26

5.14

2.5

2.6

66.43

66.27

g/l

0.18

426

3426

Benign neoplasm: Skin of trunk

129

853

1.56

5.13

3.9

1.6

67.09

67.38

g/l

0.20

116

771

Occupational exposure to risk-factors

126

832

1.58

5.13

2.8

2.9

67.53

66.61

g/l

0.69

114

769

Status post-ami

195

2209

0.71

5.11

1.8

2.4

65.87

65.56

g/l

0.23

169

1900

Other diseases of gallbladder

170

1192

1.47

5.11

2.3

2.7

65.99

66.10

g/l

0.09

155

1065

Alcoholic gastritis

341

1.92

5.08

1.5

3.2

67.59

66.79

g/l

0.30

313

Pathological resorption of teeth

595

1.67

5.06

1.8

2.2

65.31

67.01

g/l

1.29

552

Benign neoplasm: Parathyroid gland

272

2.06

5.05

2.1

2.7

67.63

66.40

g/l

0.49

249

Dental caries 2

2568

18417

1.10

5.03

2.7

2.5

67.14

66.74

g/l

1.96

2337

16962

Malignant neoplasm of breast

1789

11579

1.12

4.99

2.5

2.6

66.11

66.48

g/l

1.19

1593

10358

Burns and corrosions of external body surface, specified by site

325

2522

1.31

4.98

2.3

2.6

66.39

66.75

g/l

0.36

293

2347

Crushed, pushed or stepped on by crowd or human stampede

180

1276

1.44

4.95

2.3

2.5

66.94

67.14

g/l

0.15

165

1193

Other bursitis of hip

455

1.77

4.95

2.2

2.9

65.12

66.82

g/l

1.08

403

Parkinson's disease, including avohilmo

639

5358

1.21

4.94

1.9

2.5

65.91

65.95

g/l

0.05

547

4783

Alzheimer disease

995

8632

0.86

4.93

2.0

2.4

65.12

65.67

g/l

1.32

789

7593

Varicose veins of other sites

218

1602

1.39

4.93

2.6

2.8

66.32

66.73

g/l

0.36

192

1479

Dislocation, sprain and strain of joints and ligaments of thorax

107

686

1.61

4.93

2.3

2.6

66.08

66.45

g/l

0.20

100

632

Acute nasopharyngitis (common cold)

341

2648

1.30

4.92

2.6

2.4

66.94

67.22

g/l

0.30

314

2473

Benign lipomatous neoplasm of other sites/unspecified

293

2250

1.33

4.92

3.0

1.5

66.01

66.71

g/l

0.84

265

1987

Tuberculosis, wide

302

2332

1.33

4.91

2.2

2.5

66.06

65.89

g/l

0.14

259

2099

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

267

2.04

4.91

3.1

1.6

66.73

67.13

g/l

0.13

233

Other congenital malformations of urinary system

3.19

4.89

1.9

2.4

66.85

66.22

g/l

0.12

Other and specified injuries of hip and thigh

534

1.71

4.87

1.9

2.5

66.29

66.21

g/l

0.03

486

Dermatitis herpetiformis

428

1.79

4.85

3.9

2.8

67.48

66.51

g/l

0.53

392

Bulimia nervosa (incl. atypical)

394

1.79

4.83

1.4

2.0

65.88

68.34

g/l

2.16

374

Parapsoriasis

413

1.80

4.82

2.4

3.1

66.60

66.84

g/l

0.09

378

Brain meningioma, excluding all cancers (controls excluding all cancers)

171

1213

1.45

4.82

2.5

1.5

65.41

66.97

g/l

2.04

155

1075

Personal history of risk-factors, not elsewhere classified

198

2.17

4.81

2.0

2.4

65.08

67.25

g/l

0.70

182

Malignant neoplasm of breast, HER2-negative

1744

11508

1.12

4.81

2.5

2.6

66.07

66.48

g/l

1.34

1551

10289

Meralgia paraesthetica

116

763

1.57

4.80

1.8

2.7

67.50

66.85

g/l

0.49

106

700

Benign neoplasm of major salivary glands

360

2851

1.29

4.80

2.1

2.7

66.34

66.28

g/l

0.05

331

2596

Other contact dermatitis

251

1891

1.35

4.79

2.2

2.7

67.31

66.51

g/l

0.87

224

1724

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

363

1.86

4.78

4.5

1.6

64.93

67.00

g/l

1.17

322

Other deformities of toe(s)

122

812

1.55

4.77

2.5

2.9

65.79

66.01

g/l

0.13

105

729

Other and unspecified epidermal thickening

598

1.65

4.77

2.6

2.9

65.14

66.96

g/l

1.58

550

Acquired absence of organs, not elsewhere classified

284

1.99

4.77

5.2

2.4

63.55

66.79

g/l

1.56

255

Benign neoplasm: Skin of other and unspecified parts of face

401

3219

1.27

4.75

2.9

2.5

66.03

66.34

g/l

0.34

349

2913

Gestational [pregnancy-induced] hypertension

609

5073

1.21

4.73

2.6

2.3

66.83

67.24

g/l

0.72

576

4658

Other disorders starting during childhood or adolescence

535

1.66

4.73

3.3

2.7

65.33

66.69

g/l

0.70

507

Oral lichen ruber planus, including avohilmo

203

1489

1.40

4.71

2.7

2.9

68.06

66.76

g/l

2.19

189

1345

Other specified disorders of external ear

145

1007

1.49

4.67

3.0

2.7

66.13

66.39

g/l

0.15

127

936

Severe visual impairment, monocular

203

2.18

4.64

2.0

2.7

67.31

66.13

g/l

0.42

185

Alzheimer disease, excluding more controls

710

4012

1.20

4.64

2.1

2.8

65.25

65.91

g/l

1.33

566

3615

UC patients in KELA-register (code 208), prior to 1994

162

1148

1.46

4.63

2.7

2.8

66.69

66.77

g/l

0.04

150

1057

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

124

836

1.54

4.60

2.8

1.6

65.74

66.76

g/l

0.70

115

739

Contusion of other and unspecified parts of foot

127

856

1.52

4.60

1.9

2.7

66.15

67.09

g/l

0.72

115

799

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

134

914

1.50

4.60

2.0

2.7

66.37

67.03

g/l

0.49

124

836

Vulvovaginal ulceration/inflammation in other diseases

139

954

1.48

4.58

2.4

66.36

67.31

g/l

0.83

129

889

Hypertrophic scar

145

1005

1.47

4.57

3.0

2.6

67.17

67.10

g/l

0.04

135

929

Sequelae of injuries of upper limb

303

2360

1.31

4.57

3.0

2.8

67.11

66.78

g/l

0.33

274

2171

Malignant neoplasm of thymus

3.16

4.57

2.6

2.9

65.99

67.09

g/l

0.29

Contact with heat and hot substances

157

1107

1.45

4.54

1.9

2.7

65.94

66.84

g/l

0.79

137

1023

Benign neoplasm: Skin of eyelid, including canthus

566

4730

1.22

4.54

3.0

2.6

66.60

66.21

g/l

0.58

494

4270

Lactose intolerance

604

1.62

4.54

2.2

2.3

66.15

66.97

g/l

0.49

555

Other congenital malformations of skin

121

812

1.53

4.53

2.0

3.0

67.37

66.69

g/l

0.45

111

749

Other drug-induced secondary parkinsonism

205

2.15

4.53

2.0

2.8

66.40

66.74

g/l

0.12

187

Corneal scars and opacities

623

1.62

4.52

1.6

3.0

66.50

66.53

g/l

0.01

567

Unspecified visual impairment (binocular)

325

1.88

4.52

2.1

3.0

65.93

66.45

g/l

0.18

292

Benign neoplasm: Cerebral meninges

330

2609

1.29

4.50

2.4

2.7

65.16

66.28

g/l

2.22

296

2360

Other orthopaedic follow-up care

183

1329

1.41

4.49

2.1

2.5

66.38

66.89

g/l

0.38

165

1203

Additional codes for the location of defect, injury or illness

186

1356

1.41

4.48

2.5

2.9

66.67

66.49

g/l

0.12

177

1239

Hypermetropia

204

1507

1.38

4.46

3.2

2.7

66.05

66.36

g/l

0.26

183

1387

Melanoma in situ of trunk

291

1.94

4.45

2.9

1.6

64.82

67.33

g/l

1.50

261

Alzheimer’s disease (Late onset)

685

6879

0.84

4.43

2.0

2.3

65.23

65.63

g/l

0.62

543

6007

Oligomenorrhoea

623

1.59

4.41

2.4

2.3

66.62

67.01

g/l

0.21

567

Unspecific neurodegenerative disorder

1474

11330

0.89

4.40

2.1

2.5

65.38

65.83

g/l

1.33

1192

10068

Atopic conjunctivitis

124

841

1.51

4.40

2.1

2.6

66.92

67.07

g/l

0.09

113

782

Other noninflammatory disorders of vagina

238

1805

1.34

4.38

2.5

2.3

66.41

66.46

g/l

0.04

211

1619

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

240

1824

1.34

4.38

2.1

1.6

66.41

67.09

g/l

0.74

219

1647

Other lesions of median nerve

106

700

1.57

4.38

2.1

2.6

65.06

66.32

g/l

0.98

630

Erectile dysfunction

337

2687

1.29

4.36

2.4

2.6

65.30

65.85

g/l

0.61

308

2430

Benign neoplasm: Other and unspecified parts of mouth

126

863

1.51

4.36

3.2

3.0

67.05

66.79

g/l

0.13

112

789

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

3.37

4.36

1.2

2.3

64.68

66.52

g/l

0.32

Subacute thyroiditis

118

796

1.53

4.35

2.4

2.7

67.45

67.10

g/l

0.21

108

730

Lichen sclerosus et atrophicus

333

2646

1.28

4.34

2.5

66.98

66.63

g/l

0.38

307

2366

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

129

888

1.50

4.31

2.6

1.6

64.91

67.32

g/l

3.50

119

799

Benign neoplasm: Other parts of oropharynx

174

2.20

4.31

5.1

1.8

67.59

67.86

g/l

0.08

154

Juvenile Open Angle Glaucoma

2.66

4.31

3.0

2.8

67.71

68.13

g/l

0.08

Melanoma in situ of other and unspecified parts of face

334

1.88

4.28

2.9

3.0

64.99

65.85

g/l

0.30

296

Other bursitis of knee

272

1.93

4.27

2.4

3.1

66.19

66.90

g/l

0.25

249

Injury of nerves and spinal cord at neck level

506

1.67

4.26

2.5

3.1

65.32

66.64

g/l

0.64

461

Benign neoplasm: Parotid gland

283

2212

1.31

4.26

2.2

2.7

66.63

66.42

g/l

0.17

259

2026

Vertigo of central origin

400

1.77

4.25

1.9

3.2

66.24

66.47

g/l

0.08

361

Ethmoidectomy

411

3348

1.25

4.25

2.4

2.6

66.64

66.75

g/l

0.11

373

3088

Allergic contact dermatitis due to drugs in contact with skin

522

1.66

4.25

1.9

2.9

65.62

66.91

g/l

0.74

478

Anisometropia and aniseikonia

107

712

1.55

4.24

2.4

3.1

65.80

66.58

g/l

0.56

651

Sequelae of injuries of head

163

1174

1.42

4.23

2.3

2.8

66.07

67.01

g/l

0.97

147

1087

Unspecified jaundice

180

1320

1.40

4.22

1.9

2.5

63.49

66.35

g/l

3.85

167

1201

Asthma mixed form (mode)

154

1097

1.43

4.20

2.1

67.00

67.07

g/l

0.05

141

973

Pilonidal cyst

212

1589

1.35

4.20

2.3

66.21

67.41

g/l

1.75

199

1492

Chronic Coagulation defects

460

1.69

4.19

2.7

2.9

66.69

67.21

g/l

0.28

422

Other and unspecified disorders of pigmentation

130

2.39

4.17

2.5

2.8

67.45

66.60

g/l

0.21

120

Nephropathy induced by other drugs, medicaments and biological substances

4.31

4.17

1.8

67.82

66.44

g/l

0.29

Dental caries 2 and operation codes, only avohilmo

2227

15086

0.91

4.17

2.6

2.7

67.48

66.58

g/l

7.24

2014

13880

Other acantholytic disorders

3.16

4.16

1.7

2.4

66.28

66.09

g/l

0.04

Burn and corrosion of ankle and foot

282

1.90

4.16

2.2

2.8

65.23

66.92

g/l

0.64

258

Benign neoplasm: Lip

439

1.71

4.15

3.6

1.6

66.47

67.49

g/l

0.45

392

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

463

1.69

4.14

2.3

1.5

65.72

67.38

g/l

0.85

414

Residual foreign body in soft tissue

139

976

1.46

4.14

2.9

2.7

66.04

66.75

g/l

0.59

131

891

Perforation of tympanic membrane

327

2608

1.28

4.13

3.0

2.5

65.67

66.47

g/l

1.08

293

2393

Left hemicolectomy

647

1.58

4.13

2.2

3.0

65.62

66.18

g/l

0.28

593

Preparation and fitting of bite rail to mouth

382

3100

1.25

4.08

2.7

2.8

67.28

67.11

g/l

0.18

360

2862

Benign leiomyoma with endometriosis

486

4046

1.22

4.06

2.6

1.6

66.08

66.86

g/l

1.47

433

3580

Alopecia areata

503

1.64

4.06

3.5

2.5

66.62

66.81

g/l

0.08

463

Nonspecific lymphadenitis

174

1276

1.39

4.04

2.5

2.6

65.79

67.08

g/l

1.33

162

1191

Dementia in Alzheimer disease

529

5367

0.83

4.02

1.8

2.4

65.05

65.75

g/l

1.03

399

4706

Congenital malformations of the nervous system

320

1.80

4.02

2.1

3.2

66.48

66.80

g/l

0.15

299

Perioral dermatitis

381

1.74

4.02

2.0

2.7

66.88

67.40

g/l

0.18

351

Dental pulpitis 3

181

951

1.38

4.01

1.9

1.8

66.83

67.63

g/l

0.59

171

904

Ovarian dysfunction

143

1013

1.43

4.00

2.1

2.2

67.88

67.77

g/l

0.07

135

954

Use of memantine

817

8146

0.86

3.96

2.1

2.4

65.23

65.61

g/l

0.67

647

7127

Use of other anti-dementia drugs

817

8146

0.86

3.96

2.1

2.4

65.23

65.61

g/l

0.67

647

7127

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.91

3.95

7.5

1.4

66.59

67.01

g/l

—

Ulcerative rectosigmoiditis

243

1879

1.32

3.93

2.4

2.6

68.01

66.88

g/l

1.50

226

1743

Benign neoplasm of male genital organs

447

1.68

3.91

3.2

1.7

65.88

67.18

g/l

0.66

404

Glaucoma suspect

1401

12626

1.12

3.90

2.5

2.6

66.21

66.18

g/l

0.04

1264

11321

Disorders of eyelid in diseases classified elsewhere

110

750

1.51

3.90

1.7

2.9

65.97

66.97

g/l

0.74

100

679

Injury of muscle and tendon at lower leg level

506

4247

1.21

3.90

2.6

66.32

66.70

g/l

0.48

466

3942

Lagophthalmos

312

1.84

3.90

3.3

2.8

66.69

66.34

g/l

0.11

286

FESS (DNB20)

391

3202

1.24

3.89

2.3

2.6

66.81

66.80

g/l

0.01

354

2953

Drug-induced acute pancreatitis

4.64

3.88

4.0

65.52

66.82

g/l

—

Injuries involving multiple body regions

111

758

1.50

3.88

3.0

2.7

66.23

66.80

g/l

0.31

688

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

320

1.81

3.85

2.5

1.4

65.29

67.18

g/l

1.10

284

Nasal polyp

692

5967

1.17

3.85

2.5

2.6

66.72

66.46

g/l

0.41

634

5447

Injury of eye and orbit

413

3404

1.23

3.82

2.7

2.6

65.59

66.81

g/l

2.71

374

3164

Other neurotic disorders

168

1240

1.39

3.82

1.8

2.8

66.36

66.69

g/l

0.22

145

1130

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

385

3154

1.24

3.81

3.1

1.6

66.46

67.16

g/l

1.04

344

2834

Benign neoplasm: Tongue

584

1.58

3.81

3.9

1.6

66.10

67.15

g/l

0.67

525

Urethritis and urethral syndrome

457

1.65

3.81

3.5

2.7

66.47

67.20

g/l

0.45

422

conjunctival haemorrhage

272

2151

1.29

3.79

2.2

2.6

65.53

66.35

g/l

1.13

252

1963

Parkinson's disease

600

5132

1.19

3.78

1.9

2.5

65.97

65.98

g/l

0.00

515

4583

Palindromic rheumatism

226

1.96

3.77

2.2

3.1

64.99

66.67

g/l

0.88

207

Alzheimer’s disease (Early onset), excluding more controls

979

0.61

3.73

1.3

2.4

65.52

65.53

g/l

0.01

869

Benign neoplasm: Connective and other soft tissue, unspecified

271

1.87

3.72

2.2

2.6

66.21

66.88

g/l

0.21

253

Benign neoplasm: other/unspecified salivary gland

628

1.55

3.72

2.0

1.6

65.72

67.09

g/l

1.05

565

Right hemicolectomy

225

1743

1.32

3.72

2.7

64.98

66.22

g/l

1.39

209

1585

Benign neoplasm: Liver/bile ducts

444

1.65

3.72

2.1

1.5

66.73

67.88

g/l

0.70

400

Moyamoya

9.04

3.71

1.0

1.4

67.29

66.39

g/l

—

Dissection of aorta

121

851

1.47

3.71

1.8

2.7

64.83

66.26

g/l

1.36

104

769

Haemangioma, any site

268

2118

1.29

3.71

2.7

66.81

66.52

g/l

0.26

239

1941

Use of rivastigmine

393

4730

0.82

3.70

1.7

2.4

65.58

65.61

g/l

0.03

314

4093

Operations for atrial fibrillation

402

1.71

3.68

1.7

3.3

65.93

66.34

g/l

0.14

364

Haemangioma and lymphangioma, any site

283

2253

1.28

3.68

3.0

2.7

66.75

66.56

g/l

0.17

253

2067

Parkinson's disease, strict definition

557

4750

1.19

3.67

1.9

2.5

66.10

65.98

g/l

0.14

477

4238

Other peripheral vertigo

325

2633

1.26

3.66

1.9

2.7

66.48

66.40

g/l

0.07

283

2410

Leiomyoma of uterus

2143

11198

1.09

3.65

2.6

2.5

66.34

66.60

g/l

0.86

1889

10097

Oral lichen ruber planus

600

1.56

3.65

3.2

3.0

68.03

67.07

g/l

0.75

549

Malignant melanoma

547

4659

1.19

3.64

2.9

2.6

65.90

66.13

g/l

0.29

491

4197

Other acquired deformities of musculoskeletal system and connective tissue

154

1131

1.40

3.64

2.6

2.8

65.34

66.83

g/l

1.60

140

1038

Myocardial infarction, with ST-elevation

702

6094

1.17

3.63

2.1

2.5

64.80

66.02

g/l

3.91

631

5438

Endometriosis of ovary

496

4169

1.20

3.63

2.3

2.4

66.82

66.55

g/l

0.33

450

3796

Other predominantly sexually transmitted diseases, not elsewhere classified

389

3203

1.23

3.61

2.2

2.4

66.67

67.35

g/l

0.97

355

2971

Other and unspecified injuries of abdomen, lower back and pelvis

280

1.82

3.61

2.2

2.6

67.27

66.65

g/l

0.24

256

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

309

1.77

3.60

2.8

2.9

65.40

66.57

g/l

0.44

285

Schizophrenia or delusion

960

8499

1.14

3.60

2.1

2.4

65.96

66.83

g/l

2.66

858

7820

Other disorders of cornea

307

2475

1.26

3.60

2.3

2.6

66.27

66.58

g/l

0.30

278

2265

Granuloma annulare

311

1.78

3.59

1.8

3.1

68.42

67.34

g/l

0.66

281

Other vitreous opacities

137

991

1.42

3.59

2.8

3.0

66.91

66.29

g/l

0.47

122

901

Single delivery by forceps and vacuum extractor

183

1479

0.75

3.58

1.9

67.34

67.62

g/l

0.19

172

1376

Superficial injuries involving multiple body regions

512

1.59

3.57

3.6

2.8

66.23

66.93

g/l

0.35

466

Other puerperal infections

144

1044

1.40

3.57

2.5

2.1

67.27

67.78

g/l

0.37

134

981

Other and unspecified mononeuropathies of lower limb

652

1.52

3.53

1.6

2.6

66.37

67.01

g/l

0.43

595

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

145

1060

1.40

3.53

2.4

1.6

65.17

67.04

g/l

2.01

137

951

Meningitis

155

1145

1.38

3.52

2.7

66.63

66.85

g/l

0.12

143

1057

Senility

173

2.04

3.51

1.5

2.0

64.54

65.44

g/l

0.30

150

Explicit viral Sepsis

8.88

3.51

1.1

1.5

68.90

68.43

g/l

—

Pyoderma

429

1.65

3.49

3.0

66.83

66.92

g/l

0.03

388

Personal history of allergy to drugs, medicaments and biological substances

203

1.96

3.48

2.0

2.2

66.86

67.83

g/l

0.30

188

Open wound of wrist and hand

1400

12558

1.11

3.48

2.6

2.5

66.63

66.79

g/l

0.35

1304

11583

Single spontaneous delivery

1173

6969

0.89

3.47

2.7

2.3

66.57

66.33

g/l

0.49

1058

6209

Prolonged pregnancy

167

2027

0.75

3.46

2.3

2.1

66.86

67.84

g/l

0.97

154

1897

Maltreatment syndromes

113

791

1.45

3.46

2.1

2.4

67.37

67.85

g/l

0.28

102

750

Dependent personality disorder

438

1.63

3.45

2.3

2.9

65.32

67.46

g/l

1.36

406

Primary open-angle glaucoma

1313

11579

1.12

3.44

2.4

2.5

66.29

65.89

g/l

1.10

1164

10241

Benign neoplasm of brain and other parts of central nervous system

189

1443

1.34

3.44

2.9

1.5

66.29

67.14

g/l

0.75

165

1306

Left ventricular outflow tract obstruction, narrow definition

141

1030

1.40

3.43

2.3

2.8

63.81

66.40

g/l

3.15

135

953

Female genital prolapse

1022

5244

1.13

3.39

2.4

2.5

66.66

66.38

g/l

0.57

923

4708

Other, unspecified and serous retinal detachments

110

775

1.47

3.38

2.6

2.9

67.01

66.40

g/l

0.36

711

Transient acantholytic dermatosis [Grover]

3.39

3.37

1.3

2.4

66.26

65.87

g/l

0.08

Benign neoplasm of eye and adnexa

346

2850

1.24

3.36

2.7

2.6

66.06

66.33

g/l

0.29

309

2602

Benign neoplasm: Long bones of lower limb

625

1.51

3.35

2.2

2.9

67.32

67.26

g/l

0.03

578

Other acute skin changes due to ultraviolet radiation

121

868

1.43

3.34

2.0

2.8

66.40

66.91

g/l

0.27

107

789

Contusion of ankle

101

699

1.48

3.33

1.7

2.8

66.03

67.29

g/l

1.12

647

Primary open-angle glaucoma, strict

1062

9506

1.13

3.33

2.4

2.5

66.35

65.85

g/l

1.26

950

8404

Dislocation, sprain and strain of joints and ligaments of head

107

750

1.46

3.30

2.7

66.68

67.20

g/l

0.33

703

Schizophrenia, schizotypal and delusional disorders

962

8571

1.13

3.29

2.1

2.4

65.92

66.81

g/l

2.79

860

7882

Benign neoplasm: Thymus

3.09

3.29

2.2

1.5

65.89

66.85

g/l

0.21

Inflammation of lacrimal passages (acute and unspecified)

390

1.65

3.25

4.2

2.7

66.31

67.11

g/l

0.36

350

Medical abortion

2122

10646

1.09

3.25

2.1

2.6

66.40

66.55

g/l

0.37

1897

9599

Haemorrhage in early pregnancy

704

6002

1.15

3.25

2.6

2.5

66.61

67.05

g/l

0.87

650

5521

Calcific tendinitis of shoulder

173

1316

1.34

3.25

2.6

2.8

66.25

66.80

g/l

0.43

157

1208

Melanocytic naevi of scalp and neck

405

1.62

3.22

3.0

1.6

66.49

67.94

g/l

0.78

367

Anomalies of dental arch relationship, including avohilmo

470

3576

1.19

3.22

2.8

2.6

67.02

67.04

g/l

0.02

429

3311

Correction of physiology of bite - very demanding therapy visit

533

1.54

3.22

2.5

66.53

67.58

g/l

0.65

497

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

712

5994

1.15

3.20

2.5

1.5

65.47

66.81

g/l

4.38

639

5257

Benign neoplasm of other and unspecified sites

682

1.48

3.20

2.7

1.6

65.35

67.29

g/l

1.65

612

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

210

1643

1.30

3.20

3.7

1.5

65.39

66.84

g/l

1.63

189

1469

Benign neoplasm: Thymus

3.03

3.19

2.2

2.8

65.89

66.81

g/l

0.20

Haemoglobinuria due to haemolysis from other external causes

13.32

3.19

1.6

2.0

61.62

68.14

g/l

—

486

1.56

3.19

2.2

2.8

67.21

67.97

g/l

0.42

450

Endometriosis ASRM stages 1,2

448

3790

1.19

3.18

2.3

2.4

67.34

67.07

g/l

0.37

403

3491

Separation of retinal layers (serosa)

131

961

1.40

3.17

2.8

67.24

66.74

g/l

0.36

120

889

Disorders of breast

1532

12990

1.10

3.13

2.3

2.5

66.83

66.57

g/l

0.74

1380

11697

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

481

1.57

3.13

3.0

1.5

65.45

67.46

g/l

1.47

429

Other and unspecified corneal deformities and disorders

101

711

1.46

3.11

2.4

3.0

67.06

67.13

g/l

0.03

649

Vestibular neuronitis

302

2477

1.24

3.09

2.4

2.8

67.17

66.46

g/l

1.03

270

2270

Delivery

1192

6980

0.90

3.08

2.7

2.3

66.50

66.34

g/l

0.30

1082

6220

Amputation of thigh

109

782

1.44

3.06

2.2

2.4

62.57

65.56

g/l

2.66

692

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

582

1.51

3.05

2.4

1.5

65.34

67.27

g/l

1.22

524

Tuberculosis

246

1978

1.27

3.05

2.3

2.6

65.79

65.96

g/l

0.13

213

1773

Injury of blood vessels at shoulder and upper arm level

3.37

3.05

2.8

2.0

67.13

66.73

g/l

0.05

Nontoxic single thyroid nodule

231

1843

1.28

3.04

2.3

2.8

67.01

66.64

g/l

0.35

204

1683

Open wound of hip and thigh

647

1.47

3.04

2.0

2.6

64.96

66.90

g/l

1.48

596

Benign neoplasm: Skin, unspecified

114

823

1.42

3.04

2.2

1.5

65.62

67.35

g/l

1.54

102

742

Burns and corrosions of multiple and unspecified body regions

436

1.58

3.04

1.7

2.9

67.16

66.95

g/l

0.08

404

hereditary angioödema type 3

8.04

3.02

2.5

1.7

71.25

68.71

g/l

—

malignant neoplasm of male genital organs

1751

10242

1.09

3.01

2.6

65.66

66.31

g/l

2.77

1554

9378

Oral leukoplakia and related diseases

197

1547

1.30

3.00

2.7

66.87

66.46

g/l

0.34

182

1404

Fistulae involving female genital tract

375

1.64

3.00

2.5

2.4

67.57

67.05

g/l

0.16

343

Pyogenic granuloma

351

1.65

2.99

2.1

3.0

65.54

66.65

g/l

0.53

317

Benign neoplasm: Conjunctiva

658

1.47

2.99

1.9

1.6

65.28

67.36

g/l

2.54

592

Use of rasagiline

100

713

1.46

2.97

1.4

3.1

65.32

66.36

g/l

0.79

644

Benign neoplasm: Prostate

151

2.06

2.96

3.9

1.9

64.34

67.04

g/l

1.07

133

Rheumatic valve diseases

611

1.49

2.96

2.7

2.5

65.69

65.93

g/l

0.10

539

Examination and encounter for administrative purposes

132

981

1.37

2.95

3.6

2.5

66.86

66.15

g/l

0.53

121

894

Cholera

145

1096

1.36

2.93

3.5

2.8

65.85

66.61

g/l

0.71

126

991

Benign neoplasm: Liver

384

1.61

2.93

2.2

1.6

66.39

67.89

g/l

0.86

343

Contracture of muscle

2.58

2.93

1.2

4.3

62.84

67.04

g/l

1.12

Presence of other devices

853

7612

1.13

2.92

2.7

2.4

65.94

66.07

g/l

0.20

784

6749

Injury of muscle and tendon at hip and thigh level

289

2374

1.24

2.91

2.1

2.7

66.18

66.77

g/l

0.69

273

2195

Follow-up care involving plastic surgery

117

856

1.40

2.90

3.2

2.5

67.19

67.08

g/l

0.05

775

Other melanin hyperpigmentation

574

1.50

2.89

3.0

65.95

66.79

g/l

0.49

518

Hordeolum and other deep inflammation of eyelid

158

1209

1.33

2.89

3.0

2.8

67.57

66.68

g/l

0.64

140

1120

Retinoblastoma

9.77

2.86

24.4

1.0

62.16

62.47

g/l

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

182

1425

1.31

2.86

2.1

2.9

67.05

66.55

g/l

0.46

171

1287

Certain zoonotic bacterial diseases

420

1.58

2.85

2.6

2.8

66.10

67.00

g/l

0.41

380

Endovascular or surgical operations to intracerebral aneurysms

210

1673

1.28

2.84

2.0

2.9

65.86

66.63

g/l

0.77

190

1524

Exposure to other and unspecified animate mechanical forces

475

1.53

2.83

2.4

65.02

67.53

g/l

1.46

444

Felty syndrome

133

2.10

2.81

2.0

3.2

63.67

66.43

g/l

0.89

119

Complications predominantly related to the puerperium

631

5540

1.15

2.79

2.5

2.4

67.26

67.13

g/l

0.17

586

5113

Other effects of reduced temperature

2.99

2.79

1.7

1.9

66.47

66.46

g/l

0.00

Other and unspecified injuries of wrist and hand

101

726

1.42

2.78

2.2

2.6

66.51

66.98

g/l

0.27

667

Epiphora

554

1.50

2.77

2.3

3.0

65.85

66.85

g/l

0.58

497

Idiopathic progressive neuropathy

3.38

2.77

1.4

3.4

68.68

67.71

g/l

0.16

Acute and transient psychotic disorders

327

2732

1.21

2.76

1.9

2.6

65.93

66.94

g/l

1.46

292

2535

Congenital malformations of aortic and mitral valves

118

873

1.38

2.75

2.4

3.0

63.00

66.58

g/l

4.59

112

808

Peritonsillar abscess

574

5015

1.15

2.74

2.6

2.5

67.30

66.84

g/l

0.75

541

4640

Injury of muscle and tendon at shoulder and upper arm level

1328

12174

1.10

2.74

2.5

2.7

66.59

66.51

g/l

0.15

1223

11169

Inguinal or femoral hernia, bilateral

399

3403

1.19

2.73

2.4

2.6

66.01

66.29

g/l

0.29

352

3108

Triptan medication for migraine, single purchase ok

2465

15621

1.07

2.72

2.4

2.5

67.18

66.80

g/l

1.93

2277

14383

Migraine, single triptan purchase ok & required. ICD-code if available is included

2465

15621

1.07

2.72

2.4

2.5

67.18

66.80

g/l

1.93

2277

14383

All dysplastic lesions of the vulva

125

936

1.36

2.70

1.6

2.6

65.01

67.19

g/l

1.84

108

859

Inguinal hernia, bilateral

391

3336

1.19

2.67

2.4

2.6

66.02

66.29

g/l

0.28

346

3047

Other disorders of Eustachian tube

649

1.44

2.67

2.0

2.7

66.15

66.80

g/l

0.29

599

Beta thalassaemia

8.41

2.66

12.6

1.0

67.08

69.04

g/l

—

Secondary parkinsonism+Parkinsonism in other disease

718

1.42

2.66

2.4

2.7

64.46

66.39

g/l

1.54

652

Subarachnoid haemorrhage

362

3068

1.20

2.66

2.4

2.6

65.51

66.22

g/l

0.98

315

2750

Lactose intolerance, other/unspecified

540

1.48

2.66

1.7

2.3

66.31

67.17

g/l

0.44

495

Other degenerative diseases of the basal ganglia

438

1.56

2.65

1.8

3.1

65.02

65.51

g/l

0.21

390

Benign neoplasm: Skin of scalp and neck

500

1.50

2.64

2.4

1.6

66.88

67.56

g/l

0.36

454

Benign neoplasm: Other parts of oropharynx

209

1.81

2.63

5.1

2.8

67.59

66.65

g/l

0.37

190

Embolic stroke with flimmer

668

1.43

2.63

2.0

2.2

65.73

65.90

g/l

0.07

589

Other and unspecified myoneural disorders

2.38

2.61

1.4

2.6

65.53

67.46

g/l

0.38

Malignant neoplasm of endocrine gland

220

1783

1.25

2.58

3.3

2.8

66.56

66.59

g/l

0.02

205

1628

Other and unspecified iridocyclitis

128

970

1.35

2.57

3.1

2.8

68.46

66.69

g/l

1.99

116

889

Other benign neoplasms of connective and other soft tissue

312

2620

1.21

2.55

2.8

2.6

66.25

66.56

g/l

0.31

280

2398

Personal history of malignant neoplasm

114

851

1.37

2.54

4.3

2.5

65.41

66.77

g/l

1.28

102

771

Hypersensitivity pneumonitis due to organic dust

408

1.55

2.54

2.8

3.3

67.58

66.58

g/l

0.35

373

Rheumatic fever incl heart disease

114

852

1.37

2.54

3.6

2.7

65.38

66.09

g/l

0.43

106

759

Foreign body in alimentary tract

167

1314

1.29

2.54

1.8

2.8

65.92

66.29

g/l

0.24

149

1203

Other diseases of peritoneum

146

1131

1.32

2.52

1.8

2.7

66.36

66.47

g/l

0.06

126

1025

Tuberculosis of other organs

583

1.45

2.50

2.1

2.9

66.45

65.91

g/l

0.24

522

Secondary parkinsonism

701

1.41

2.50

2.3

2.7

64.20

66.50

g/l

1.99

635

Unspecified maternal hypertension

152

1.90

2.49

1.7

2.1

66.30

67.94

g/l

0.68

141

Other facial nerve disorders

624

1.43

2.49

2.9

2.7

66.03

66.95

g/l

0.54

569

Malignant neoplasm of liver and intrahepatic bile ducts

120

909

1.36

2.48

1.8

2.8

65.33

65.88

g/l

0.26

103

818

Retinoblastoma, excluding all cancers (controls excluding all cancers)

7.21

2.47

24.4

1.0

62.16

63.88

g/l

—

Postmenopausal atrophic vaginitis

886

4806

1.12

2.46

2.5

2.6

67.36

66.38

g/l

3.74

803

4321

Delivery, wide proxy

1003

5880

0.90

2.46

2.6

2.3

66.64

66.28

g/l

0.78

907

5207

L02BA Anti-estrogens

513

4493

1.15

2.45

2.9

2.5

66.26

66.61

g/l

0.48

464

4049

Thyroiditis, unspecified

322

1.61

2.45

2.0

2.5

66.08

67.70

g/l

0.76

297

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

260

3116

0.82

2.43

2.7

2.6

64.85

66.16

g/l

1.73

231

2826

Unspecified severe protein-energy malnutrition

3.61

2.43

1.4

1.5

59.32

66.51

g/l

—

Ulcerative proctitis

165

1303

1.29

2.42

2.2

2.6

67.22

66.89

g/l

0.20

154

1201

Disorders of globe

637

1.42

2.42

2.6

2.8

66.50

66.41

g/l

0.04

573

Dislocation of lens

372

1.56

2.42

2.7

66.28

65.75

g/l

0.22

344

Perforation of oesophagus

127

2.03

2.41

2.0

3.6

61.60

66.08

g/l

1.64

114

Spinal enthesopathy

719

1.39

2.40

2.9

2.2

66.93

65.13

g/l

1.49

617

Other infective (teno)synovitis

2.27

2.40

1.3

3.2

65.87

67.34

g/l

0.39

Apocrine sweat disorders, other sweat gland disorders

2.27

2.40

5.6

2.8

63.54

67.13

g/l

0.95

Anorexia (incl.atypical)

130

995

1.32

2.39

2.2

2.3

66.59

67.43

g/l

0.71

121

922

Other intracranial haemorrhages

116

881

1.35

2.37

3.0

2.7

65.67

65.88

g/l

0.11

105

789

Other spirochaetal diseases

864

7824

1.11

2.36

2.6

67.02

66.52

g/l

1.23

750

7128

Gonococcal infection

681

1.40

2.36

2.4

2.5

66.23

67.40

g/l

0.65

628

Benign neoplasm: Skin of ear and external auricular canal

138

1073

1.32

2.36

1.9

2.7

66.10

66.34

g/l

0.13

119

981

Arthropod-borne viral fevers and viral haemorrhagic fevers

307

2596

1.20

2.36

3.0

2.7

65.46

66.64

g/l

1.85

293

2392

2.73

2.35

2.2

4.0

67.30

68.99

g/l

0.24

Tuberculosis of other organs, strict

676

1.40

2.33

2.2

2.8

66.48

65.89

g/l

0.30

604

Mental and behavioural disorders due to cocaine

4.26

2.33

1.3

4.8

66.94

66.66

g/l

—

Benign neoplasm: Skin of lip

287

1.63

2.32

3.6

1.6

69.14

67.59

g/l

0.64

252

Other diseases of appendix

280

1.64

2.31

1.8

2.5

66.33

67.13

g/l

0.23

257

Dissection of cerebral arteries, nonruptured

135

1.94

2.31

2.3

64.28

68.24

g/l

2.18

124

Dronedarone medication

102

763

1.37

2.31

2.0

2.8

65.49

67.02

g/l

1.32

690

Respiratory tuberculosis, confirmed and not-confirmed

204

1665

1.25

2.30

2.2

2.6

66.14

65.96

g/l

0.13

178

1496

Respiratory tuberculosis

204

1666

1.25

2.29

2.2

2.6

66.14

65.95

g/l

0.13

178

1497

Lyme disease

854

7746

1.11

2.28

2.6

67.02

66.51

g/l

1.28

740

7055

Unspecified chronic bronchitis

124

955

1.32

2.26

2.0

2.9

66.34

66.23

g/l

0.05

113

861

Benign neoplasm: Liver/bile ducts

501

1.45

2.26

2.1

2.8

66.73

67.31

g/l

0.29

455

Stenosis and insufficiency of lacrimal passages

311

2645

1.19

2.26

2.5

67.13

66.32

g/l

1.28

283

2379

Acute otitis externa, noninfective

370

1.54

2.25

2.8

3.0

66.44

67.21

g/l

0.33

339

Malignant neoplasm of oesophagus

673

1.39

2.24

2.1

3.0

59.06

65.82

g/l

6.90

612

Normotensive glaucoma

316

2697

1.19

2.24

2.2

2.6

66.49

66.17

g/l

0.34

290

2408

Conductive hearing loss, unspecified

256

2141

1.21

2.24

3.4

2.6

66.99

66.53

g/l

0.45

234

1960

Secondary malignant neoplasm of other and unspecified sites

364

1.55

2.24

2.3

3.1

65.21

66.06

g/l

0.33

331

Medicines for HER+ breast cancer

1209

10863

1.09

2.22

2.7

2.6

66.43

66.39

g/l

0.06

1078

9724

Malignant neoplasm of prostate

1717

10118

1.08

2.22

2.6

65.67

66.27

g/l

2.45

1521

9260

Wilms' tumor, excluding all cancers (controls excluding all cancers)

123

1.97

2.21

4.7

1.9

65.07

67.09

g/l

0.52

106

Schizoaffective disorder

197

1606

1.24

2.21

1.8

2.7

65.25

67.02

g/l

2.50

180

1497

Melanoma in situ of trunk

357

1.55

2.21

2.9

3.1

64.83

66.20

g/l

0.64

325

Female infertility, associated with anovulation

126

972

1.31

2.20

1.7

1.9

67.78

67.76

g/l

0.01

119

906

Benign neoplasm: Larynx

682

1.38

2.19

2.3

1.6

66.48

67.27

g/l

0.47

614

Blood alcohol or alcohol intoxication level

420

1.48

2.19

1.7

2.4

64.85

67.28

g/l

1.76

391

Bitten or struck by other mammals

274

2308

1.20

2.19

2.5

2.7

66.96

66.92

g/l

0.03

256

2139

Benign neoplasm of middle ear and respiratory system

263

2215

1.20

2.16

2.2

2.7

66.07

66.54

g/l

0.52

243

2025

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

285

1.60

2.16

3.2

1.6

64.71

67.97

g/l

1.91

257

Alport

3.91

2.15

1.7

4.0

64.29

67.56

g/l

—

Presbyopia

178

1443

1.25

2.14

2.0

2.7

66.64

66.92

g/l

0.19

163

1336

Other and unspecified acute skin changes due to ultraviolet radiation

678

1.38

2.14

2.1

2.9

65.93

66.61

g/l

0.32

612

Alzheimer’s disease, wide definition, excluding more controls

605

3668

1.13

2.14

2.0

2.8

65.36

65.88

g/l

0.82

485

3293

Ankle and foot

177

1.77

2.12

5.5

2.7

65.65

67.04

g/l

0.43

163

Anxious personality disorder

261

1.60

2.11

2.1

3.0

67.89

68.34

g/l

0.19

242

Other appendicitis

248

2081

1.21

2.11

2.8

2.7

66.32

66.70

g/l

0.34

222

1925

Carcinoma in situ of breast, intraductal

234

1954

1.21

2.10

2.2

1.5

66.69

67.12

g/l

0.36

209

1737

Contusion of toe(s) without damage to nail

399

1.48

2.10

1.6

2.9

66.21

67.52

g/l

0.70

373

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

151

1202

1.27

2.10

2.3

2.2

65.94

67.82

g/l

2.37

144

1134

Hepatocellular carcinoma

562

1.42

2.09

2.1

2.9

65.48

65.79

g/l

0.11

507

Diabetes mellitus in pregnancy

601

3471

1.13

2.08

1.8

2.1

67.02

67.68

g/l

1.43

559

3246

Benign neoplasm: Choroid

198

1632

1.24

2.08

3.1

2.8

66.07

66.42

g/l

0.29

175

1488

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

185

1509

1.24

2.07

2.2

2.6

66.86

67.13

g/l

0.21

171

1396

Adenocarcinoma and papilloma adenocarcinoma of rectum

253

2987

0.84

2.06

2.7

2.6

64.86

66.20

g/l

1.75

224

2704

Sequelae of infectious and parasitic diseases

231

1931

1.21

2.06

3.0

2.5

66.53

66.63

g/l

0.07

208

1765

Alcohol abuse counselling and surveillance

312

1.55

2.05

1.4

2.7

67.18

66.93

g/l

0.07

295

Carcinoma in situ of larynx

2.89

2.04

1.9

2.5

68.24

66.46

g/l

—

Female infertility, tubal origin

109

836

1.32

2.04

2.1

2.3

67.71

67.56

g/l

0.08

783

Torsion of ovary, ovarian pedicle and fallopian tube

377

1.49

2.04

1.8

2.3

67.38

66.90

g/l

0.25

353

conjunctival degenerations and deposits

547

1.41

2.03

3.1

2.8

67.25

66.78

g/l

0.23

494

Benign neoplasm: Skin of lower limb, including hip

563

1.40

2.02

3.2

1.5

66.63

67.49

g/l

0.47

507

Tooth eruption problems

242

2010

1.20

2.01

2.9

2.2

66.56

67.43

g/l

1.18

233

1880

Benign neoplasm: Brain, supratentorial

273

1.58

2.01

1.9

1.5

68.52

67.88

g/l

0.21

244

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

242

2036

1.20

2.01

2.0

2.5

66.25

66.99

g/l

0.79

225

1864

Other and unspecified injuries of shoulder and upper arm

641

1.37

2.01

2.3

2.8

67.23

66.95

g/l

0.11

585

Other disorders of optic disc

250

1.61

2.00

1.6

2.7

65.23

67.20

g/l

0.77

228

Mixed conductive and sensorineural hearing loss

432

3807

1.15

1.99

2.7

2.6

65.23

66.18

g/l

1.64

382

3432

Struck by thrown, projected or falling objec

128

1009

1.29

1.98

2.3

2.7

66.59

66.74

g/l

0.09

118

939

Vertical strabismus

729

1.34

1.98

2.2

3.0

65.58

66.69

g/l

0.75

673

Alzheimer’s disease (Late onset), excluding more controls

577

3441

1.13

1.98

2.1

2.7

65.37

65.84

g/l

0.68

461

3081

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

2.50

1.97

1.8

1.6

66.00

68.24

g/l

0.48

Undefined dementia

320

3402

0.86

1.97

1.7

2.2

64.20

65.53

g/l

2.19

262

2913

Respiratory tuberculosis, clinically confirmed

316

1.54

1.97

1.9

3.0

67.26

66.00

g/l

0.57

282

Disturbances of smell and taste

129

1021

1.29

1.96

2.4

3.1

66.36

66.81

g/l

0.27

119

935

Moderate mental retardation

2.04

1.96

2.6

3.9

70.36

65.54

g/l

1.99

Benign neoplasm: Skin of trunk

129

1021

1.29

1.96

3.9

2.9

67.09

66.68

g/l

0.31

116

935

Other sexually transmitted chlamydial diseases

100

762

1.32

1.95

1.8

68.49

68.29

g/l

0.11

720

Spontaneous abortion

1115

8206

0.92

1.93

2.5

2.6

67.09

66.80

g/l

0.69

1011

7504

Contact with other hot fluids

550

1.39

1.93

1.5

3.1

65.73

66.83

g/l

0.62

510

Dementia in other diseases classified elsewhere

159

1293

1.25

1.93

1.5

2.7

65.86

66.17

g/l

0.21

129

1171

Effects of foreign body entering through natural orifice

741

6736

1.11

1.93

2.6

2.5

66.79

66.68

g/l

0.15

681

6220

Hypothermia

425

1.45

1.93

1.7

2.9

62.51

66.32

g/l

2.24

393

Convergent concomitant strabismus

134

1065

1.27

1.93

2.5

2.7

67.13

67.00

g/l

0.07

126

992

Erythema ab igne [dermatitis ab igne]

4.91

1.92

1.0

1.2

68.32

66.83

g/l

—

Outcome of delivery

216

1604

0.83

1.92

1.8

2.2

67.71

67.93

g/l

0.17

203

1495

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

2.45

1.90

1.7

3.3

66.00

66.78

g/l

0.14

Nontraumatic intracranial haemmorrhage

732

6661

1.11

1.89

2.4

2.5

65.35

66.08

g/l

1.67

640

5921

Burn and corrosion of wrist and hand

690

1.34

1.89

2.1

2.7

66.88

67.13

g/l

0.14

636

Burn and corrosion of trunk

631

1.36

1.88

1.8

2.8

66.02

66.89

g/l

0.47

580

Striae atrophicae

183

1.69

1.88

1.8

2.7

66.76

67.22

g/l

0.12

171

Ankylosing hyperostosis [Forestier]

312

1.53

1.87

3.8

2.7

67.89

66.50

g/l

0.60

286

Foreign body in respiratory tract

144

1161

1.26

1.87

2.3

2.8

66.48

66.55

g/l

0.03

130

1062

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

3.30

1.86

1.6

1.7

60.59

65.19

g/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

634

5690

1.11

1.86

2.3

66.76

67.13

g/l

0.62

572

5252

Degenerative diseases of the nervous system

1206

9755

0.92

1.85

2.0

2.4

65.31

65.77

g/l

1.16

974

8623

Hydrocephalus

264

2260

1.18

1.85

2.3

2.6

67.18

66.19

g/l

1.29

232

2030

Other osteochondropathies

192

1596

1.22

1.85

3.0

2.6

66.19

66.95

g/l

0.65

175

1481

Crossbite

133

983

1.27

1.84

2.4

2.8

66.58

67.02

g/l

0.29

120

922

Injury of urinary and pelvic organs

412

1.44

1.83

3.1

2.8

65.63

66.61

g/l

0.40

377

Other and unspecified degenerative diseases of nervous system

636

1.36

1.83

1.4

2.8

65.91

65.93

g/l

0.01

570

Spermatocele

264

2262

1.18

1.83

2.2

2.5

66.15

66.40

g/l

0.22

250

2049

Foreign body entering into or through eye or natural orifice

225

1900

1.20

1.83

2.6

2.7

65.60

66.68

g/l

1.18

201

1764

Carcinoma in situ of other and unspecified sites

113

891

1.30

1.82

2.6

1.6

65.99

66.78

g/l

0.55

101

798

Disorders of brain, other and unspecified

201

1.65

1.82

1.3

2.3

63.36

66.99

g/l

1.30

179

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

532

1.38

1.81

1.4

1.6

65.56

66.37

g/l

0.41

464

Increased muscle tone

132

1.82

1.81

4.1

3.9

65.29

66.26

g/l

0.21

122

Open bite

721

1.32

1.79

1.6

2.4

67.28

67.30

g/l

0.01

678

Unspecified dementia

318

3290

0.86

1.79

1.8

2.4

64.20

65.62

g/l

2.44

261

2864

Vasomotor rhinitis (mode)

219

1851

1.20

1.78

2.0

2.8

66.49

66.42

g/l

0.05

194

1696

Malignant neoplasm of bladder

266

2287

1.18

1.78

2.2

2.5

65.53

65.90

g/l

0.31

236

2051

Vascular syndromes of brain in cerebrovascular disorders

167

1380

1.23

1.77

2.8

2.7

66.06

g/l

0.00

156

1263

Foreign body or object entering through skin

165

1359

1.23

1.76

2.3

2.8

66.25

66.99

g/l

0.76

152

1257

Melanocytic naevi of scalp and neck

466

1.40

1.76

3.0

66.49

66.85

g/l

0.14

431

Polycystic ovarian syndrome, broad definition

174

1437

1.22

1.76

1.6

1.9

68.04

67.93

g/l

0.08

164

1341

Congenital malformations of genital organs

196

1629

1.21

1.76

2.2

2.5

66.67

67.12

g/l

0.41

184

1512

Dental pulpitis 3, only avohilmo

151

893

1.24

1.76

1.8

67.23

67.49

g/l

0.15

143

850

Supervision of high-risk pregnancy

406

2160

1.14

1.76

2.0

2.2

67.39

67.64

g/l

0.29

381

2018

Retinal breaks without detachment

521

4685

1.12

1.75

2.6

66.47

66.37

g/l

0.12

464

4269

Certain conditions originating in the perinatal period

134

954

1.25

1.74

3.1

2.5

65.53

67.10

g/l

1.19

127

899

Thromboangiitis obliterans

2.05

1.73

1.5

3.1

63.08

66.63

g/l

1.11

Pneumonia due to Haemophilus influenzae

2.23

1.73

6.5

2.9

68.47

67.63

g/l

0.14

Chalazion

330

2886

1.15

1.73

3.3

2.6

66.85

66.55

g/l

0.32

304

2648

Use of galantamine

184

2192

0.83

1.72

1.4

2.4

67.03

65.53

g/l

1.86

154

1897

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

129

1041

1.26

1.71

2.6

2.8

64.91

66.54

g/l

1.86

119

949

Fourth [trochlear] nerve palsy

556

1.37

1.71

1.7

3.2

67.41

66.70

g/l

0.41

508

Renal cell carcinoma of kidney

124

999

1.27

1.69

2.8

2.9

65.74

66.00

g/l

0.13

115

904

Endometriosis ASRM stages 3,4

655

5968

1.10

1.68

2.3

2.4

66.69

66.67

g/l

0.03

590

5389

Benign neoplasm: Prostate

183

1.67

3.9

3.0

64.34

66.00

g/l

0.56

159

Viral haemorrhagic fevers, not elsewhere classified/unspecified

239

2049

1.18

1.66

3.0

2.7

65.32

66.68

g/l

1.83

229

1898

Complications of labour and delivery

1683

9955

0.94

1.66

2.7

2.5

67.11

66.72

g/l

1.27

1551

9056

Sequelae of other and unspecified infectious and parasitic diseases

142

1160

1.24

1.66

2.5

2.6

67.06

67.40

g/l

0.21

129

1081

Benign neoplasm: Rectum/anal canal icd-9

214

1.60

1.66

1.6

1.4

66.29

66.55

g/l

0.08

182

Graves disease, strict definition

251

2159

1.17

1.65

2.3

2.6

65.75

67.02

g/l

1.93

229

1977

L02BG Aromatase inhibitors

981

9107

1.08

1.65

2.6

2.7

66.34

66.33

g/l

0.01

874

8159

Eustachian salpingitis and obstruction

165

1368

1.22

1.65

2.4

2.3

66.67

67.59

g/l

0.84

157

1282

Injury of nerves at wrist and hand level

100

786

1.29

1.64

3.8

2.9

67.21

66.93

g/l

0.13

721

Benign neoplasm: Lip

543

1.36

1.63

3.6

3.0

66.47

66.75

g/l

0.10

489

Procedures for purposes other than remedying health state

516

1.36

1.63

2.0

2.3

66.05

67.63

g/l

1.17

478

Scar conditions and fibrosis of skin

104

823

1.28

1.62

2.6

2.7

65.88

67.08

g/l

0.73

753

Primary angle-closure glaucoma

155

1285

1.23

1.62

2.2

2.8

66.01

66.05

g/l

0.02

135

1154

Malignant neoplasm of vulva

241

1.56

1.61

2.5

3.1

64.93

66.85

g/l

0.76

218

Other fall from one level to another

658

6008

1.10

1.61

2.5

66.36

66.55

g/l

0.28

604

5527

Benign neoplasm of male genital organs

545

1.36

1.61

3.2

2.8

65.88

65.91

g/l

0.01

500

Coalworker pneumoconiosis

3.89

1.60

1.8

2.5

60.20

66.84

g/l

—

Beningn neoplasm: Meninges, unspecified

348

1.45

1.60

2.5

1.6

65.47

67.33

g/l

1.09

306

LSIL lesion of the vulva

605

1.33

1.60

1.7

2.6

64.99

67.71

g/l

1.92

565

Benign neoplasm: Liver

441

1.39

1.59

2.3

3.0

66.39

67.44

g/l

0.53

401

Infections of genitourinary tract in pregnancy

229

1963

1.18

1.58

2.6

2.5

66.60

67.02

g/l

0.40

212

1788

Other drug-induced osteomalacia in adults

3.73

1.58

1.0

3.1

67.22

66.12

g/l

—

Other corneal oedema

186

1.63

1.57

3.9

3.1

66.00

66.64

g/l

0.14

167

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

2.14

1.56

3.3

3.2

68.58

66.06

g/l

0.60

Graves ophthalmopathy, strict

486

1.37

1.56

1.4

2.7

65.77

67.27

g/l

0.82

447

Femoral hernia

151

1253

1.22

1.56

2.5

2.6

66.42

66.40

g/l

0.01

134

1153

Polyp of middle ear

2.69

1.56

3.1

1.8

64.37

66.63

g/l

—

Benign neoplasm: other/unspecified salivary gland

741

1.30

1.56

2.0

3.0

65.72

66.52

g/l

0.50

673

170

1.65

1.55

2.6

2.4

66.22

67.90

g/l

0.52

157

Hand

101

1.86

1.55

2.4

1.9

67.75

67.63

g/l

0.02

Colorectal adenocarcinoma

622

6796

0.91

1.54

2.5

65.00

66.06

g/l

2.45

549

6062

Pregnancy with abortive outcome

2167

10774

1.05

1.54

2.3

2.6

66.63

66.56

g/l

0.15

1935

9698

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

185

1562

1.19

1.54

2.2

2.6

66.86

67.34

g/l

0.43

171

1446

Alzheimer’s disease (Atypical or mixed), excluding more controls

262

1968

1.16

1.54

2.2

2.5

64.37

65.75

g/l

1.69

206

1732

Other disorders of male genital organs

100

794

1.28

1.53

2.8

2.9

65.62

66.97

g/l

1.15

742

Other porphyria

2.60

1.53

3.0

1.6

69.63

68.11

g/l

—

Pneumoconiosis due to asbestos and other mineral fibres

655

1.31

1.53

1.7

2.5

67.47

65.71

g/l

1.38

588

Dislocation, sprain and strain of joints and ligaments of knee

1890

16668

1.06

1.53

2.2

2.6

66.69

66.96

g/l

0.86

1722

15409

Preterm labour and delivery

650

5954

1.10

1.50

2.9

2.5

66.93

66.96

g/l

0.04

599

5485

Benign neoplasm: Skin of upper limb, including shoulder

386

1.40

1.50

4.0

1.6

64.45

67.90

g/l

2.00

349

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

125

1.75

1.50

4.3

1.9

68.14

67.23

g/l

0.20

109

Congenital ichthyosis

2.16

1.50

4.5

2.2

65.24

66.95

g/l

0.31

Brain meningioma

162

1360

1.21

1.50

2.3

2.8

65.35

66.37

g/l

1.04

146

1223

Malignant neoplasm of thyroid gland

197

1681

1.19

1.49

3.0

2.8

67.02

66.61

g/l

0.33

184

1533

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

374

3337

1.13

1.49

2.5

1.6

65.14

66.53

g/l

2.48

329

2916

Malignant neoplasm of rectum

263

3005

0.87

1.49

2.5

2.6

64.61

66.21

g/l

2.51

237

2724

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

363

1.42

1.49

2.3

2.9

65.35

65.97

g/l

0.20

322

Pedal cyclist injured in noncollision transport accidents

300

2639

1.15

1.48

1.8

2.6

66.27

66.77

g/l

0.58

269

2438

Poor fetal growth

197

1677

1.18

1.48

1.5

2.1

67.88

67.77

g/l

0.07

181

1570

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

3.38

1.48

1.8

1.3

68.20

66.04

g/l

—

Lesion of sciatic nerve

163

1372

1.21

1.47

1.7

2.6

67.15

65.86

g/l

1.23

148

1230

Other perinatal haematological disorders

3.30

1.46

1.2

3.3

64.84

59.65

g/l

—

Disorders of pituitary gland, other and/or unspecified

126

1.74

1.46

2.1

2.2

61.66

67.31

g/l

1.82

115

Pedestrian injured in transport accident

196

1675

1.18

1.46

1.9

2.6

66.68

66.50

g/l

0.13

172

1536

Non-allergic asthma

268

2345

1.15

1.45

2.5

2.8

66.95

66.30

g/l

0.66

252

2138

Carcinoma in situ, bladder

102

821

1.27

1.44

2.8

1.6

65.87

66.71

g/l

0.55

738

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

158

1.65

1.44

1.8

1.7

64.88

66.63

g/l

0.68

137

Embedded teeth, including avohilmo

165

1389

1.20

1.43

3.2

2.2

66.56

67.57

g/l

1.25

158

1297

Disorders of lacrimal system and orbit in diseases classified elsewhere

555

1.32

1.43

1.3

2.7

66.14

67.29

g/l

0.65

509

Benign neoplasm: Tongue

706

1.29

1.43

3.9

2.9

66.10

66.98

g/l

0.53

641

Acute alcohol intoxication ICD-9

110

894

1.25

1.42

1.5

2.9

65.96

66.33

g/l

0.20

820

Benign neoplasm of other and unspecified sites

788

1.27

1.40

2.7

2.9

65.35

66.77

g/l

1.03

718

Other benign neoplasm of uterus: Other parts/unspecified

143

1198

1.21

1.39

3.2

1.5

66.15

66.26

g/l

0.06

116

1016

Allergic colitis

247

1.47

1.38

3.0

2.6

62.82

66.09

g/l

1.18

234

Contact with lifting and transmission devices, not elsewhere classified

394

1.38

1.36

2.1

3.0

67.86

66.92

g/l

0.40

362

Severe combined immunodeficiency [SCID] with reticular dysgenesis

2.00

1.35

1.2

3.1

64.15

66.57

g/l

0.57

Papillary adenocarcinoma of thyroid gland

149

1255

1.20

1.35

2.9

2.8

66.93

66.67

g/l

0.16

141

1137

Other benign neoplasms of uterus

174

1488

1.19

1.33

3.2

1.5

65.92

66.42

g/l

0.32

139

1276

HSIL lesion of the vulva

379

1.38

1.32

1.6

2.8

64.54

67.76

g/l

1.53

347

Benign neoplasm of breast

364

3271

1.12

1.31

2.4

2.5

66.30

66.51

g/l

0.23

321

2936

Other benign neoplasm of uterus: Corpus uteri

162

1.60

1.31

3.8

1.3

65.08

68.09

g/l

0.75

143

Desensitization to allergens

756

1.25

1.31

2.5

2.2

68.21

67.77

g/l

0.27

713

Disorders of muscle tone of newborn

2.93

1.31

1.2

1.9

63.90

59.41

g/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

311

1.42

1.31

2.7

1.6

66.88

67.66

g/l

0.27

277

Carcinoma in situ of larynx

2.26

1.31

1.9

4.4

68.24

66.15

g/l

—

Purulent endophthalmitis

155

1.62

1.30

3.8

3.2

66.94

66.10

g/l

0.16

140

Wilms' tumor

147

1.63

1.29

4.7

2.0

65.07

66.28

g/l

0.28

133

Kela-code for behavioural disturbances in mental retardation

190

0.51

1.29

1.6

2.4

60.76

66.19

g/l

—

174

Intentional self-harm by sharp object

311

1.40

1.28

1.9

2.7

64.15

67.66

g/l

1.58

288

Melanocytic naevi of other and unspecified parts of face

138

1160

1.20

1.27

2.8

1.5

67.43

67.38

g/l

0.02

129

1046

Simple and mucopurulent chronic bronchitis

137

1154

1.20

1.26

1.8

2.8

66.42

65.93

g/l

0.29

121

1035

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

461

1.33

1.25

2.3

1.6

66.55

67.00

g/l

0.19

409

Graves ophthalmopathy

558

1.30

1.25

1.4

2.8

66.04

67.43

g/l

0.83

515

Other and unspecified intracranial injuries

683

1.26

1.24

1.9

2.7

67.12

66.33

g/l

0.42

622

Infections specific to the perinatal period

108

1.69

1.24

1.3

3.7

63.66

63.72

g/l

0.01

100

Hypertrophy of breast in women and men

518

4751

1.10

1.24

2.2

2.5

66.65

66.83

g/l

0.23

479

4370

Dementia due to Parkinsons disease, excluding more controls

515

1.31

1.24

1.5

2.5

64.84

65.96

g/l

0.45

461

Benign neoplasm: Conjunctiva

765

1.25

1.23

1.9

3.2

65.28

66.82

g/l

1.62

701

Carcinoma in situ of cervix uteri

156

1328

1.18

1.23

2.3

1.5

66.67

67.59

g/l

0.97

142

1216

Macular hole

191

1659

1.17

1.23

2.7

2.8

65.92

66.10

g/l

0.11

172

1502

Pedal cyclist injured in transport accident

629

5819

1.09

1.23

2.2

2.5

66.60

66.68

g/l

0.10

565

5350

Laparoscopic right hemicolectomy

187

1623

1.17

1.22

2.4

2.8

65.93

66.39

g/l

0.33

161

1476

Deep bite

245

1888

1.14

1.21

3.6

2.7

66.76

66.81

g/l

0.03

223

1755

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

1.92

1.21

4.0

1.2

65.92

67.43

g/l

0.22

Carcinoma in situ of uteri, other/unspecified

127

0.46

1.21

4.3

2.1

67.33

67.42

g/l

—

118

Urticaria due to cold and heat

141

1.60

1.21

1.7

2.3

68.57

67.48

g/l

0.32

129

Embolic stroke

163

1399

1.18

1.21

1.7

2.6

65.35

65.95

g/l

0.43

146

1253

Endometriosis of rectovaginal septum and vagina

224

1967

1.15

1.21

2.2

2.4

66.81

66.20

g/l

0.67

196

1768

Benign neoplasm: Skin of lip

334

1.38

1.20

3.6

2.5

69.14

66.86

g/l

1.12

298

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

120

1001

1.21

1.20

2.4

2.2

67.18

67.54

g/l

0.26

112

937

Unspecified lump in breast

464

4246

1.10

1.19

2.2

2.5

66.72

66.55

g/l

0.21

420

3822

LSIL lesion of the vagina

274

1.42

1.19

1.7

2.7

66.35

67.50

g/l

0.37

249

HSIL lesion of the cervix uteri, vagina or vulva

402

3650

1.11

1.19

2.3

66.78

67.21

g/l

0.55

363

3364

Malignant neoplasm of stomach

172

1486

1.17

1.19

2.1

2.6

62.13

66.17

g/l

7.94

159

1338

Abscess of Bartholin gland

464

1.31

1.19

2.9

2.7

67.68

67.64

g/l

0.01

438

Drug-induced autoimmune haemolytic anaemia

2.20

1.19

5.4

1.3

68.09

66.50

g/l

—

Benign neoplasm of thyroid gland

733

1.25

1.18

2.5

1.5

68.52

67.46

g/l

0.73

653

Carcinoma in situ of middle ear and respiratory system

103

1.73

1.18

1.6

1.9

68.14

66.85

g/l

0.34

Histrionic personality disorder

111

1.69

1.17

1.3

2.5

67.18

66.95

g/l

0.04

100

Carcinoma in situ of breast, other/unspecified

328

1.38

1.16

2.3

1.4

68.81

67.55

g/l

0.45

293

Severe visual impairment, binocular

104

1.70

1.14

2.6

2.4

62.70

65.56

g/l

0.58

Periodontal disease, other/unspecified

1.81

1.14

3.4

2.4

64.58

65.40

g/l

0.16

Vascular dementia (subcortical)

102

847

1.23

1.14

2.4

65.57

65.58

g/l

0.01

755

Other disorders of breast

337

3045

1.11

1.13

2.2

2.5

66.93

66.65

g/l

0.32

294

2762

Other and/or unspecified nontoxic goitre

254

2261

1.13

2.2

2.7

66.61

66.50

g/l

0.09

229

2032

Generalized epilepsy

781

1.23

1.13

2.7

2.8

66.86

66.93

g/l

0.03

724

Benign lipomatous neoplasm of other sites/unspecified

293

2631

1.12

1.13

3.0

2.6

66.01

66.33

g/l

0.30

265

2388

Acute appendicitis, with complications

636

5913

1.08

1.13

2.6

2.5

66.31

66.54

g/l

0.31

580

5422

Embolism and thrombosis of abdominal aorta

2.07

1.13

1.1

2.6

66.33

67.18

g/l

—

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

2.35

1.12

1.6

1.3

57.24

65.06

g/l

—

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

112

1.66

1.12

3.5

1.6

67.30

67.19

g/l

0.03

105

Benign neoplasm: Extrahepatic bile ducts

1.97

1.12

1.4

1.3

68.37

67.97

g/l

0.09

Sequelae of tuberculosis

523

1.29

1.12

3.3

2.4

65.85

65.34

g/l

0.19

455

Schizotypal disorder

398

1.32

1.12

1.6

2.6

66.99

67.92

g/l

0.35

374

Macular cyst

722

1.24

1.12

2.7

3.2

64.58

66.24

g/l

1.30

657

Injury of blood vessels at lower leg level

1.72

1.11

1.6

2.9

67.51

67.04

g/l

0.09

All dysplastic lesions of the vagina

523

1.28

1.11

2.5

2.8

67.43

67.52

g/l

0.03

486

Endometriosis diagnosis and infertility diagnosis occurring together

215

1894

1.14

1.11

2.4

2.5

67.62

67.41

g/l

0.18

196

1757

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

139

1188

1.18

1.11

1.7

1.6

65.64

66.42

g/l

0.54

128

1039

Other and unspecified injuries of thorax

356

1.34

1.10

1.8

2.9

65.28

67.01

g/l

1.08

322

Acrodermatitis continua

2.14

1.10

1.4

1.7

67.42

65.98

g/l

—

Contraceptive management

965

7196

0.94

1.09

2.5

2.4

67.44

67.22

g/l

0.42

898

6730

Iliotibial band syndrome

203

1.46

1.08

2.9

3.3

66.63

67.03

g/l

0.09

190

Short stature, not elsewhere classified

213

1.42

1.07

3.7

3.9

63.25

64.33

g/l

0.27

206

Paranoid personality disorder

349

1.34

1.07

2.7

3.1

68.00

67.18

g/l

0.29

320

Benign neoplasm: Skin of scalp and neck

589

1.26

1.07

2.4

2.9

66.88

66.60

g/l

0.12

537

Loose body in joint

508

1.28

1.07

2.1

2.9

66.59

66.26

g/l

0.13

467

Inflammatory disorders of breast

136

1163

1.18

1.07

2.6

2.5

66.66

67.27

g/l

0.44

122

1068

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

590

1.26

1.06

3.0

65.45

66.74

g/l

0.78

539

Abscess of mediastinum

2.02

1.06

1.9

4.1

61.31

66.40

g/l

—

Abnormal spermatozoa

428

3935

1.10

1.05

2.4

2.7

66.01

66.09

g/l

0.08

387

3573

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

383

3500

1.10

1.05

2.6

1.6

64.71

66.73

g/l

5.01

346

3095

Benign lipomatous neoplasm of of intra-abdominal organs

1.86

1.05

4.5

2.4

65.13

66.75

g/l

0.40

Other and unspecified disease of Bartholin gland

699

1.24

1.05

2.6

2.9

65.99

66.69

g/l

0.31

639

Divergent concomitant strabismus

195

1716

1.15

1.05

2.2

2.6

66.34

66.79

g/l

0.34

182

1579

Benign lipomatous neoplasm

994

9407

1.06

1.05

2.8

2.6

66.39

66.45

g/l

0.10

902

8538

Disorders of aromatic amino-acid metabolism

1.97

1.05

1.8

2.2

67.73

66.88

g/l

—

Vascular dementia

301

2629

1.12

1.04

2.2

2.3

64.79

65.49

g/l

0.75

241

2291

Burn and corrosion of hip and lower limb, except ankle and foot

448

1.29

1.04

1.4

2.9

66.49

66.86

g/l

0.12

407

Other and unspecified hydrocephalus

449

1.29

1.03

2.2

2.9

66.95

66.19

g/l

0.29

404

Glaucoma-related operations

189

1666

1.15

1.03

2.6

2.7

66.19

66.11

g/l

0.05

167

1495

Use of biperiden

146

1262

1.17

1.03

2.0

2.7

65.14

66.63

g/l

1.25

125

1164

Obstructed labour due to malposition and malpresentation of fetus

359

3708

0.91

1.02

2.0

2.3

67.56

67.36

g/l

0.21

336

3460

Benign neoplasm: Vertebral column

1.93

1.02

5.0

1.3

64.86

68.06

g/l

—

Neuroendocrine tumor and carcinoma of small intestine

336

1.34

1.02

3.2

3.4

64.71

66.69

g/l

0.93

306

Malignant neoplasm of head and neck

272

2451

1.12

1.01

2.3

2.7

65.00

66.17

g/l

1.60

249

2229

Carcinoma in situ of other and unspecified genital organs

353

1.33

1.01

1.9

1.4

63.09

67.80

g/l

2.12

320

Impacted teeth

295

2478

1.11

1.01

2.2

2.1

66.76

67.53

g/l

1.02

283

2326

Benign neoplasm of brain and other parts of central nervous system

189

1667

1.14

1.01

2.9

2.7

66.29

66.52

g/l

0.15

165

1530

Complications following abortion and ectopic and molar pregnancy

105

886

1.20

1.00

2.2

2.9

66.57

66.84

g/l

0.16

805

Kaposi sarcoma

2.06

1.00

1.6

4.0

60.59

65.02

g/l

—

Use of ropinirole

121

1035

1.19

1.00

2.0

3.0

66.01

66.42

g/l

0.22

947

Diseases of thymus

1.88

1.00

2.0

2.8

65.02

66.81

g/l

—

Malignant neoplasm of oral cavity

106

897

1.20

0.99

1.9

3.0

64.94

66.35

g/l

0.96

815

Pregnancy, childbirth and the puerperium

922

5108

0.94

0.99

2.3

2.4

66.34

66.25

g/l

0.13

813

4491

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

240

2151

1.13

0.99

2.1

2.8

66.41

66.54

g/l

0.10

219

1964

Pedestrian injured in collision with car, pick-up truck or van

550

1.25

0.99

1.6

2.9

67.52

66.97

g/l

0.25

499

Transient global amnesia

266

2945

0.89

0.99

2.3

2.6

65.55

66.42

g/l

1.02

232

2680

Benign neoplasm of ovary

538

5005

1.08

0.98

2.7

2.6

65.82

66.52

g/l

1.38

493

4482

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

171

1501

1.15

0.98

2.7

1.6

66.25

67.32

g/l

1.22

157

1358

Labour and delivery complicated by umbilical cord complications

106

896

1.19

0.98

2.8

2.5

67.86

67.47

g/l

0.22

100

834

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

1161

0.84

0.97

2.6

68.06

66.83

g/l

1.16

1063

163

1422

1.15

0.97

2.7

2.3

65.80

65.82

g/l

0.01

150

1226

Other specified/unspecified deforming dorsopathies

364

1.31

0.97

2.4

2.9

66.62

67.31

g/l

0.23

343

Colour vision deficiencies

1.83

0.96

1.5

3.0

69.95

66.15

g/l

1.18

Antepartum haemorrhage, not elsewhere classified

146

1268

1.16

0.96

2.0

2.1

67.99

67.85

g/l

0.08

137

1192

Inflammatory disease of cervix uteri

188

1665

1.14

0.95

2.3

2.5

66.62

66.60

g/l

0.01

166

1505

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

110

1.61

0.95

2.6

1.2

67.91

66.50

g/l

0.31

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

144

0.55

0.95

2.1

2.5

64.50

66.57

g/l

—

134

Maternal care for known or suspected malpresentation of fetus

245

2034

0.90

0.95

2.3

2.1

67.42

67.90

g/l

0.52

234

1899

Operations 1 for CAVS

1.85

0.95

1.6

3.4

63.12

65.50

g/l

0.51

Maternal care related to the fetus and amniotic cavity and possible delivery problems

957

5948

0.94

2.4

2.3

67.73

67.29

g/l

1.19

898

5496

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

622

5826

1.07

0.94

2.5

1.6

65.00

66.59

g/l

4.88

549

5138

Accidental poisoning by and exposure to other gases and vapours

102

1.62

0.94

1.3

2.7

64.71

67.09

g/l

0.51

Squamous cell neoplasms and carcinoma of cervix

118

1.57

0.94

3.5

2.4

67.30

67.12

g/l

0.05

110

Carcinoma in situ of oesophagus

2.25

0.94

1.0

1.2

64.27

66.74

g/l

—

Mucinous and mucinous cystic tumor of rectum

127

0.53

0.93

1.1

2.8

64.49

66.49

g/l

—

117

Congenital malformation of optic disc

2.23

0.93

1.0

4.0

66.73

64.98

g/l

—

Congenital malformations of spine and bony thorax

1.64

0.93

1.9

2.7

66.21

66.33

g/l

0.02

L02BX Other hormone antagonists and related agents

194

1729

1.14

0.93

3.4

2.6

65.00

65.76

g/l

0.72

166

1579

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

185

1.44

0.93

2.8

3.6

65.34

66.66

g/l

0.45

171

Dental caries 2, only avohilmo

2379

18143

1.04

0.92

2.6

2.5

67.43

66.74

g/l

4.85

2157

16707

Bacterial meningitis

812

1.20

0.91

3.0

2.9

65.98

66.85

g/l

0.42

748

Dysplasia of cervi uteri

569

4109

1.07

0.91

2.5

2.2

66.91

66.81

g/l

0.11

516

3760

Nontoxic diffuse goitre

795

1.20

0.90

2.8

66.58

66.97

g/l

0.23

721

Cardiovascular disorders originating in the perinatal period

1.96

0.90

1.4

4.2

65.89

63.20

g/l

—

Sickle-cell disorders

1.94

0.90

2.9

2.6

64.61

65.53

g/l

—

Benign neoplasm: Skin, unspecified

114

980

1.18

0.90

2.2

2.8

65.62

66.59

g/l

0.66

102

888

Rickettsioses

1.93

0.90

1.5

2.1

64.95

66.31

g/l

—

Female infertility

747

4344

1.06

0.90

2.4

2.3

67.17

66.95

g/l

0.33

682

4002

Pregnancy examination and test

264

1487

1.11

0.90

1.8

2.0

67.81

67.92

g/l

0.09

254

1384

Burn and corrosion confined to eye and adnexa

431

1.27

0.89

2.4

2.7

67.03

67.08

g/l

0.02

401

Burns and corrosions confined to eye and internal organs

512

1.25

0.89

2.7

66.79

67.25

g/l

0.19

472

Malignant neoplasm of penis

1.67

0.89

2.9

2.4

67.36

66.66

g/l

0.10

Other endophthalmitis

112

1.57

0.88

4.7

3.1

68.66

66.19

g/l

0.65

Other benign neoplasm of uterus: Corpus uteri

179

1.44

0.88

3.8

2.5

65.08

66.94

g/l

0.40

162

Multiple delivery

158

1789

0.88

0.87

3.3

2.2

67.94

66.85

g/l

1.22

151

1636

Pedal cyclist injured in other and unspecified transport accidents

294

2685

1.10

0.86

2.6

66.90

66.62

g/l

0.25

266

2476

Family history of certain disabilities and chronic diseases leading to disablement

714

1.20

0.86

1.4

2.6

65.79

67.90

g/l

1.67

663

Malignant neoplasm of vagina

1.85

0.86

5.9

2.6

62.61

66.66

g/l

—

Contact with sharp glass

660

1.21

0.86

2.4

2.5

67.93

67.28

g/l

0.32

615

Chronic mastoiditis

708

1.20

0.86

2.0

2.8

66.80

66.15

g/l

0.33

640

Carcinoma in situ of uteri, other/unspecified

112

0.52

0.85

4.3

1.2

67.33

67.71

g/l

—

103

Male infertility

716

1.20

0.84

1.6

2.7

67.50

67.45

g/l

0.02

682

Carcinoma in situ of prostate

122

1.53

0.83

2.6

2.0

68.91

66.98

g/l

0.47

106

Carcinoma in situ of oesophagus

1.95

0.82

1.0

1.9

64.27

66.70

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

120

1042

1.16

0.82

2.4

2.2

67.18

67.76

g/l

0.46

112

982

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

152

1346

1.14

0.82

1.8

2.7

65.33

66.07

g/l

0.46

132

1213

Toxic effects of substances chiefly nonmedicinal as to source

288

2636

1.10

0.82

2.1

2.7

66.50

66.80

g/l

0.26

269

2441

Other disorders of prostate

110

953

1.17

0.81

2.9

2.6

66.71

66.20

g/l

0.30

103

870

Thyroid crisis or storm

1.73

0.81

1.0

2.6

64.59

69.10

g/l

—

All dysplastic lesions of the cervix uteri

504

4706

1.07

0.81

2.4

2.3

66.98

67.20

g/l

0.27

459

4354

Vascular dementia (undefined)

122

1055

1.16

0.80

1.9

2.2

64.89

65.24

g/l

0.16

919

Myocardial infarction, unclassifiable

803

7536

0.95

0.80

2.3

2.4

64.88

65.80

g/l

2.74

727

6627

LSIL lesion of the cervix uteri, vagina or vulva

286

2619

1.10

0.80

2.4

2.5

66.30

67.32

g/l

1.37

259

2416

Contact with nonpowered hand tool

112

972

1.16

0.80

2.0

2.8

67.85

66.67

g/l

1.06

105

904

Major anomalies of jaw size

511

1.23

0.79

1.9

2.8

66.29

67.29

g/l

0.51

479

Fall on and from ladder

240

2185

1.11

0.79

3.1

2.8

66.43

66.46

g/l

0.02

222

2011

Other disorders of choroid

341

1.29

0.79

2.1

3.0

67.01

66.22

g/l

0.26

310

Benign neoplasm: Extrahepatic bile ducts

1.72

0.79

1.4

3.2

68.37

67.18

g/l

0.29

Dislocations, sprains and strains involving multiple body regions

2.31

0.79

1.4

1.3

72.08

64.84

g/l

—

Perineal laceration during delivery

219

2155

0.90

0.78

2.0

67.88

67.68

g/l

0.17

204

2001

Seminoma of testis, excluding all cancers (controls excluding all cancers)

132

1.46

0.77

1.9

64.52

67.78

g/l

1.03

117

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

706

1.19

0.77

1.8

2.9

68.18

66.68

g/l

1.16

653

Benign neoplasm: Brain, supratentorial

333

1.28

0.77

1.9

3.0

68.52

66.97

g/l

0.64

301

Benign neoplasm: Brain, infratentorial

133

0.59

0.76

1.3

3.6

64.83

66.59

g/l

—

125

Malignant melanoma of skin

373

3469

1.08

0.76

2.7

2.6

65.94

66.21

g/l

0.30

334

3151

Other mosquito-borne viral fevers

1.92

0.76

1.9

2.5

63.66

66.70

g/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

668

4231

1.06

0.74

2.5

2.3

67.14

66.94

g/l

0.29

609

3897

Chondromalacia

645

1.19

0.74

2.6

2.7

67.23

67.01

g/l

0.11

600

Vascular dementia (mixed)

399

1.25

0.73

2.3

2.4

64.56

65.68

g/l

0.48

359

Any dementia

1452

10602

0.96

0.73

2.0

2.5

65.03

65.87

g/l

3.53

1191

9396

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

106

925

1.16

0.72

3.0

1.5

67.18

67.42

g/l

0.13

834

Other menopausal disorders

770

4666

0.95

0.72

2.4

2.6

67.01

66.52

g/l

1.07

696

4250

Malignant neoplasm of palate

1.73

0.72

2.4

2.5

65.56

67.15

g/l

—

Hereditary corneal dystrophies

853

1.16

0.71

1.6

3.1

66.63

66.44

g/l

0.09

773

Embedded and impacted teeth

455

3626

1.07

0.71

2.6

2.2

66.73

67.45

g/l

1.36

436

3399

Superficial injury of neck

310

1.27

0.70

1.4

2.8

66.62

67.15

g/l

0.19

284

Malignant neoplasm of breast, HER-positive

1109

10511

1.04

0.70

2.5

2.6

66.49

66.38

g/l

0.18

984

9405

Puerperal sepsis

342

3183

1.08

0.69

2.7

2.6

67.04

g/l

0.00

314

2934

HSIL lesion of the cervix uteri

338

3144

1.08

0.68

2.3

67.04

67.31

g/l

0.28

310

2907

Family history of malignant neoplasm

240

2203

1.09

0.68

3.0

2.4

66.04

67.17

g/l

1.63

222

2019

Benign mammary dysplasia

441

4148

1.07

0.67

2.5

66.47

66.33

g/l

0.14

395

3701

Premature rupture of membranes

340

2682

0.93

0.65

2.2

67.93

67.64

g/l

0.32

314

2496

Dermatitis due to ingested food

371

1.23

0.65

2.7

3.1

67.16

65.88

g/l

0.50

354

Dislocation, sprain and strain of joints and ligaments of elbow

138

1236

1.12

0.65

2.4

2.5

65.98

66.99

g/l

0.91

127

1150

Maternal care for known or suspected abnormality of pelvic organs

430

3155

0.94

0.64

2.7

2.3

66.82

67.47

g/l

1.11

391

2918

Vascular dementia (other)

165

1.37

0.63

1.9

2.6

64.59

64.97

g/l

0.06

149

Glaucoma, exfoliation

395

3712

1.07

0.63

2.5

2.4

66.23

65.78

g/l

0.52

342

3243

Carcinoma in situ of middle ear and respiratory system

122

1.44

0.63

1.6

3.3

68.14

66.13

g/l

0.62

110

Carcinoma in situ of breast, other/unspecified

362

1.24

0.63

2.3

2.8

68.81

67.03

g/l

0.72

326

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

139

1.40

0.63

2.2

1.4

67.04

66.85

g/l

0.03

120

Beningn neoplasm: Meninges, unspecified

408

1.22

0.62

2.5

2.6

65.47

66.43

g/l

0.44

367

Benign neoplasm of other and unspecified female genital organs

110

976

1.14

0.62

2.8

1.4

66.18

67.41

g/l

0.87

865

Rubella [German measles]

741

1.16

0.62

2.6

2.4

67.97

67.19

g/l

0.46

713

Tonsillectomy and adenotomy

1325

9548

0.97

0.62

2.3

67.14

67.05

g/l

0.17

1235

8912

Benign neoplasm: Skin of lower limb, including hip

667

1.17

0.62

3.2

3.0

66.63

67.03

g/l

0.18

611

Pterygium

837

1.15

0.61

2.7

2.9

66.57

66.28

g/l

0.16

765

Vaginal lichen planus

112

0.60

0.61

1.1

2.5

69.11

67.19

g/l

—

100

Valgus deformity, not elsewhere classified

131

1.40

0.61

1.2

3.3

67.49

66.99

g/l

0.12

118

Congenital malformations of ovaries, fallopian tubes and broad ligaments

109

969

1.13

0.59

1.9

2.3

67.75

67.42

g/l

0.22

104

903

Obstructed labour due to maternal pelvic abnormality

353

3759

0.94

0.59

3.0

2.5

66.77

66.97

g/l

0.21

323

3460

Communicating hydrocephalus

549

1.18

0.59

2.0

3.2

67.23

66.25

g/l

0.45

502

Labour and delivery complicated by fetal stress [distress]

338

2409

0.93

0.59

1.8

2.0

67.02

67.71

g/l

1.01

316

2244

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1732

13738

1.03

0.58

2.5

66.60

66.67

g/l

0.14

1582

12540

Gestational diabetes (for exclusion)

663

4477

1.05

0.58

2.1

2.2

67.22

67.48

g/l

0.44

614

4185

Benign neoplasm: Rectum/anal canal icd-9

266

1.26

0.58

1.6

2.8

66.29

65.85

g/l

0.13

232

Diving or jumping into water causing injury other than drowning or submersion

1.54

0.57

1.3

3.2

68.70

67.53

g/l

0.29

Marfan's syndrome

1.48

0.57

1.8

2.9

65.12

67.13

g/l

0.29

Spina bifida

1.67

0.57

1.0

3.4

69.52

66.22

g/l

—

L02BB Anti-androgens

324

3042

1.07

0.57

2.8

2.5

65.58

65.70

g/l

0.11

292

2703

Oesophagitis, drug-induced

1.51

0.55

1.2

1.6

66.98

67.16

g/l

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.51

0.55

1.3

3.1

66.87

66.77

g/l

—

Long labour

421

3884

0.94

0.55

2.3

67.29

67.17

g/l

0.12

396

3603

Benign neoplasm: Skin of upper limb, including shoulder

451

1.19

0.55

4.0

3.2

64.45

66.91

g/l

1.21

413

Toxic effect of ethanol

768

1.14

0.54

1.9

2.5

64.61

67.04

g/l

2.47

712

Other obstetric trauma

761

0.86

0.54

1.9

2.2

68.01

67.93

g/l

0.03

715

Other and unspecified water transport accidents

1.49

0.54

2.8

2.5

64.30

67.05

g/l

—

Acute inflammation of orbit

108

1.41

0.54

6.4

2.2

68.20

67.19

g/l

0.15

103

Acute thyroiditis

1.48

0.53

2.8

2.5

66.82

68.42

g/l

0.54

Vascular dementia (sudden onset)

0.61

0.53

1.7

2.6

63.77

66.29

g/l

—

Deep endometriosis

249

2321

1.08

0.53

2.1

2.4

66.75

66.63

g/l

0.10

219

2093

Chronic diseases of tonsils and adenoids

2536

16405

0.98

0.53

2.4

2.6

67.00

66.69

g/l

1.34

2340

15096

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

1.45

0.52

3.7

2.1

67.73

67.70

g/l

0.01

Adrenomedullary hyperfunction

1.42

0.52

1.7

3.2

66.03

66.85

g/l

—

Other benign neoplasm of uterus: Other parts/unspecified

143

1306

1.11

0.52

3.2

2.5

66.15

65.92

g/l

0.11

116

1137

Chromophobe cell carcinoma of kidney

127

1.38

0.52

2.6

2.5

67.91

66.34

g/l

0.35

114

Intracerebral haemorrhage

419

3976

1.06

0.52

2.3

2.5

65.17

65.97

g/l

1.21

370

3497

Sequelae of inflammatory diseases of the central nervous system

1.54

0.51

4.3

3.7

62.72

67.64

g/l

—

Postpartum haemorrhage due to anatomy

141

1284

1.10

0.51

1.9

2.1

68.02

67.68

g/l

0.22

131

1204

Failed induction of labour

696

1.14

0.51

1.8

66.73

68.04

g/l

1.09

647

Personality and behavioural disorders due to brain disease, damage and dysfunction

334

1.21

0.51

2.7

2.8

66.10

66.56

g/l

0.13

309

Distal bite

469

1.17

0.51

3.6

2.5

66.72

67.21

g/l

0.19

440

Benign neoplasm: Cranial nerves

623

1.15

0.51

3.5

1.6

65.45

67.21

g/l

0.85

564

Polypectomy (DHB20)

197

1826

1.09

0.50

2.4

2.7

66.50

66.56

g/l

0.04

182

1686

Toxic encephalopathy

1.58

0.50

1.3

1.6

63.83

66.65

g/l

—

Crowding of teeth, including avohilmo

128

958

1.11

0.50

3.3

2.4

65.99

67.49

g/l

1.32

122

906

Neuralgic amyotrophy

1.55

0.49

8.9

3.0

65.74

66.52

g/l

—

Inhalation and ingestion of food causing obstruction of respiratory tract

208

1.27

0.49

3.3

2.8

68.84

66.22

g/l

0.86

190

Prophylactic surgery

109

0.63

0.49

2.3

2.1

62.74

69.10

g/l

—

103

Alzheimer’s disease (Atypical or mixed)

270

2865

0.93

0.49

2.2

64.19

65.37

g/l

1.38

212

2471

Congenital musculoskeletal deformities of head, face, spine and chest

181

1.28

0.49

1.7

2.8

69.50

65.50

g/l

2.33

171

Vascular dementia (multiple infarctions)

343

0.81

0.48

2.5

2.4

63.70

65.21

g/l

0.50

307

Cyst of Bartholin Gland

749

1.13

0.47

2.3

2.5

65.44

67.36

g/l

1.22

695

Postpolio syndrome

1.47

0.47

9.6

3.8

62.71

64.84

g/l

—

Use of selegiline

149

1371

1.10

0.47

1.9

2.7

66.04

66.30

g/l

0.16

119

1247

Exposure to excessive natural heat

1.47

0.47

2.4

2.9

62.33

66.38

g/l

—

HSIL lesion of the vagina

273

1.22

0.47

3.2

2.8

68.79

67.79

g/l

0.31

253

Benign neoplasm: Larynx

826

1.12

0.47

2.3

2.7

66.48

66.37

g/l

0.05

753

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.46

0.47

1.1

3.3

64.41

68.38

g/l

—

Hyperfunction of pituitary gland, other and/or unspecified

1.45

0.47

9.0

2.7

67.83

67.31

g/l

—

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

147

1.32

0.47

5.5

1.4

65.54

68.00

g/l

1.32

134

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

255

1.23

0.46

2.8

2.9

66.64

67.23

g/l

0.16

239

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

543

1.15

0.46

1.6

2.4

66.72

67.21

g/l

0.19

501

Other benign neoplasms of uterus

174

1614

1.09

0.46

3.2

2.4

65.92

66.21

g/l

0.16

139

1413

Obstructive hydrocephalus

349

1.19

0.45

1.4

3.1

69.64

66.51

g/l

1.75

313

Postpartum haemorrhage

424

3869

0.95

0.45

2.2

2.3

67.59

67.26

g/l

0.42

393

3598

Other specified/unspecified disorders of middle ear and mastoid

1.50

0.44

2.3

1.4

72.19

65.66

g/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

368

1.18

0.44

2.7

2.9

66.88

67.06

g/l

0.05

330

Hip and thigh

1.47

0.44

4.6

1.9

64.40

65.44

g/l

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.62

0.43

2.3

2.9

64.03

66.22

g/l

—

Malignant neoplasm of trachea

0.00

0.43

0.0

2.6

—

66.23

—

Calcaneal spur

267

1.21

0.43

3.4

2.9

66.27

67.28

g/l

0.32

242

Chronic suppurative otitis media, including avohilmo

211

1976

1.07

0.43

2.0

2.7

67.03

66.57

g/l

0.38

193

1807

Brain glioblastoma and astrocytoma

380

0.83

0.42

1.8

3.4

64.90

67.02

g/l

0.66

347

Malignant neoplasm of other and unspecified major salivary glands

1.41

0.42

1.9

2.5

66.44

66.14

g/l

0.06

Osteitis due to dental implant

159

1.29

0.42

5.9

2.9

66.06

66.32

g/l

0.05

143

Problems related to social environment

586

1.13

0.41

2.9

2.5

66.85

66.30

g/l

0.28

528

Glanders and melioidosis

0.00

0.41

0.0

1.6

—

65.98

—

Maternal care for known or suspected fetal abnormality and damage

246

2061

1.06

0.41

1.7

2.1

67.37

67.80

g/l

0.49

234

1929

Knuckle pads

1.51

0.41

1.0

5.1

69.70

68.62

g/l

—

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

104

0.66

0.41

1.1

1.6

64.49

67.23

g/l

—

Other respiratory conditions originating in the perinatal period

0.00

0.41

0.0

6.4

—

58.56

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

886

0.90

0.40

3.1

2.8

64.93

66.04

g/l

0.64

789

Colorectal cancer

793

8177

0.97

0.40

2.5

65.08

66.08

g/l

2.80

707

7283

Laparoscopic left hemicolectomy

457

1.15

0.40

2.3

2.8

65.31

66.70

g/l

0.54

413

Other inflammation of vagina/vulva

569

1.13

0.40

1.2

2.5

67.91

67.67

g/l

0.12

538

Medical treatment for female infertility

341

3240

1.05

0.40

1.9

2.1

67.44

67.56

g/l

0.11

322

3023

Abnormalities of forces of labour

193

1809

1.07

0.39

2.0

2.3

68.87

67.66

g/l

1.61

175

1706

Open wound of neck

142

1.28

0.39

1.4

2.8

67.39

67.20

g/l

0.04

135

Other protozoal intestinal diseases

270

1.20

0.39

2.1

2.5

66.32

66.97

g/l

0.22

249

Toxic effect of other noxious substances eaten as food

1.39

0.39

2.6

2.9

68.70

66.97

g/l

—

Normal-pressure hydrocephalus

168

1571

1.08

0.39

2.4

2.6

67.40

65.97

g/l

1.76

150

1408

Single delivery by caesarean section

322

1958

0.95

0.39

2.0

1.9

66.73

67.36

g/l

0.80

306

1827

Occupant of special vehicle mainly used on industrial premises injured in transport accident

1.35

0.39

1.8

3.1

69.26

67.35

g/l

0.18

Any dementia, excluding more controls

1396

9467

1.03

0.39

2.0

2.6

65.05

65.90

g/l

3.47

1147

8462

Small plaque parapsoriasis

1.43

0.38

4.2

2.8

69.03

66.25

g/l

—

Bradycardia, unspecified, drug-induced

1.43

0.38

1.3

3.0

65.54

66.06

g/l

—

Exposure to excessive heat of man-made origin

170

1.26

0.38

2.8

3.0

65.48

66.35

g/l

0.18

152

Malignant neoplasm of nasal cavity and sinuses

152

1.27

0.38

4.5

2.3

65.62

66.46

g/l

0.21

137

Unspecified renal colic

134

1.29

0.38

1.7

2.5

65.29

66.56

g/l

0.27

125

Other disorders of amniotic fluid and membranes

217

2027

1.06

0.37

2.3

2.0

67.29

67.71

g/l

0.51

202

1892

Premenstrual syndrome

152

1.26

0.37

1.2

2.5

69.07

67.90

g/l

0.37

143

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

156

0.75

0.37

2.9

4.0

61.13

62.99

g/l

0.27

149

Contact with other specified venomous animals

146

0.74

0.37

1.4

2.5

66.50

67.03

g/l

0.10

134

Inguinal of femoral hernia, unilateral

688

1.11

0.37

2.3

2.5

66.16

66.51

g/l

0.18

636

Femoral hernia, unilateral

688

1.11

0.37

2.3

2.5

66.16

66.51

g/l

0.18

636

Inguinal hernia, unilateral

688

1.11

0.37

2.3

2.5

66.16

66.51

g/l

0.18

636

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

385

3693

1.05

0.36

3.1

2.6

66.46

66.63

g/l

0.16

344

3388

Injury of blood vessels at hip and thigh level

1.41

0.36

2.1

2.9

64.12

66.74

g/l

—

Malignant neoplasm of brain

742

0.90

0.35

2.9

2.8

65.49

66.68

g/l

0.46

682

Persons encountering health services in circumstances related to reproduction

1538

10638

0.98

0.35

2.6

2.5

67.07

67.03

g/l

0.09

1433

9897

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

208

2199

0.94

0.35

2.1

1.6

64.16

66.55

g/l

3.92

189

1940

Cleft lip

1.38

0.35

3.5

3.2

63.60

67.15

g/l

—

Twin gestation

148

1383

1.07

0.35

2.4

2.2

66.89

67.71

g/l

0.81

142

1298

Corneal degeneration

359

1.15

0.34

1.4

2.7

65.62

67.05

g/l

0.45

322

Traumatic amputation of wrist and hand

103

1115

0.92

0.34

1.9

2.7

66.78

66.43

g/l

0.20

1031

Colon adenocarcinoma

374

3893

0.96

0.34

2.5

65.14

65.96

g/l

1.10

329

3481

Other cestode infections

0.67

0.34

6.3

3.1

65.10

66.34

g/l

—

Gastric ulcer - Acute with haemorrhage, drug-induced

1.33

0.34

2.3

2.1

65.93

66.91

g/l

—

Toxic effect of contact with venomous animals

874

1.09

0.34

2.7

2.8

68.00

66.70

g/l

0.90

800

Benign leiomyoma with endometriosis

486

4693

1.04

0.34

2.6

2.5

66.08

66.40

g/l

0.41

433

4215

Traumatic amputation of ankle and foot

1.33

0.34

1.7

3.2

64.03

67.62

g/l

—

Malignant neoplasm of colon

507

4901

1.04

0.33

2.4

2.6

65.25

66.00

g/l

1.23

451

4368

Uterine polyps

255

2430

1.05

0.33

2.6

2.5

66.93

66.47

g/l

0.53

239

2212

Pedestrian injured in collision with pedal cycle

732

1.10

0.32

2.1

2.8

66.50

66.69

g/l

0.09

667

Carcinoma in situ of other and unspecified sites

113

1052

1.08

0.32

2.6

2.8

65.99

66.16

g/l

0.09

101

961

Schizophrenia

385

3998

0.96

0.31

2.1

2.6

65.10

66.94

g/l

4.41

342

3713

Deep bite that required surgery

197

0.81

0.31

1.6

2.2

71.76

68.21

g/l

2.68

185

Drowning and submersion while in natural water

106

0.74

0.30

1.4

2.6

66.35

66.46

g/l

—

Benign neoplasm: Brain, infratentorial

108

0.73

0.29

1.3

1.8

64.83

67.11

g/l

—

100

Erosion and ectropion of cervix uteri

727

1.09

0.29

2.6

2.3

66.12

66.14

g/l

0.01

656

Other specified/unspecified diseases of inner ear

112

1.27

0.29

2.7

2.1

66.12

65.80

g/l

0.07

Supervision of normal pregnancy

369

2190

0.96

0.29

2.1

2.2

68.19

67.73

g/l

0.70

348

2047

Calculus of lower urinary tract

168

1592

1.06

0.29

2.1

2.6

66.78

66.23

g/l

0.34

150

1455

Multiple gestation

151

1427

1.06

0.28

2.4

2.2

66.88

67.67

g/l

0.78

145

1340

Rheumatic fever with heart involvement

113

1.26

0.27

11.9

3.3

64.22

66.56

g/l

0.44

103

Childhood allergy (age < 16)

167

1303

1.06

0.27

1.4

2.0

66.85

67.42

g/l

0.40

157

1236

Toxic effect of other gases, fumes and vapours

104

1.27

0.27

1.6

3.4

66.32

67.13

g/l

0.11

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

1.33

0.27

4.7

2.2

68.11

65.79

g/l

—

Congenital malformations of oesophagus

1.28

0.27

2.1

2.7

67.63

65.24

g/l

0.47

Small cell lung cancer

664

1.09

0.27

1.4

2.8

65.56

65.76

g/l

0.08

590

Small cell lung cancer, helper endpoint

664

1.09

0.27

1.4

2.8

65.56

65.76

g/l

0.08

590

Antenatal screening

419

2283

1.03

0.26

2.1

2.2

67.82

67.71

g/l

0.12

402

2135

Qualitative platelet defects

1.25

0.26

1.3

2.8

67.10

66.12

g/l

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

112

1052

1.07

0.26

3.6

1.6

65.22

67.16

g/l

1.47

100

953

Benign neoplasm of thyroid gland

840

1.08

0.25

2.5

2.8

68.52

66.86

g/l

1.40

762

Other complications of labour and delivery, not elsewhere classified

132

1345

0.94

0.25

2.0

1.7

68.13

68.11

g/l

0.01

118

1251

Injury of muscle and tendon at wrist and hand level

373

3613

1.03

0.25

2.9

2.6

67.07

66.64

g/l

0.53

351

3344

Dyshidrosis [pompholyx]

283

1.14

0.25

2.3

2.9

67.64

67.03

g/l

0.15

262

Rheumatic fever without mention of heart involvement

0.73

0.25

1.2

2.4

64.07

66.54

g/l

—

Carcinoma in situ of other and unspecified genital organs

417

1.11

0.25

1.9

3.0

63.09

67.47

g/l

1.91

380

Benign neoplasm: Renal pelvis

1.39

0.24

1.6

1.3

68.40

66.73

g/l

—

Non-small cell lung cancer, squamous

139

1464

0.95

0.24

1.7

2.6

65.64

65.73

g/l

0.04

128

1309

Non-small cell lung cancer, squamous, helper endpoint

139

1464

0.95

0.24

1.7

2.6

65.64

65.73

g/l

0.04

128

1309

Benign neoplasm: Renal pelvis

1.35

0.24

1.6

3.3

68.40

67.86

g/l

—

Malignant neoplasm of nasal cavity and middle ear

106

1.25

0.24

4.9

2.5

63.85

66.48

g/l

0.67

Chronic suppurative otitis media

176

1681

1.05

0.24

1.9

2.6

66.81

66.47

g/l

0.23

161

1529

Contact with other sharp object(s)

116

1228

0.94

0.24

2.0

2.6

66.71

67.24

g/l

0.34

110

1148

Retained placenta and membranes, without haemorrhage

281

2713

1.04

0.23

2.6

2.4

67.08

67.04

g/l

0.03

259

2497

Other abnormal products of conception

609

3961

1.03

0.23

2.0

2.3

67.70

67.47

g/l

0.36

574

3703

Hypertrophy of breast

405

3936

1.03

0.23

2.0

2.4

66.77

66.99

g/l

0.25

372

3615

Other noninflammatory disorders of cervix uteri

140

1332

1.06

0.23

2.9

2.4

65.83

66.20

g/l

0.22

121

1183

Circumscribed brain atrophy

545

0.91

0.23

1.5

3.1

65.86

65.80

g/l

0.02

493

Malignant neoplasm of floor of mouth

124

0.79

0.22

1.3

3.1

63.70

67.15

g/l

—

112

Carcinoma in situ of other/unspecified female genital organs

0.00

0.22

0.0

1.2

—

66.56

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.22

0.0

1.9

—

68.65

—

Ototoxic hearing loss

1.21

0.22

15.0

2.4

63.26

64.79

g/l

—

Other specified air transport accidents

0.00

0.22

0.0

1.1

—

66.95

—

Malignant neoplasm of larynx

419

0.90

0.22

2.2

2.8

66.25

66.24

g/l

0.00

380

Exposure to vibration

0.00

0.22

0.0

5.0

—

66.17

—

Carcinoma in situ of breast, intraductal

234

2257

1.04

0.21

2.2

2.6

66.69

66.60

g/l

0.06

209

2037

Congenital malformations of eye, ear, face and neck

129

1227

1.05

0.21

3.0

2.7

67.43

66.96

g/l

0.24

116

1140

Niacin deficiency [pellagra]

0.00

0.21

0.0

2.4

—

67.29

—

Deaf mutism, not elsewhere classified

111

0.80

0.20

2.2

68.01

67.01

g/l

—

105

Otosclerosis

213

2208

0.96

0.20

2.1

2.9

66.30

66.48

g/l

0.13

187

2021

Frontotemporal dementia

146

1.18

0.20

2.1

2.8

67.34

66.53

g/l

—

132

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

171

1779

0.96

0.20

2.7

66.25

66.64

g/l

0.31

157

1635

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

685

1.07

0.19

3.5

1.6

63.25

66.85

g/l

2.94

615

Other congenital malformations of face and neck

520

1.08

0.19

2.0

2.6

66.80

67.16

g/l

0.12

481

Postpartum haemorrhage due to retained placenta

179

1860

0.96

0.19

2.0

2.1

68.01

67.60

g/l

0.28

162

1734

Glaucoma secondary to eye trauma

164

0.84

0.19

3.5

2.8

64.84

66.51

g/l

0.58

145

Carcinoma in situ, bladder

102

970

1.06

0.19

2.8

2.9

65.87

66.00

g/l

0.07

889

Prolapse and hernia of ovary and fallopian tube

127

1203

1.05

0.18

2.1

2.2

65.48

65.26

g/l

0.13

108

1011

Caught, crushed, jammed or pinched in or between objects

101

960

1.05

0.18

1.4

2.6

66.19

66.73

g/l

0.30

892

Postpartum care and examination

210

1293

1.04

0.18

2.1

2.0

66.75

68.17

g/l

2.17

201

1203

Malignant neoplasm of digestive organs

1452

14121

1.01

0.18

2.4

2.6

64.28

66.21

g/l

14.43

1305

12636

Carcinoma in situ of cervix uteri

156

1501

1.04

0.17

2.3

66.67

67.20

g/l

0.46

142

1387

Dental caries 1 and operation codes, only avohilmo

1024

5073

1.02

0.17

2.5

3.1

66.90

66.26

g/l

1.88

939

4685

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

106

1110

0.95

0.17

3.0

2.9

67.18

66.83

g/l

0.20

1018

Malignant neoplasm of rectosigmoid junction

412

0.92

0.17

3.8

3.0

64.48

66.20

g/l

0.52

371

Other congenital malformations of female genitalia

101

1.19

0.17

2.3

2.6

67.28

67.01

g/l

0.05

Ill-defined and unknown causes of mortality

200

2064

0.97

0.16

2.3

2.5

64.49

65.84

g/l

1.62

179

1856

Mucinous and mucinous cystic tumor

1.21

0.16

8.4

2.5

65.93

66.87

g/l

0.26

Lesion of plantar nerve

171

1653

1.04

0.16

2.2

2.7

66.67

66.45

g/l

0.14

149

1501

Other abortion

151

0.86

0.16

1.4

2.3

65.64

67.01

g/l

0.17

138

Cleft lip and cleft lip and palate

111

1.18

0.16

2.5

2.6

64.26

67.12

g/l

0.90

105

Respiratory tuberculosis, not confirmed

128

1231

1.04

0.16

2.6

2.7

65.84

66.01

g/l

0.09

114

1102

Chondrosarcoma

1.14

0.15

2.2

2.9

64.36

66.08

g/l

—

Dental caries 3 and operation codes, only avohilmo

1161

5760

1.01

0.15

2.5

3.0

66.87

66.41

g/l

1.31

1072

5315

Benign neoplasm: Vulva

513

0.93

0.15

2.8

65.33

67.08

g/l

0.62

467

Habitual aborter

224

0.89

0.15

4.4

2.2

64.84

68.25

g/l

0.99

211

Complications following myocardial infarction

207

1.12

0.15

1.6

2.3

66.37

65.54

g/l

0.23

176

Unspecified abortion

106

1016

1.05

0.15

1.7

2.7

67.29

67.31

g/l

0.01

948

Postprocedural disorders of ear and mastoid process, not elsewhere classified

212

0.89

0.14

1.3

2.5

62.46

66.28

g/l

1.22

188

Use of levodopa decarbox-comt-inhibitor

939

0.95

0.14

1.2

2.9

65.39

66.17

g/l

0.50

852

Dementia

1673

11650

0.99

0.13

2.0

2.6

65.25

65.91

g/l

2.71

1376

10412

Use of amantadine

374

1.07

0.13

2.0

2.5

66.35

67.07

g/l

0.37

340

Benign neoplasm: Vulva

452

1.07

0.13

2.8

1.4

65.33

67.33

g/l

0.74

408

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

273

2670

1.02

0.13

2.7

1.6

64.32

66.70

g/l

4.46

244

2365

Other disorders affecting eyelid function

200

0.89

0.13

2.2

2.6

66.08

66.56

g/l

0.14

181

Ankyloglossia

151

1.13

0.13

4.6

3.2

64.71

64.48

g/l

0.04

143

Seminoma of testis

171

1.12

0.12

1.9

2.8

64.52

67.14

g/l

0.78

158

Oral leukoplakia, including avohilmo

699

1.05

0.12

3.3

2.7

67.45

66.78

g/l

0.34

642

Carcinoma in situ of prostate

163

1.12

0.11

2.6

3.0

68.91

65.86

g/l

0.88

145

Benign neoplasm: Cranial nerves

740

0.96

0.11

3.5

2.9

65.45

66.75

g/l

0.56

670

Noise effects on inner ear

101

1044

0.97

0.11

2.0

2.8

65.81

66.36

g/l

0.28

971

Defect, injury or illness of neck

1.16

0.09

1.5

2.2

67.01

66.77

g/l

—

Inflammation of lacrimal passages (chronic)

419

1.05

0.09

1.7

2.7

67.49

66.65

g/l

0.35

372

Eccrine sweat disorders

1.12

0.09

1.3

3.4

70.90

67.65

g/l

—

Open bite that required surgery (Lefort1 or BSSRO)

126

1.12

0.09

1.1

2.0

68.93

67.67

g/l

0.49

117

Contact with machinery

303

3076

0.98

0.09

3.0

2.6

66.35

66.51

g/l

0.13

276

2835

Benign neoplasm: Short bones of lower limb

206

0.92

0.09

5.7

3.0

64.72

67.45

g/l

0.66

189

Malignant neoplasm of gallbladder

113

0.88

0.08

2.1

2.6

65.70

65.27

g/l

—

100

Benign neoplasm: Connective and other soft tissue of abdomen

1.04

0.08

2.8

1.9

61.18

67.32

g/l

—

Explosion of other materials

0.82

0.08

2.0

2.8

64.12

65.68

g/l

—

Choroidal haemorrhage and rupture

1.10

0.08

2.8

2.9

63.19

66.10

g/l

—

Recurrent cholesteatoma of postmastoidectomy cavity

1.07

0.07

1.0

1.7

62.04

66.49

g/l

—

Persistent delusional disorders

192

1953

0.98

0.07

2.8

2.6

65.49

66.39

g/l

0.87

174

1784

Injury of muscle and tendon at ankle and foot level

481

1.04

0.07

2.3

3.0

67.54

67.13

g/l

0.12

440

Melanocytic naevi of other and unspecified parts of face

138

1352

1.02

0.07

2.8

2.7

67.43

66.65

g/l

0.61

129

1235

Congenital lens malformations

0.87

0.07

4.3

2.3

64.09

65.35

g/l

—

Chloasma

1.08

0.07

1.0

2.8

69.34

66.96

g/l

—

Dementia, including avohilmo

1821

12500

1.01

0.07

2.0

2.6

65.40

65.94

g/l

2.03

1502

11186

Moderate visual impairment, monocular

0.88

0.07

1.4

2.7

71.76

67.23

g/l

—

Other obstructed labour

150

1528

0.98

0.07

2.5

67.23

g/l

0.00

137

1418

Cleft lip and palate

0.87

0.07

1.6

2.3

65.36

68.01

g/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1182

9340

0.99

0.07

2.4

66.82

66.94

g/l

0.22

1078

8535

False labour

532

3314

1.01

0.06

2.2

67.93

67.61

g/l

0.55

498

3098

Frontotemporal dementia, wide, incl. Pick's disease

168

1.08

0.06

2.1

2.7

67.22

66.63

g/l

0.13

153

Other ill-defined and unspecified causes of mortality

185

1824

1.02

0.06

2.2

2.5

64.37

65.92

g/l

1.84

166

1641

Pedal cyclist injured in collision with motor vehicle

627

0.97

0.05

1.7

2.8

67.22

67.07

g/l

0.06

576

Mandibular retrognathia

109

1107

0.98

0.05

3.8

2.6

67.33

67.25

g/l

0.04

103

1044

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

307

1.04

0.05

1.8

1.7

64.90

67.79

g/l

1.00

277

Intentional self-harm by hanging, strangulation and suffocation

120

0.91

0.05

1.1

3.3

70.08

67.77

g/l

0.27

108

Postpartum hemorraghe, parous women as controls

424

3739

0.99

0.04

2.2

2.3

67.59

67.32

g/l

0.32

393

3486

Benign neoplasm of other and unspecified female genital organs

110

1118

0.98

0.04

2.8

2.6

66.18

66.78

g/l

0.33

1008

Burn and corrosion of shoulder and upper limb, except wrist and hand

403

0.97

0.04

3.6

3.1

65.44

66.87

g/l

0.46

366

Maternal care for cervical incompetence

856

1.02

0.03

4.0

2.8

66.18

66.97

g/l

0.54

780

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

279

2769

1.01

0.03

2.6

1.6

64.37

66.71

g/l

4.46

250

2453

LSIL lesion of the cervix uteri

195

1933

1.01

0.03

2.7

2.4

66.53

67.51

g/l

0.97

176

1795

Benign neoplasm: Short bones of lower limb

181

1.05

0.03

5.7

1.8

64.72

67.88

g/l

0.80

163

Impacted maxillary canine

108

0.92

0.03

1.9

2.4

69.49

64.52

g/l

—

102

Benign neoplasm: Retina

118

0.93

0.03

2.3

2.5

66.13

66.65

g/l

0.10

106

Maternal care for other known or suspected fetal problems

369

2355

1.01

0.02

1.6

2.0

67.55

67.83

g/l

0.31

349

2203

Ectopic pregnancy

392

3938

1.00

0.02

2.1

2.7

67.29

66.97

g/l

0.46

353

3657

Other maternal disorders predominantly related to pregnancy

1470

9259

1.00

0.02

2.4

2.5

66.91

66.98

g/l

0.14

1352

8512

Acquired stenosis of external ear canal

232

1.04

0.02

2.1

2.8

65.33

66.22

g/l

0.29

215

Foreign body on external eye

373

3745

1.00

0.02

3.1

2.6

67.26

66.78

g/l

0.61

348

3497

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

103

1.07

0.02

1.8

2.2

68.05

66.18

g/l

0.53

Malignant neoplasm of eye, brain and central nervous system

103

1020

1.01

0.02

3.9

2.7

65.27

66.37

g/l

0.57

934

Abnormal findings on antenatal screening of mother

929

0.99

0.01

2.0

1.9

67.25

68.10

g/l

0.45

867

Dementia due to Parkinson's disease

668

0.99

0.01

1.5

2.8

64.84

65.76

g/l

0.35

591

Malignant neoplasm of breast, HER-negative

635

6331

1.00

0.01

2.6

65.35

66.31

g/l

2.21

567

5634

Left side

126

0.95

0.00

1.5

2.8

69.33

66.28

g/l

0.82

119

Postpartum hemorraghe, all women as controls

424

4228

1.00

0.00

2.2

67.59

67.39

g/l

0.22

393

3940

Cholesteatoma of middle ear

149

1489

1.00

0.00

2.2

2.6

66.21

66.23

g/l

0.01

137

1354

Motorcycle rider injured in other and unspecified transport accidents

100

1004

1.00

0.00

1.9

2.5

66.18

67.34

g/l

1.21

944

Carcinoma in situ of breast

101

0.99

0.00

1.4

1.5

67.61

68.20

g/l

—

Carcinoma in situ of breast, lobular

169

1.01

0.00

4.1

2.5

67.60

67.32

g/l

0.04

156

Benign neoplasm: Retina

107

1.03

0.00

2.3

1.3

66.13

67.47

g/l

0.29

Other congenital malformations of tongue, mouth and pharynx

159

1.00

0.00

4.8

2.8

64.46

65.48

g/l

0.19

148

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

243

0.99

0.00

2.5

1.7

65.46

66.93

g/l

0.44

211

Thyrotoxicosis with toxic single thyroid nodule

185

0.97

0.00

2.9

2.4

68.25

67.43

g/l

0.19

166

Other specified and unspecified disorders of lens

265

1.02

0.00

3.0

2.6

65.17

65.80

g/l

0.19

241

Carcinoma in situ of breast, lobular

165

1.03

0.00

4.1

1.5

67.60

68.21

g/l

0.09

149

Anthrax

0.00

0.0

2.8

—

66.36

—

Handgun discharge, undetermined intent

0.00

0.0

6.4

—

64.57

—

Enophthalmos

0.00

0.0

8.8

—

67.97

—

Psoriatic arthropathies, strict definition

0.00

0.0

12.6

—

66.63

—

Systemic sclerosis induced by drugs and chemicals

0.00

0.0

1.6

—

67.40

—

Leukoderma, not elsewhere classified

0.00

0.0

1.4

—

66.32

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.0

1.2

—

69.50

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.93

0.00

2.8

1.3

61.18

67.43

g/l

—

Status migrainosus, drug-induced

0.00

0.0

10.8

—

67.70

—

Malignant neoplasm of placenta

0.00

0.0

9.8

—

64.56

—

Monkeypox

0.00

0.0

1.3

—

63.35

—

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

0.0

1.3

—

70.26

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.0

4.7

—

68.68

—

Gottron papules

0.00

0.0

1.0

—

68.76

—

Smallpox

0.00

0.0

1.1

—

66.81

—

Androgen resistance syndrome

0.00

0.0

12.4

—

64.17

—

Down's syndrome

1.00

0.00

5.8

3.4

67.14

66.30

g/l

—

Murder, homicide, or other assault by handgun discharge

0.00

0.0

9.6

—

70.61

—

Peutz-Jeghers syndrome

0.00

0.0

1.0

—

68.06

—

Exposure to unspecified type of radiation

0.00

0.0

1.0

—

66.43

—

Pedal cyclist injured in collision with train or tram

0.00

0.0

1.0

—

63.50

—

Infliximab

0.95

0.00

2.2

2.8

69.68

68.03

g/l

—

Carcinoma in situ of breast

100

1.00

0.00

1.4

2.6

67.61

67.49

g/l

—

Operations of war

0.00

0.0

5.7

—

65.32

—

Familial erythrocytosis

0.93

0.00

2.8

67.58

67.50

g/l

—

Hereditary factor IX deficiency

0.00

0.0

1.1

—

65.36

—

Corneal pigmentations and deposits

0.97

0.00

1.1

3.0

69.70

66.03

g/l

—

Benign neoplasm: Respiratory system, unspecified

0.94

0.00

1.2

1.9

72.02

67.27

g/l

—

Relapsing panniculitis [Weber-Christian]

0.00

-0.00

0.0

1.8

—

64.95

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS